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Abstract
Molecular scaffolds work to dynamically assemble signal transduction pathways in 
certain cellular locations at the precise physiological time required. Scaffold 
proteins often contain multiple binding domains that allow more than one partner at 
once, helping to assemble a biochemical pathway or protein network. This thesis 
aims to characterise two such scaffold proteins.
The first is a major scaffold protein, Synapse Associated Protein 97 (SAP97) that 
facilitates the clustering of potassium and glutamate channels to the post synaptic 
density. SAP97 contains multiple domains all joined by unique unstructured linker 
domains that are thought to provide flexibility within the protein and have proved 
problematic in previous attempts to crystallise the protein.
Three large multiple domain SAP97 constructs, A546, A461 and A70 were 
expressed and purified. These were then characterised using SAXS, SEC-MALLS, 
and NMR. SAXS studies demonstrated that SAP97 constructs existed in an 
ensemble of forms in dynamic equilibrium. Two dominant populations of an 
extended and compact form were discovered, propagated through the long 
unstructured linker regions between the PDZ domains. Subsequent NMR confirmed 
that the PDZ domains were mobile and were not influencing the GK-SH3 domain. 
The second scaffold, A-Kinase Anchoring Proteins 79 (AKAP79) that mediates 
phosphorylation through PKA at the plasma membrane was also characterised using 
several biophysical techniques. Full length AKAP79 which is notoriously difficult 
to work with was successfully cloned, expressed and purified and using NMR 
found to be unstructured. The AKAP79 calmodulin binding domain, a short 20 
amino acid peptide with a 1-11 CaM binding motif was also cloned, expressed and 
purified and was shown to bind with calmodulin in which both their N-and C- 
domains are involved.
The interactions between SAP97 and AKAP79 were investigated. The central 
domain of AKAP79 that has previously been shown to interact with SAP97 was 
cloned, expressed and purified using a novel process of Ligation Independent 
Cloning. However, central domain was shown not to bind to SAP97 under the 
conditions used with NMR and ITC.
These new data help to further the understanding of the nature of scaffold proteins 
SAP97 and AKAP79 and then* interactions with other proteins.
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CHAPTER 1
INTRODUCTION
1.0 Introduction
In the body cells are constantly communicating with each other, passing messages 
between each other, recognising them, interpreting them and responding to them. 
These messages from external stimuli are often simple chemicals or more complex 
hormones and the message earned is relayed from the cell surface to specific 
intracellular targets via protein - protein interactions that has been likened to a 
complex biochemical circuit (Harris and Lim, 2001). These signal transduction 
pathways are still not fully understood but a mechanism to organise and localise all 
the specific proteins must occur. This is cun'ently thought to be achieved by one of 
two mechanisms, either bringing together active signalling molecules into a 
multiple protein network or by activating dormant enzymes (signalling molecules) 
that are held in position close to their substrates (Pawson and Scott, 1997). The 
proteins charged with the task of fixing in position and aligning the network are 
often termed the scaffold.
The work described in this thesis highlights a small part of a protein network that 
closely follows the second network conditions above. An ion channel, the 
potassium inward rectifier is held in position and activated by a complex network of 
protein-protein interactions. The main proteins involved that will be studied in some 
detail are SAP97, AKAP79, Calmodulin, and KIR2.1. Each of these will be 
discussed in the following sections along with descriptions of scaffold proteins.
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1.0.1 Scaffolding, Adaptor and Anchoring Proteins
When constructing a house a scaffold is required to provide support and to allow the 
correct tools and materials to be assembled in the right order at the right time. The 
cellular machinery is no different. Molecular scaffolds work to dynamically 
assemble signal transduction pathways in certain cellular locations at the precise 
physiological time required. The scaffold has many functions; it controls the 
assembly of a multitude of protein and is involved with the trafficking and the 
subcellular location of protein networks (Welling, 2008).
The post synaptic density (PSD) of a cell is an electron dense area under the plasma 
membrane that contains receptors, scaffold proteins, signalling proteins such as 
kinases and phosphatases all linked to the actin cytoskeleton. The distribution, 
concentration and organisation of specific protein components are regulated by the 
scaffold proteins (Lisman et al., 2002). This is shown schematically in Figure 1.0 
that shows the role PDZ domains play in the pre and post synapse; localising the 
receptor to the membrane before tethering it and assembling a large molecular 
complex (Kim and Sheng, 1996; Kim and Sheng, 2004). Figure 1.0 also highlights 
the complexity of receptor networks that are created and rely upon the scaffold 
proteins to function.
One example of a scaffold is the protein SAP97 that facilitates the clustering of 
potassium channels to the post synaptic density (Doyle et al., 1996; Froehner, 1993; 
Kim and Sheng, 1996; Leonoudakis et al., 2001).
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Figure 1.0. A diagrammatic overview of the organization of PDZ proteins at a mammalian 
excitatory synapse. The schematic of known interactions of PDZ containing proteins at the 
glutamatergic synapse. The PDZ domains are indicated by purple circles within the scaffold proteins. 
As this is an overview of a known mechanism each individual protein in the diagram will not be 
discussed in detail (Kim and Sheng 2004).
Scaffold proteins often contain more than one binding domain. Commonly found 
domains are the src homology 2 (SH2) or src homology 3 (SH3) domains that can 
bind either short phosphopeptide motifs or proline rich peptide sequences, in the 
form PxxP, respectively. A further example is the PDZ domain which is discussed 
in more detail below (Pawson and Scott, 1997). These multiple binding domains 
gives the scaffold protein the ability to bind more than one partner at once, helping 
to assemble the biochemical pathway or protein network.
4
1.1 MAGUK Proteins
The Membrane Associated Guanylate Kinases (MAGUKs) are a major family of 
scaffold proteins. They are characterised by a catalytically inactive guanylate kinase 
like domain (GK) juxtaposed to a src homology 3 (SH3) domain and one, three or 
five PDZ domains. MAGUKs have been recognised in several species including 
mammals, drosophila and C. elegans. They are located primarily at the post 
synaptic density (PSD) and tight junctions in neurons although they can be found 
throughout many organs in the body. Major mammalian members include PSD- 
95/SAP90, PSD-93/chapsyn-l 10, SAP97 and SAP102, ZD-1-3, CASK, PALS-1-3, 
p55-l-7, Carma-1-3 and Magi-1-3 and Cap-subunit-1-4. Two of these are atypical 
MAGUKs, Magi substitute the SH3 domain for a WW domain and the Ca[3- 
subunit-1-4 contains an SH3-GK domain but without any PDZ domains and is 
located at the cytoplasmic C-terminal of a voltage-dependent calcium channel 
(Dobrosotskaya et al., 1997; Funke et al., 2005; Kornau et al., 1997; Opatowsky et 
al., 2004; Willott et al., 1993). Figure 1.1 is a schematic representation of some 
MAGUK proteins, highlighting the domain compositions.
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Figure 1.1. Schematic of mammalien MAGUK structures.Common MAGUKs and the domain 
configuration of each protein. The more unusual domains are L27, a mulitmerisation domain 
(discussed below), CaMK, calcium-calmodulin kinase, CARD, caspase recuitment domain and WW 
a double tryptophan motif. The Ca(i subunit of the voltage gated ion channel, CaV is also included 
though not technically a MAGUK protein (Adapted from Funke et al 2005)
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1.1.1 Roles of MAGUKs
The plethora of binding domains found in the MAGUKs makes them 
multifunctional. At epithelial tight junctions, ZO-1 acts dynamically to assemble 
and regulate the cell boundaries. This is achieved by the simultaneous anchoring of 
the cytoskeleton to the tight junction, binding the filamentous actin directly and 
indirectly through binding to a-catenin and cingulin. ZO-1. to 3 are also anchored to 
the tight junction membrane, the PDZ domains interact with the claudins and the 
GK domain to occludens, both trans membrane adhesion proteins creating a large 
complex (Shen et ah, 2008). MAGUKs are also instrumental in the clustering of ion 
channels and receptors together at the postsynaptic density. PSD95, has been shown 
to cluster the ion channel Kvl.4 (Kim and Sheng, 1996) and the major glutamic 
recptors, NMD A (Kornau et al., 1997), AMPA 2006 (Beique et al., 2006) and 
Kainate (Garner et al., 2000).
MAGUKs are also important in signal transduction pathways. Once PSD95 has 
clustered the NMDA receptor the secondary messenger, nNOS (Ca2+/calmodulin 
activated nitrogen oxide synthases) is localised at the NMDA receptor through 
interactions with the second PDZ domain of PSD95 (Brenman et al., 1996). With 
all the proteins in place localised increases in Ca may result m localised increases 
in nitric oxide that will open the NMDA receptor.
Much of the previous work on MAGUKs has focused on PSD95; in this work 
investigations will be carried out for the lesser studied close family member, 
SAP97.
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1.2. MAGUK Structure and Functions
To understand MAGUKs function firstly it is necessary to understand the function 
of all the constituent parts before looking at the whole. Outlined below will be the 
most common individual MAGUK domains but will, were possible concentrate on 
those from SAP97.
1.2.1 PDZ Domains
The PDZ domain is one of the most abundant proteins in the genome estimated to 
be found in over 250 different proteins and is involved in protein - protein 
interactions (Hung and Sheng, 2002). The term PDZ was derived from the first 
letters of the three original proteins in which it was discovered, PSD-95, Drosophila 
large Disc protein and protein ZO-1, all MAGUK proteins (Kennedy, 1995). 
Containing approximately 90 amino acids they were characterised by a Gly-Leu- 
Gly-Phe (GLGF) repeat found within its sequence (Cho et al., 1992), which when it 
was first solved (Cabral et al., 1996) was found to play a major role at the binding 
site, as a cradle within the binding loop, Figure 1.2 (Doyle et al., 1996).
8
Figure 1.2. Ribbon structure of PDZ 1 domain from SAP97. The GLGF motif is shown at the 
base of the binding cleft (in green). Adapted from Wang et al 2005.
The structure of the PDZ domain is well conserved in mammalian cells with 6 p- 
sheets (A - F) and 2 a-helices (A and B). Each PDZ domain contains a specific 
binding site or pocket formed by pB and aB with the aB running anti parallel to the 
PB sheet, figure 1.2. The loop that follows the pB-sheet contains the GLGF motif 
that is essential in stabilising the binding interaction (Doyle et al., 1996).
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The binding pocket was shown to have specificity for four C-terminal residues from 
the binding partner protein, with the basis of the specificity determined by the first 
residue in the j3B sheet and the second residue of the terminal peptide that forms the 
basis of the PDZ classification. Three general classes of PDZ domain have now 
been discovered; Class I domains, which recognize the carboxyl terminal motif S/T- 
X - ®, where X is any amino acid and O is a hydrophobic amino acid, Class II 
domains, which recognize the carboxyl-terminal motif X-<D -X- <D, and Class III 
domains, which recognize X-D/E-X- <I> as then* preferred carboxyl-terminal motif 
(Hung and Sheng, 2002). Only Class I domains are found in SAP97.
1.2.2 SH3-GK domains
Along with the PDZ domain the SH3-GK domains are present in all MAGUKs. 
Figure 1.3 shows a sequence alignment of various SH3-GK domain. The Src 
homology 3 or SH3 domain is a small protein - protein interaction domain that 
binds sequences rich in prolines favouring the PxxP core motif where x can be any 
amino acid (Li, 2005). However, in MAGUKs the SH3 domain rarely binds to 
proline rich motifs (Funke et al., 2005). The GK domain is homologous to the yeast 
guanylate kinase domain that catalyses GMP to GDP with ATP (Berger et al., 
1989) but in MAGUKs it is catalytically inactive possibly due to missing three 
amino acids in the ATP binding site (Lue et al., 1994).
The first structure of the SH3-GK domain was elucidated in PSD95 (McGee et al., 
2001; Tavares et al., 2001). The structure showed two unexpected features of the 
SH3-GK domain. Firstly, that the SH3-GK domains were intimately linked, with
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the SH3 domain being a split domain, its final P-sheet formed from the C-terminus 
polypeptide chain found beyond the GK domain (Figure 1.4). Secondly, the Hook 
region which connects the SH3 and GK domains forms part of the SH3 domain, 
with the Hook a-helix masking the usual site of protein — protein interaction on the 
SH3 binding domain. The latter feature explains the lack of interactions to proline- 
rich motifs (McGee et al., 2001).
Recently a crystal structure of the SH3-GK domains of ZO-1 was solved, Figure 
1.5. Initially they used the full domains but the crystals diffracted poorly so they 
removed the U5 Hook region that was poorly resolved in PSD95. They were then 
able to solve the structure and without the use of molecular replacement using 
PSD95. The resulting structure gave unbiased domain positions (Lye et al., 2010). 
The refined structure showed the SH3 and GK domains as separate units that were 
joined by a spilt domain as in PSD95. However, the two domains were more open 
in conformation than in PSD95. This was attributed to a cis-proline (P714) in PSD95 
that lies between the split domain (3-sheet and the last GK a-helix (aVI) and which 
is replaced by a glutamine in ZO-1 (Lye et al., 2010). Interestingly, the cis - proline 
is present in SAP97 suggesting a more closed conformation akin to PSD95.
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Figure 1.3: see next page for full description.
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Figure 1.3. Sequence alignment of the SH3, Hook and GK domains. Alignment of different 
proteins in the SWISS-PROT database using ClustalW2. Arrows and spirals depict areas of p-sheet 
and a-helix of PSD95 (McGee ct al., 2001). The GK domain is in green, SH3 magenta and Hook 
cyan, note the hook sequence is also cyan. * indicates conserved residues and red letters show PSD95 
P714 that is suspected to bring tire SH3 and GK domains closer together (Lye et al., 2010).
Figure 1.4. PSD95 SH3-GK Domains. The SH3 (magenta) and GK domains (green) of PSD-95 
share a P-sheet and the Hook (cyan) region contains an a-helix that separates structural components 
of the SH3 fold. The insert is a schematic representation of the SH3-GK module showing how the 
Hook divides the SH3 domain into two sub-domains. Adapted from (McGee et al., 2001).
In the ZO-1 structure the Hook region was truncated but using the poorly diffracted 
SH3-GK domain it was possible to show that the truncation did not affect the 
structural conformation. An unpublished structure of ZO-3 (3KFV) with intact 
Hook domain was deposited into the protein data bank (PDB). This also showed an 
open conformation about the spilt domain similar to ZO-1 and when overlaid with 
the PSD95 and ZO-1 it showed that the inter-domain angle of the Hook helix was 
variable through each conformation suggesting that the Hook regions variable
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length and angle in various different MAGUKS is related to its function (Lye et al.,
2010).
Figure 1.5. ZO-1 SH3-GK Domain. The SH3 (magenta) shows an open conformation in relation to 
the GK domain (green). The Hook (cyan) region is truncated, orange indicates the site of truncation.
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Hook
Figure 1.6. Calcium voltage channel, CaV (i-subunit-2a SH3-GK domain. The SIC (magenta) 
shows a long -helix at the amnio terminal end followed by part of the Hook (cyan) region and then 
GK domain (green).
Another crystal structure of an SH3-GK domain has been solved, that of voltage 
gated ion channel, CaV (3-subunit-2a (Opatowsky et ah, 2004). The structure 
showed an extra, long a-helix at the amino terminus, with smaller P-sheets and 
longer loop regions in the SH3 domain than when compared to PSD95 and ZO-1. 
The GK core domain was similar to PSD95 but its ability to bind small nucleotides 
was compromised. Unlike PSD95 and ZO-1 there was no split domain between the 
SH3 and GK domains and as a result the SH3-GK domains showed an even more 
open conformation and with the Hook region directed away from the GK domain, 
Figure 1.6.
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Table 1.0; MAGUK SH3-GK domain binding partners and locations
SH3-GK Domain
binding
Binding partner Location Reference
SAP97 AKAP79 SH3 (Colledge et al., 2000)
Calmodulin, CaM Hook (Paarmann et al., 2002)
GAKIN GK (Hanada etal., 2000)
GKAP GK (Wu et al., 2000)
Protein 4.1 Hook (Lue et al., 1994)
PSD95 AKAP79 SH3 (Colledge et al., 2000)
GAKIN GK (Hanada et al., 2000)
GKAP GK (Wu etal., 2000)
kainate SH3 and GK (Garcia etal., 1998)
ZO-1 a -Catenin SH3 and Hook (Muller et al., 2005)
Calmodulin, CaM GK (Paarmann et al., 2002)
Occludin GK and Hook (Schmidt et al., 2004)
ZONAB SH3 (Lye etal., 2010)
CaV p-subunit-2a AID-CaV a -subunit GK (Hidalgo and Neely, 2007)
Anhak SH3/GK (Buraei and Yang, 2010)
Ca2+activated
K+channel
GK (Buraei and Yang 2010)
Dynamin SH3 (Hidalgo and Neely 2007)
RIM1 SH3 Hook GK (Buraei and Yang 2010)
Zinc Transporter 1
(ZnT-l)
Unknown (Buraei and Yang 2010)
Several binding partners for the SH3-GK domains mentioned above have been 
identified and are shown in Table 1.0. Some of the large binding proteins such as 
occludin and a-catenin were shown to bind across two domains. While CaM which 
has been shown to bind to the Hook domain of SAP97, interacts with the GK 
domain in ZO-1. The SH3-GK domain of CaV p-subunit-2a interacts with the a-
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interaction domain (AID) from CaV, an oc-helical domain that binds tightly into a 
groove on GK. More recently interactions with several other binding partners have 
been discovered. These interactions are predominantly other ion channels including 
the Large-conductance Ca2+-activated K+ channel (BKCa), Zinc Transporter 1 
(ZnT-1) and Bestrophin, a retinal chloride channel. Binding of other proteins such 
as the large scaffolding protein, Anhak and the GTPase, dynamin have also been 
reported (Hidalgo and Neely 2007; Buraei and Yang 2010).
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1.2.3 L27 Domain
The L27 domain was first identified in the C. elegans Lin-2 and Lin-7 proteins 
before mammalian orthologs were found in MAGUK proteins SAP97, CASK and 
PALS (Doerks et ah, 2000). Studies of the L27 domain of SAP97 showed a 
propensity to form homomultimers (Nakagawa et ah, 2004). This was followed by 
NMR structures of L27 domain of SAP97 and the L27 domain of CASK that 
showed the formation of a heterotetramer, Figure 1.7 and identified the mechanism 
of formation; the individual L27 domains were found to exist in an unfolded state, 
only forming a-helices upon the formation of a heterodimer and subsequently the 
heterotetramer. What was also noted was that the a-helices of both SAP97 and 
CASK were very similar in structure even though the sequence similarity was only 
16% (Feng et ah, 2004). The mulitmerisation is thought to increase the clustering of 
SAP97 and CASK at the plasma membrane.
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SAP97
SAP97
Figure 1.7. L27 hetero-tetrameric complex in SAP97 and CASK. Top, shows the two S AP97 L27 
domains (magenta) interacting with the two CASK L27 domains (green). Bottom shows a proposed 
model for the polymerisation of SAP97 with CASK and a third protein MATS. The SAP97 L27 
binds with the first of the CASK L27 domains while the second CASK L27 domain binds to MALS 
forming a heterodimeric unit which then goes to form hetero-tetrameric interaction (shown by the 
dashed lines). Adapted from Feng et al 2004.
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1.3 SAP97
A principal member of the MAGUK family, synapse associated protein, SAP97 is 
localised to the cytoskeleton and expressed in many cell types including the heart 
and kidneys, but is found extensively at the synapses where it was first identified 
(Lue et al, 1994). SAP97 contains an L27, three PDZ and SH3-GK domains, all 
joined by unique unstructured linker domains named U1 - U5 that are thought to 
provide flexibility within the protein, Figure 1.8 (Wu et al., 2000). The U5 / Hook 
linker region has also been shown to contain several mRNA splice variants leading 
to different isoforms of SAP97 that are suggested to play a role in tissue specificity 
with the U5 14 isoform found only in brain and liver (McLaughlin et al., 2002). 
SAP97 is also known to have two sites of phosphorylation at Ser-29 in the L27 
domain and Ser-232 in the PDZ1 domain that are both known to be phosphorylated 
by calcium/calmodulin kinasell (CaMKII) that is suggested to play a role in 
trafficking the SAP97 to the plasma membrane (Mauceri et al., 2007).
Ul/N U2 U3 U4 Hook / U5
t i . *
L27 PDZ1) PDZ2) PDZ3) SH3 !
1-70 218-313 314-406 461-546 571-664 721-911
Figure 1.8. Schematic of SAP97 showing the locations of each domain. Individual domains are 
joined together by linker regions termed U regions that are unstructured.
1.3.1 SAP97 Structure
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There are no high resolution structures of intact full-length SAP97. Individually 
however, the structure for all three PDZ domains of SAP97, have previously been 
characterised, PDZ1 by NMR (Wang et al., 2005) and PDZ2 and PDZ3 by 
crystallography (Cabral et ah, 1996; von Ossowski et ah, 2006; Zhang et ah, 2007). 
The structure of SH3-GUK domain remains unsolved in SAP97 although the 
structure of the SH3-GK from the related MAGUK protein PSD95 have been 
solved, see above (McGee et ah, 2001; Tavares et ah, 2001).
In 2000, Wu et al. reported a computational model of SAP97 using the known 
crystal structures of similar PDZ domains and molecular models of all the subunits. 
They used the modelled structure to explain the various interactions between 
SAP97 and target proteins binding. The model that was generated showed SAP97 
as a compact structure with intramolecular interactions between domains. 
Furthermore, they demonstrated that these interactions were regulated, that is the 
domains associate and dissociate depending on what SAP97 interacts with, Figure 
1.9. The model suggested interactions between the SH3 and GK domains, later 
shown to occur in PSD95 (McGee et al., 2001) and interactions between Hook and 
GK domains such that the Hook domain would sterically hinder the binding of 
GKAP to the GK domain and that this could be regulated by the binding of the L27 
or N (Ul) domain to the Hook (Wu et al., 2000).
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Hook
PDZ1
PDZ3
Figure 1.9. Computational model of SAP97. Model derived using the program FTDOCK with the 
individual domains taken form SAP97 or domain homologues found by blast. GK in green, SH3 in 
magenta, PDZ3 red, PDZ2 orange, PDZ1 yellow, U3,4,5 in cyan, N grey and L27 in blue. Adapted 
from Wu et al 2000.
Although there is some support for a compact SAP97 as predicted by Wu et al 
2000, the low resolution structure electron micrographs (EM) showed only 35% of 
the particles formed a compact structure whereas for the majority 65%, elongated 
rods were observed (Nakagawa et al., 2004). The same group also showed that 
SAP97 usually occurred in a dimeric form mediated through the L27 domain 
(Nakagawa et al., 2004).
Conformation dynamics within SAP97 was determined more recently for the PDZ 
region. Two constructs of PDZ12 and PDZ123 were analysed by small angle X-ray 
scattering and solution NMR, Figure 1.10. The data showed that there was little
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interdomain conformational movement in PDZ12, most likely due to the short U2 
linker region. Similar observations were also made in the NMR studies of PSD95 
PDZ12 (Long et ah, 2003). Greater conformational movement and freedom was 
observed in the PDZ123. This was expected due to the presence of the longer U3 
linker region (Goult et ah, 2007).
Figure 1.10. Structural conformation variation of PDZ1-3 domain from SAXS data. 20 rigid 
body SAXS models (BUNCH) are superimposed over a low resolution ab initio surface envelope 
(grey). A, shows PDZ12 overlaid and aligned on PDZ1. B shows PDZ123 aligned over PDZ12 
(blue/green) then superimposed over the surface envelope, showing that PDZ3 (red) is highly mobile, 
taken from Goult et ah 2007
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1.3.2 SAP97 Interactions
With several distinct binding domains and located in several different tissues it is of 
no surprise that SAP97 binds to many different partners. Consequently, there are 
many suggested roles for SAP97 within the cell. Outlined below are a few these.
1.3.2.1 PDZ-mediated interactions and functions
One of the first roles discovered for the PDZ domains was the clustering and 
trafficking of potassium channels (Craven and Bredt, 1998; He et al., 2006), 
specifically the potassium inward rectifier, Kir2.1 (Leonoudakis et al., 2001).
Kir2.1 is a tetrameric membrane spanning ion channel with a large cytoplasmic 
pore domain that contains several sites of phosphorylation by PKA and PKC. In 
addition, PtdIns(4,5)P2 and Mg2+ binds to and blocks the channel. The C-terminus 
has a PDZ-binding motif ESEI (Bichet et al., 2003). Each of the SAP97 PDZ 
domains were shown to bind to the C-terminal sequence 418EPRPLRRESEI428 of 
Kir2.1, although it was shown that PDZ2 had the greatest affinity (Goult et al., 
2007). SAP97 was also shown to cluster the Kvl.4 potassium channel at the cell 
membrane through its PDZ domains (Kim and Sheng, 1996). The PDZ domains 
were also indicated to cluster the glutamate receptor AMPA at the plasma 
membrane (Leonard et al., 1998).
1.3.2.2 SH3-GK-mediated interactions and functions
The SH3 domain that was shown to bind the scaffolding anchor protein, AKAP79 
(see below) albeit in a proline independent manner (Colledge et al., 2000), whilst
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the Hook linker region between the SH3 and GK domains binds to calmodulin, 
CaM (Paaraiann et ah, 2002). The binding of either AKAP79 or CaM may regulate 
the scaffolding action of SAP97; CaM has been suggested to sterically hinder the 
binding of protein 4.1, a cytoskeletal binding protein that also binds to the Hook 
region (Colledge et ah, 2000; Paarmann et al., 2002). Whether CaM and AKAP79 
can bind SAP97 together or whether they oppose each other has not been 
investigated. More recently, the SH3 domain of SAP97 has also been found to bind 
to a-secretase (Marcello et al., 2007).
The SAP97 and PSD95 GK domains have both been shown to interact with 
guanylate kinase-associated protein, GKAP. No function for the interaction with 
SAP97 has been found so far although GKAP has been shown to colocalise with 
PSD95 to cluster Kvl.4 ion channels (Kim and Sheng, 1996).
SAP97 has also been shown to localise to the cytoskeleton in epithelial cells 
initially though binding of the Hook region to Protein 4.1 (Lue et al., 1994). 
However, it was then shown that interactions with the cytoskeleton occurred 
primarily through the L27 domain and not through associations with protein 4.1 
(Wu et al., 1998).
SAP97 has been studied in many different tissues, each identifying different binding 
partners and functions. This shows that SAP97 is a versatile MAGUK protein able 
to perform different roles, forming complexes and interactions with different 
proteins when required throughout the cells when required.
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1.4 A-Kinase Anchoring Protein, AKAP
A second major family of proteins involved in scaffolding at the plasma membrane 
are the A-Kinase Anchoring Proteins (AKAPs). These belong to a diverse family of 
more than 50 proteins that were originally differentiated by their molecular weight 
such as AKAP18,79, 220 and 350 but also contain the proteins gravin and WAVE1 
(Wiskott-Aldrich verprolin-homology protein-1). They are characterised by a 
protein kinase-A (PKA) anchor domain and are able to compartmentalise to specific 
sites in the cell through interactions with other scaffolds that enables PKA to be 
distributed and bind to or interact with other signalling or scaffold molecules 
(Welling, 2008; Wong and Scott, 2004).
1.4.1 Roles of AKAP
Many ion channels are regulated by phosphorylation from broad acting kinases and 
phosphatases and the AKAPs play a major role here as a scaffold protein. In the 
inactive state, the regulatory (R) subunits of PKA bind to the C-terminal region of 
AKAP. Upon activation by cAMP, PKA is released in its catalytically active form 
from AKAP. Active PKA proceeds to phosphorylate other proteins in its vicinity 
(Carr et ah, 1992; Uhler et ah, 1986).
More details of the precise mechanism of the process described above has only been 
revealed recently (Kinderman et al., 2006). cAMP-dependent Protein kinase A
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contains two subunits, one catalytic (C) and the second regulatory (R). The N- 
terminal of the R subunit contains a small binding domain commonly called the 
dimerisation/docking domain (D/D). This is composed of an anti-parallel four a- 
helix bundle that provides a docking surface for AKAP. The R subunit binds AKAP 
through a 14 - 18 amino acid amphipathic helix (an a-helix with opposing 
hydrophobic and hydrophilic faces), Figure 1.11 (Carr et ah, 1992; Kinderman et 
ah, 2006). At C-terminus of PKA, two tandem cAMP binding domains are present; 
when cAMP binds to these sites, a conformational change occurs in the R subunit 
which releases the C subunit (Kinderman et ah, 2006).
The R subunit is also found in two isoforms RI and RII which confer specificity for 
different AKAPs, though the D/D domain fold is conserved in each subunit (Gold et 
ah, 2006).
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Figure 1.11. Rlla subunit of PKA dimerisation/docking domain in complex with D-AKAP2.
Structures 90° to each other showing peptide D-AKAP263c>.64g bound to the D/D domain of the RHa 
subunit of PKA. Adapted from Kinderman et al 2006.
The compartmentalisation of AKAPs is vital to the specificity of the PKA catalysis 
with AKAPs located at the plasma membrane, in nuclei, mitochondria, 
microtubules and the actin cytoskeleton. Two mechanisms have so far been 
identified. The first tethers AKAPs to membranes via interactions with 
phospholipids (AKAP79), myristoyl groups (gravin) or by both myristoyl and 
palmitoyl groups (AKAP18). The second uses splice variants that direct different 
protein-protein interactions; for example, AKAP350 binds to the NMDA receptor 
but the AKAP450 elongated splice variant binds to the centrosome (Wong and 
Scott, 2004).
AKAPs ability to bind to other signalling molecules and enzymes allows them to 
orchestrate signal transduction. This multiple binding was first established using 
yeast two hybrid assay in 1995 when it was found that AKAP79 bound PKA and
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the Ca2+/calmodulin-dependent protein phosphatase 2B, calcineurin (CaN) 
simultaneously (Coghlan et aL, 1995). A year later PKC was found to bind 
independently to both PKA and CaN (Klauck et aL, 1996).
Analysis of AKAP18 showed that it contained a domain that resembled 2H 
phosphoesterases (2H from two conserved histidines), which are enzymes that 
catalyse small nucleotides. Structural characterisation the AKAP1876-292 domain 
revealed that it interacts with 5’AMP and cytosine monophosphate (CMP) although 
no phosphoesterase activity was identified, suggesting that it may catalyse another 
nucleotide or that it acts as an AMP sensor, Figure 1.12 (Gold et al., 2008).
1 5' AMP / CMP binding pocket
Figure 1.12. AKAP18 central domain. The domain resembles 2H phosphoesterase and binds both 
5'AMP and cytosine monophosphate (CMP) in the central binding pocket. No catalysis has been 
observed. Adapted from Gold et al 2008.
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My research will focus on AKAP79. Although one of the most widely studied 
AKAPs its structural data and binding mechanisms have yet to be explored in full.
1.5 AKAP79
The 427 amino acid protein, AKAP79 (also named AKAP5) has a molecular weight 
of ~47KD and is a member of a small closely related family of AKAPs along with 
the murine (AKAP150) and bovine (AKAP75) analogues.
1.5.1 AKAP79 Structure and Function
AKAP79 compartmentalises to the plasma membrane and has been found in 
various cell types including the post-synaptic density (PSD) of the neuron (Carr et 
al., 1992), the kidney (Welling, 2008) and heart cells (Dart and Leyland, 2001). The 
mechanism by which AKAP79 attaches to the plasma membrane is through three 
N-terminal highly basic regions (named A, B and C) that have been shown to 
localise to the plasma membrane through fluorescence microscopy and bind to the 
acidic phospholipid, phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). 
However, it is not known whether binding to acidic phospholipids is purely 
electrostatic or specific for PtdIns(4,5)P2, Figure 1.13 (DellAcqua et ah, 1998). The 
N-terminal region was also shown to bind to both PtdIns(4,5)P2 and F-actin at the 
dendritic spine (Gomez et ah, 2002) and to cadherins in epithelial cell tight 
junctions (Gorski et al., 2005).
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The highly basic A region, AKAP7932-51 was shown to bind PKC in an inactive 
bound form (Klauck et al., 1996). This was interesting on two counts. First, the 
region was not a known PKC binding sequence, thus it was suggested that this was 
an unique class of PKC that binds in a phosphotidylserine dependent manner (Faux 
and Scott, 1997). Second, the A region was already known to be a CaM binding site 
to AKAP. It was found that CaM/Ca2+compete with PKC for the binding site, 
providing a mechanism for secondary messenger (Ca2+) regulation for releasing 
inactive PKC from AKAP79 (Faux and Scott, 1997).
This was further complicated by the fact that AKAP79 binding to membranes and 
the actin cytoskeleton was shown to be regulated by the binding of CaM or PKC 
(Dell'Acqua et al., 1998; Gomez et al., 2002; Gorski et al., 2005). More recent work 
has shown that only AKAP79 compartmentalisation was required for neuronal 
development at dendritic spines and not the action of PKA or CaN. This was 
achieved by monitoring the clustering of AMPA receptors to the membrane and 
actin cytoskeleton using mutant AKAP79 constructs without the PKA or CaN
MAGUK Binding domain CaN /
--------------------- PKA •
145-315 315-360 393-413
Figure 1.13. Schematic of AKAP79. Showing the locations of binding sites. A B and C represent 
highly basic regions. Exact MAGUK binding domain is unknown but is suggested to lie within 
region shown.
domains (Robertson et al., 2009).
CaM / PKC
A) B)c)-
31-53 76-101 116-145
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The binding complex of AKAP79 to the RII subunit of PKA has been solved by 
solution NMR (Newlon et al., 2001). The group expressed the RII binding domain 
(1-44) of the R subunit dimer and synthesised the amphipathic helix from 
AKAP7 9393-413. They found that the amphipathic helix bound at 45° to the dimer in 
a hydrophobic pocket by the same method as D-AKAP2 shown previously (Figure 
1.14).
Figure 1.14. Rlla subunit of PKA dimerisation/docking domain in complex with AKAP79.
Structures 90° to each other showing peptide AKAP79392^i3 (magenta) bound to the D/D domain of 
the Rlla subunit of PKA (green). Adapted from Newlon et al 2001
No further structural characterisation has been carried out on AKAP79 (or any other 
AKAPs). This is most likely due to a lack of secondary structure in the central 
region and difficulties in expressing AKAPs in bacteria (Gold et al., 2008)
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1.5.2 AKAP79 Interactions
AKAP79 has been shown to associate and bind with several partners including 
PKA, PKC and CaN (Klauck et al.t 1996). More recently binding with other 
proteins has been identified including CaM (Dell'Acqua et al., 1998), SAP97, 
PSD95 (Colledge et ah, 2000) and Kir2.1 (Dart and Leyland, 2001). However, 
through its ability to form simultaneous interactions with more than one binding 
partner AKAP has a scaffolding role in creating protein networks much akin to 
SAP97.
Through fluorescence resonance energy transfer (FRET) microscopy analysis and 
patch clamping it was shown that AKAP79 was able to assemble a network of, 
PKA, CaN and the L-type Ca2+ channel, Cayl .2 all localised to the cell membrane. 
The experiments also showed that the PKA and CaN, respectively, phosphorylated 
and dephosphorylated the Cay 1.2, that is, directly opposing each other (Oliveria et 
ah, 2007). Further research also using FRET showed that a complex of AKAP79 
and SAP97 was able to localise to the cell membrane with the PDZ domains of 
SAP97 associated to the (3-adrenergic receptors ((fi-AR). This enabled SAP97 to 
facilitate in the PKA mediated phosphorylation of Sei'312 on the (3-adrenergic 
receptor (Gardner et ah, 2007).
Complexes of AKAP79 and SAP97 have also been linked to localising and 
assembling complexes with glutamate receptor-1 domain (GluRl) of AMPA
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(Colledge et al., 2000). Further to this work it has been found that AKAP79 also 
enhances the regulation of PKC phosphorylation of GluRl (Tavalin, 2008).
As mentioned previously, SAP97 has been shown to associate with the K+ Channel 
Kir2.1 (Goult et al.} 2007). Interestingly, AKAP79 has also been shown to bind 
directly with Kir2.1 thus possibly anchoring PKA closer in proximity to Kir2.1 
(Dart and Leyland, 2001). Following on from the AKAP79-SAP97-piAR assembly, 
one could assume that a similar assembly of AKAP79-SAP97-Kir2.1 would also 
form although this complex remains to be proven either in vitro or in vivo.
1.6 Calmodulin
Nearly all cellular processes utilize the divalent cation Ca as a secondary 
messenger. Ca2+ effects are mediated through the highly conserved, 17 kDa calcium 
binding protein, calmodulin, CaM (Klee et al., 1980), a protein that has been shown 
to interact with both SAP97 and AKAP79.
1.6.1 Roles of Calmodulin
CaM is an important regulatory protein that modulates the activity of signalling 
molecules through its Ca2+ sensitivity and has been shown to interact with over one 
hundred different proteins (Xia and Storm, 2005). The diversity of physiological 
roles is also large ranging from the comprehensively studied CaM dependent serine
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and threonine proteases to the anthrax adenylate cyclase. The diversity is attributed 
to the abundance and conservation of the protein across eukaryote species and even 
to the prokaryote, bacillus anthracis (Hoeflich and Ikura, 2002).
1.6.2 Calmodulin Structure
The CaM structure contains N and C-terminal lobes joined by a flexible linker 
region. On each lobe there are two EF hand motifs that allow CaM to bind 4 Ca2+ 
molecules, Figure 1.15. Saturation with Ca2+ leads to a conformational change that 
facilitates the binding to many enzymes and proteins transducing a signal to the 
target (Swulius and Waxham, 2008).
The solved structure of CaM was first reported in 1988 at 2.2 A in the calcium 
bound form (Babu et ah, 1988). This was followed by a 1 A model by Wilson 2000 
that shows the flexible central helix open for binding (Wilson and Brunger, 2000). 
The crystal structures also showed that the EF hands were folded into a helix-loop- 
helix motif and that the loop. The Ca2+ ions are coordinated to the EF hands by the 
12 amino acids loop through side chain oxygen atoms from amino acids in positions 
1, 3, 5 and 7. The coordination sphere is completed by a H2O molecule, Figure 1.15 
(Grabarek, 2006).
35
Figure 1.15. A ribbon representation of CaM, Left shows CaM (from Paramecium tetraurelia) 
bound with Ca2+ represented as magenta spheres derived from 1A X-ray crystallography, showing 
the extended dumbell conformation when bound to Ca2+ (Wilson et al 2000). Right shows the apo 
CaM (from Xenopus laevis) solved by NMR in the closed state (Zhang et al 1995). Bottom shows 
the helix-loop-heilx motif from an EF hand showing the coordination of the Ca2+ cation, taken from 
Garbarek 2006.
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When CaM is without any Ca2+ ions it is said to be in the apo state whose structure 
is very different from the Ca2+-bound state (Figure 1.15), The angles of the a- 
helices of the EF-hands motifs increase by 36° - 44° which closes access to the 
central region (Zhang et aL, 1995).
The CaM model can be thought of as being like a pair of head phones; when Ca is 
bound, the ear pieces are pulled apart allowing you to place said ‘headphones’ on. 
However, when the Ca2+ is absent the ‘headphones’ close shut.
1.6.3 Calmodulin Function
Calmodulin contains a high proportion of methionine residues, 9 from 148. These 
methionines have been shown to form a malleable nonpolar binding surface, this 
coupled to long flexible side chains provides exposed hydrophobic patches that are 
involved in targeted binding (Vogel et ah, 2011).
The binding surfaces of CaM have been shown to bind to a basic amphipathic helix 
that contains positive residues flanked by and possibly interspersed with 
hydrophobic residues but the target binding sequences often showed no homology. 
However, a pattern between target sequences was discovered. Several binding 
motifs were found in which the hydrophobic side of the a-helix interacted with the 
hydrophobic residues on CaM. Motifs 1-8-14 and 1-5-10 were first identified, were 
the numbers relate to the position of the hydrophobic residue in the target sequence, 
Figure 1.16 (Meador et al, 1993; Rhoads and Friedberg, 1997; Vogel et al„ 2011). 
More recently 1-12 and 1-16 motifs have been identified but these are rarer. There
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was also a calcium independent motif discovered; the IQ that contains the motif 
IQxxxRGxxxR. Overall in 2000 there were approximately 180 different sequences 
shown to bind CaM (Yap et al., 2000)
Figure 1.16. Ribbon representation of CaM Complexes, Left shows CaM comlpexed with CaM 
kinase I peptide in a 1-14 binding mode, adapted from pdb 2L7L (Vogel et al., 2011). Right shows 
CaM comlpexed with CaM kinase II peptide in a 1-5-10 binding mode, adapted from pdb 1CDM 
(Meador, Means et al. 1993).
CaM has been shown to bind to both SAP97 and AKAP79 (Faux and Scott, 1997; 
Paarmann et al., 2002). In SAP97, CaM binds to the Hook region that may interfere 
with the binding of both the cytoskeletal protein 4.1 and AKAP79, that may 
regulate SAP97s clustering ability (Colledge et al., 2000; Paarmann et al., 2002). In 
AKAP79, an influx in secondary messenger Ca2+ activates CaM which competes 
with PKC to bind to the highly basic region, regulating the release of inactive PKC 
from AKAP79. The Ca2+ also has the effect of releasing the dephosphatase,
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calcineurin. CaN which binds to AKAP79 (Faux and Scott, 1997; Oliveria et al.
2007).
1.7 Summary
SAP97 and AKAP79 are two scaffolding proteins that interact together and with 
other regulatory proteins including CaM, PKA, PKC and with the receptor and ion 
channel Kir2.1.
Kir2.1 is a member of a large family of potassium ion channels. The potassium 
inward rectifier, is predominantly expressed in the heart where maintains the resting 
membrane potential, buffers external K+, and repolarises cardiac muscle action 
potential through its strong inward rectifier function (Doupnik et ah, 1995; Kubo et 
al., 2005).
The structure contains two main constituents, a tetrameric membrane spanning pore 
region and a large intracellular cytoplasmic pore region formed by the carboxy- and 
amino-terminal domains. As mentioned previously the cytoplasmic domains 
contains several sites of phosphorylation by PKA and PKC. In addition, 
PtdIns(4,5)P2 and Mg2+ binds to and blocks the channel. The C-terminus has a PDZ- 
binding motif ESEI that has been shown to interact with SAP97 (Bichet et al., 
2003).
There are no published mechanisms for a SAP97-AKAP79-Kir2.1 complex, 
although, they have been shown to interact with each other. Recent physiological
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work on Kir channels in vivo using patch clamping did suggest that PKC inhibits 
Kir while PKA activate the channels (Park et al., 2008). However, there was no 
mention of the mechanisms by which these regulations were achieved, it could be 
possible that AKAP79 and CaM are involved. Below is a theoretical model of the 
SAP97-AKAP79-Kir2.1 complex, Figure 1.17.
Figure 1.17. Possible model for SAP97-AKAP79-Kir2.1 complex. The Kir2.1 (red) is clustered to 
the plasma membrane by S AP97 PDZ domains. AKAP79 is then able to anchor at the phospholipids 
and interact with the SAP97 that could enable PKA to phosphorylate Kir2.1 (green arrow). An 
increase in CaM may regulate the complex by releasing the AKAP79 from the phospholipids and 
possibly interfering with the SAP97 AKAP79 interactions (purple arrows).
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1.8 Aims of Project
The overall goals of this thesis are to obtain comprehensive structural information 
on (i) AKAP79 and (ii) SAP97 and to understand how both these proteins are 
regulated through their interactions with other proteins. To achieve these goals, the 
specific aims are as follows.
The Biophysical Characterisation of AKAP79. This will be done by making 
constructs for E.coli expression of full length and separate domains of AKAP79, 
protein purification and characterisation using NMR, SECMALLS and circular 
dichroism were relevant. This will be followed by the examination of protein- 
protein interactions in the SAP97-AKAP79 system. This includes AKAP79 
interaction with SAP97, determination of binding affinities using Isothermal 
Calorimetry (ITC) and by identifying residues important for interactions using 
NMR chemical shift mapping.
Investigating the interactions of AKAP79 with Calmodulin. This will identify 
residues important for interactions using NMR chemical shift mapping and by 
determining binding affinities using Isothermal Calorimetry (ITC)
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The Biophysical Characterisation of SAP97. This will be done by expressing, 
purifying and characterising the different domains of SAP97 including A70, A461, 
A546, GK and SAPN1 domain using NMR and / or SECMALLS This will be 
followed by the examination of the protein-protein interactions between SAP97 and 
Calmodulin by determining binding affinities using fluorescence spectrophotometry 
and by identifying residues important for interactions using NMR chemical shift 
mapping. The protein-protein interactions between SAP97 and Kh'2.1 C-terminus 
fragment will then be examined by expressing and purifying 13C/15N C368, and 
interpreting the assigned spectra when complexed with SAP97 PDZ2.
Finally SAP97 will be characterised using small angle X-ray scattering (SAXS) to 
investigate and interpret the large multi domain SAP97 A70, A461, A546 constructs.
42
CHAPTER 2
TECHNICAL INTRODUCTION TO SMALL
ANGLE X-RAY SCATTERING
2.0 Introduction
Small angle X-ray scattering (SAXS) is a powerful method that allows the study of 
biological macromolecules in solution. SAXS can be used to analyse peptides to 
viruses to protein complexes in physiological or denaturing conditions, without the 
need to crystallise. This technical introduction will outline: (a) the basic theory of 
SAXS and (b) the analysis strategy of the scattering. Most important the different 
computer programmes that are commonly used for data analyses are described in 
some detail.
2.1 Scattering
The basic principal of SAXS is to pass a collimated (parallel), monochromatic beam 
of X-rays through a solution of highly purified, monodisperse macromolecules. The 
intensities of the scattered X-rays are measured as a function of the scattering angle 
(Figure 2.1). The wave vector of the X-ray beam is K = 2nlX where X is the X-ray 
wavelength. The isotropic scattered intensity, I, is recorded as a function of the 
momentum transfer, s = 47tsin0 / X where 20 is the angle between the incident and 
scattered beam. The scattering from the background buffer solution is measured 
separately and subtracted from the protein solution (Svergun, 2010)
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Detector
A Sample
Monochromatic beam, K0
Radiation Source
•X-ray generator (A = 0.1-0.2 nm) 
•Synchrotron (A = 0.05 - 0.5 nm)
9
9
9
Scattered beam, K1 = 2ti/A
S = Kx - Ko
Solution blank
(1) BSA sample
(2) Buffer
(3) Difference
s, nm
Figure 2.1. Schematic of basic SAXS experiment. A, shows a simplified standard experimental set 
up. B, shows the resultant scattering data for a BSA standard. Adapted from (Mertens and Svergun, 
2010).
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2.2 GNOM
The initial scattering data can be analysed for several parameters by the computer 
program, GNOM (Svergun, 1992). These include the regularization parameter, P(r) 
that gives information on the shape of the proteins in solution such as whether it is 
spherical or rod shaped. It represents the histogram of distances between pairs of 
points within protein and is related to the maximum dimension, Dmax of the protein 
(Koch et al 2003). P(r) is measured indirectly because any small errors in the 
scattering would cause large errors in P(r); this is compounded by the finite number 
of intensities that are measured during scattering. To increase the accuracy further 
the program GNOM uses a priori assumptions about the protein in question which 
include the Dniax of the protein which can then be refined later to improve the 
quality of the solution.
Finally GNOM will also calculate an accurate value of the radius of gyration, Rg of 
the protein, a measure of the size of the protein derived from the root mean square 
distance of the central particle to the scattering length density distribution (Koch et 
al., 2003; Svergun, 1992).
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2.3 Shape determination
2.3.1 GASBOR
Recent modelling approaches have allowed the construction of low resolution three 
dimensional models directly from scattering data through ab initio modelling. 
Initially, a single envelope model (SASHA) was created. This was followed by a 
bead model (DAMMIN) but this too has been superseded by a dummy residue 
model, GASBOR. This method uses the data generated by GNOM and the number 
of amino acids in the protein to create the model and tries to use fewer parameters 
than other modelling programs to increase calculation speed. Each amino acid is 
represented by a dummy residue (DR) and during the iterative process each DR is 
randomly moved to an arbitrary point, 0.38 nm from the next DR within a shell of 
constraints provided by Dmax and the scattering data until a solution is generated 
(Figure 2.2). This method does not provide a unique solution but a manifold of 
configurations that correspond to nearly the same scattering pattern. The differences 
between each model are less than the previous methods (Svergun et al., 2001). The 
models from each individual run can be superimposed or averaged using another 
program, DAM AVER that measures the normalised spatial discrepancy (NSD) for 
each residue in each run and then compares each run to each other, removing 
outlying runs and superimposing and averaging the other runs to give a final 
average 3D model
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Figure 22. Ab initio models of Chitin binding protein, CHB1 used to show differences between 
different 3D modelling programs. A, uses an envelope model from SASHA, B uses the bead 
model, DAMMIN and C uses the dummy residue method, GASBOR. Models are rotated through 
90°. Taken and adapted from Koch, Vachette et al. 2003.
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2.4 Rigid Body Modelling
Large macromolecules often comprise of many individual domains. To study these 
macromolecules, the individual domains could be fitted directly into the low 
resolution ab initio GASBOR models. However, it is more reliable to use a rigid 
body modeller program such as BUNCH or EOM that assemble models using direct 
refinement of the scattering data (Mertens and Svergun, 2010).
2.4.1 BUNCH
Bunch uses scattering data to build models of multi-domain proteins or protein 
complexes from X-ray crystal or NMR structures, or homology models of the 
subunits and domains (Petoukhov and Svergun, 2005). The models allow for 
proteins or domains to be connected without steric clashes and can incorporate 
missing linker regions. The method uses heuristic algorithms, that is an algorithm of 
best fit or best solution for the model is optimised iteratively to find the best 
solution amongst all possible solutions. It does not however guarantee the best 
solution is found and is often considered an approximate solution. Added to this the 
linker regions processed by ab initio modelling using dummy residues (DR) are 
often assumed to be rigid (Mertens and Svergun, 2010).
49
2.4.2 Ensemble Optimisation Method, EOM
This method has been developed to analyse flexible systems such as unfolded 
proteins or multi domain proteins with long flexible linkers (Bernado et ah, 2007). 
Instead of using the usual method of searching for a single model or conformation 
that fits the experimental scattering data and which adheres to physical and 
biochemical scrutiny, EOM was developed to look at flexible proteins that may 
exist in a mixture of forms.
The EOM consist of two parts. Firstly an object is represented by an ensemble of 
many different conformers. The ensemble is usually 10000 conformers that are 
randomly generated but possible conformations to cover the conformational space. 
The average scattering of the ensemble is then found by averaging each scattering 
profile of each individual conformer. Secondly, a genetic algorithm is then 
employed for a pool of subsets and further evolved for 5000 generations to 
complete the ensemble optimisation. The structures were generated from the 
ensemble and were then analysed to quantify their diversity (frequency) and 
distribution dependent on the radius of gyration (Rg) of the ensemble.
2.5 Homology Modelling
The rigid body modellers require high resolution crystal structures for their 
refinements. Where these are not available, homology models are created using the 
high resolution structures of related proteins domains or folds as templates. Two
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main types of homology modelling exist, ab initio and comparative and these are 
described in detail below.
2.5.1 Ab initio Modelling -1TASSER
I-TASSER is a computational model run through a web server that uses a 
combination of techniques including ab initio modelling to predict 3D structures of 
proteins from just their amino acid sequence and then predict their function (Roy et 
aL, 2010). The program methodology progresses through 4 stages which are briefly 
described below:
Stage 1- Threading; initially, bioinfonnatics techniques, such as BLAST identify 
evolutionary relatives and then a multiple sequence alignment to predict the 
secondary structure is defined. This alignment is then threaded through a “meta­
threading server” called LOMETS (houses seven individual threading programs) 
that searches a representative PDB library for similar solved structures or structural 
motifs to match the secondary structure prediction. The best predicted models are 
then chosen based on the standard deviation of the energy values relative to all the 
alignments (Z-score).
Stage 2-Assembly; Fragments of the threading alignment structure template that 
aligned well are excised and used to assemble a conformational model. To this are 
added the areas that did not align to any structural motif (loops and tails) generated 
through ab initio modelling. A Monte Carlo simulation technique is used to 
assembly the fragments guided by PDB statistical terms (hydrophobicity, H-bonds,
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Ca correlations) spatial restraints from threading templates and sequence based 
contact prediction. Conformations are then clustered and the lowest free energy 
state conformers or “decoys” identified. The 3D coordinates of all the clustered 
decoys are then averaged to form a “cluster centroid”, essentially a cluster of many 
different conformations with the lowest free energy that are averaged together.
Stage 3-Model selection and refinement; the cluster centroids are sent back to the 
stage 1 fragment assembly for a second iteration, this time pooling external 
restraints from the threading alignments on the decoys in the cluster. This enables 
the removal of steric clashes and refines the topology. The decoys are then clustered 
again and those with the lowest energy state are inputted into a refinement program, 
REMO, that generates the final structure using an all atom model that is built on Ca 
and H-bonding networks.
Stages 4- Structural based functional annotation; to attempt to elucidate the function 
of the queried protein the newly defined structure is matched to other proteins of 
known structure and function in the PDB.
The five best predicted structures are then presented, their qualities assessed by their 
C-scores which are determined by a calculation based on the number of decoys in 
the cluster compared to the total, the RMSD of the decoys to the cluster average and 
the Z-score.
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2.5.2 Comparative modelling (CM) - MODELLER
This program generates the most probable model structures of a sequence using the 
alignment to other known structures as templates. The process uses a set of spatial 
restraints that are replicated from the template to the new model. These include Ca 
— Ca and main chain N - O distances and main chain and side chain dihedral angles 
(SaU and Blundell, 1993).
The program itself runs off scripts written in the Python computer language and is 
run from the command prompt. The modelling process follows a logical 
progression;
• Sequence inputted
• Template identified / inputted
• Sequences aligned
• Models generated
• Models Evaluated
Models are generated and these are evaluated using the DOPE (Discrete Optimized 
Protein Energy) score that uses probability theory based on the atomic distance 
statistical potential of the model and the template (Shen and Sali, 2006).
2.6 CRYSOL
When high resolution protein or domain structures or models generated from these 
structures, by ab initio or computer modelling methods are compared to the original
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scattering data the structural similarity needs to be validated. CRYSOL is a program 
that was developed to evaluate and validate the models to SAXS profiles by using 
curve fitting to the scattering profiles. The program calculates a scattering pattern 
using the experimentally derived scattering amplitudes and the hydration shell of 
the atomic group of the residues (Svergun et al., 1995).
2.7 Computational summary
The methods described above involve many computational steps, these have been 
outlined in the flow diagram below, Figure 2.3.
Figure 2.3. Flow diagram of SAXS interpretation. Initial data collection and data processing is 
earned out at the synchrotron or X-ray source. The remaining interpretation requires freeware 
programs and can be processed on any modem computer.
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CHAPTER 3
MATERIALS AND METHODS
3.0 Introduction
Throughout this study many methods of cloning, protein expression and purification 
have been used and developed for several different protein constructs of SAP97 and 
AKAP79. To allow the discussion to follow the method directly, the method 
development and final methods for the SAP97 and AKAP79 protein constructs will 
not be in this chapter but will be discussed in full in Chapters 4 (for AKAP9) and 6 
(for SAP97).
This chapter will concentrate on other proteins used in the study, assays and other 
methods used throughout this thesis.
3.1 Chemicals and Reagents
PCR reagents were purchased from Novagen, DNA miniprep kits were from 
QIAGEN. Luria Broth (LB), yeast extract and agar were from Merck while the 
tryptone was from Melford and agarose was purchased from Bioline. Isopropyl (T 
D-l-thiogalactopyranoside (IPTG) was from Melford along with dithiothreitol 
(DTT), ampicillin (Amp), kanamycin (Kan) and Tris HC1. Chromatography 
columns and media were purchased from GE Healthcare. 15N Ammonium chloride, 
13C Glucose and D2O were purchased from Goss Scientific. Unless otherwise 
stated, all other chemicals used were from Sigma-Aldrich and were of the correct 
purity required.
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3.2 Protein Constructs.
T7 vectors were used throughout the study, the AKAP79 constructs were all created 
as part of this project while all the other constructs were supplied by Dr. Mark 
Leyland, University of Leicester, Table 3.1 gives a full list of all the DNA 
constructs used in this thesis.
Table 3.1 Summary of all constructs. Including purification tags, specific cleavage site and vector 
to be cloned into. TEV = Tobacco Etch Virus protease, SUMO = Small Ubiquitin Modified protein 
and PP = Precission Protease
Protein Construct Vector
AKAP79 Full Length HexaHis-TEV-1 -427 pET Mil
AKAP79N HexaHis-TEV-1 - 153 pET M11
AKAP79M HexaHis-TEV-153 - 315 pET M11
AKAP79C HexaHis-TEV-315 - 427 pETMll
AKAP79 M Sumo SUMO-HexaHis-SUMO cleavage-153 - 315 pOPIN-S
AKAP7919^1 SLIMO-HexaHis-SUMO cleavage-19-61 pOPIN-S
AKAP7919.52 SUMO-HexaHis-SUMO cleavage-19-52 pOPIN-S
AKAP7925.6, SUMO-HexaHis-SUMO cleavage-25-61 pOPIN-S
SAP97 A70 HexaHis-TEV-70 -911 pLEIC-01
SAP97 A461 HexaHis-TEV-461 - 911 pLEIC-01
SAP97 A546 HexaHis-TEV-546 - 911 pLEIC-01
SAP97 GK HexaHis-TEV-721 -900 pLEIC-01
S AP97 N PDZ1 HexaHis-TEV-70-313 pLEIC-01
SAP97 PDZ2 GST-PP-313-412 pGEX-6P
Kir2.1 C368 GST-PP-368-428 PGEX-6P
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3.3 AKAP79 Cloning
The vectors pET-Mll (Pinotsis et al., 2006) and pOPIN-S (Berrow et al., 2007) 
were used in these studies. The vector maps are shown below, Figure 3.1.
Xhol (15S) 
Notl (166) 
EagI (166) 
HmdIII (173) 
Sail (179)
Sac I (190) 
EcoRI (192) 
BamHI (19S) 
Kpnl COS)
Clal (4777)
fl ongm
RstI C49) 
BamHI (457) 
Sail 
EagI
Ongm (3445)
MADpETM-11
TEV-sste 
. llnkei 
His-tag
SapI (376S)
BcU (1797)
Figure 3.1. Vector map and multiple cloning site sequence of vector pET-Mll.
58
3.3.1 Standard Cloning - pET-M 11
For cloning into pET-M 11 primers were designed complimentary to the AKAP 
sequences; the forward sequence included the restriction site for Ncol and the 
reverse sequence included a stop codon followed by the Kpnl restriction site 
sequence. The melting temperatures were similar at approximately 60°C.
PCR of primers for each reaction amplified with designed primers using the human 
AKAP79 gene supplied by Dr Caroline Dart, University of Liverpool, as a template 
and KOD hotstart polymerase (Novagen). PCR conditions were initial melting at 
98°C for 2 minutes followed by 30 cycles of 95°C/15 seconds (DNA denaturation), 
45°C/15 seconds (primer annealing) and 72°C/40 seconds (polymerase extension). 
The annealing temperatures were changed to match the melting temperature of each 
set of primers. PCR products were cleaned with QIAquick PCR purification kit 
(QIAGEN). PCR products and pETM-11 plasmid were digested by restriction 
enzymes, Ncol and Kpnl (New England Biolabs). Digest products were ligated 
with QuickLigase (Novagen) and transformed into XL-1 cells (Novagen). Inserts 
were verified by automated sequencing (Geneservice).
3.3.2 Ligation Independent cloning - pOPIN-S
Primer design differed with Ligation Independent cloning (Lie). The primers were 
still complimentary with the target sequence but including 15 bp extensions
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homologous to the vector, for pOPIN-S 5’-GCGAACAGATCGGTGGT-35 and 3’- 
ATGGTCTAGAAAGCT-5 ’.
The PCR conditions used were the same as for pETM-11 above. The PCR product 
was incubated with DPN1 (New England Biolabs) to remove any remaining 
template and the PCR product cleaned with QIAquick PCR purification kit 
(QIAGEN). The pOPIN-S vector was cut with Hindlll and Ncol (New England 
Biolabs) and cleaned before being mixed with PCR product in 1:1.5 vector to PCR 
product e.g. 200 ng/1 cut vector + 300 ng/1 PCR product made up to 10 pi with mili 
Q water. The PCR mix was then added to In-Fusion™ (Clonetech) dried reaction 
mix and incubated for 30 minutes at 42°C using a thermocycle. The reaction was 
stopped by the addition of 40 pi cold TE buffer and 4 pi of the ligated mixture was 
then transformed into 50 pi XL1 blue cells, heat shocked for 45 seconds at 42°C. 
450 pi GS96 broth (for anaerobic bacteria) was added and incubated for 1 hour at 
37°C. The cells were spun down (2 minutes 11000 g), 350 pL of broth removed and 
resuspended (by flicking) before the whole suspension is plated out and incubated 
overnight at 37°C. Control plates of 2 pi PCR product plus 8 pi mili Q water were 
also used. The In-Fusion™ Lie confers blue white selection that required agar plates 
containing 34 mg/1 Kanamycin, 1 mM IPTG, 250 mg/ml X-gal (dissolved in ImL 
DMF). The transformed colonies containing the insert DNA showed up white.
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3.4 Protein purification
3.4.1 Calmodulin - unlabelled and labelled.
The calmodulin, CaM pET-15b vector was a gift from Dr. A.Kitmitto, Manchester 
University. Unlabelled CaM was prepared by transforming E.Coli BL21(DE3) from 
Novagen with the pET-15b CaM plasmid. Two microlitres of plasmid was added to 
50 pL competent BL21 (DE3) cells, mixed by flicking and then incubated at on ice 
for 30 minutes. Cells were then heat shocked at 42°C for 45 seconds before being 
placed back on ice. Luria broth (LB) was then added up to 1000 pi and then 
incubated at 37°C for 60 minutes, shaking at 200 rpm. One hundred microlitres of 
the transformed cells were then aliquoted onto an antibiotic containing agar plate 
(100 mg/1 ampicillin, Amp for CaM), spread evenly and incubated overnight at 
37°C. The agar plate was removed for storage at 4°C for 1 to 2 weeks.
Cells were expressed at 37°C until 0.7 - 0.9 OD6oo then induced with 1 mM IPTG 
for 3 hours at 37°C, harvested by centrifugation 11000 g for 15 minutes and 
resuspended in CaM lysis buffer (50 mM Tris, 2 mM DTT, pH 7.5). Cells were 
disrupted using the French press (Sim Aminco) at 1000 PSI and centrifuged (48000 
g at 4°C for 30 minutes), the supernatant was recovered and CaCb added to a final 
concentration of 2 mM. The supernatant was then heated to 65 °C for 3 minutes in a 
water bath with constant shaking before chilling on ice. The supernatant was then 
centrifuged once more (48000 g at 4°C for 20 minutes) to remove denatured
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proteins. The resultant supernatant was collected and filtered through 0.22 pm 
syringe filter ready for chromatography.
The first purification step used hydrophobic interaction for separation. The 
supernatant was loaded onto a 20 mL HiPrep™ phenyl sepharose column (GE 
Healthcare), pre-equilibrated with CaM buffer A (50 mM Tris, 200 mM NaCl, 2 
mM CaCh, 0.5 mM DTT, pH 7.5). The column was washed with CaM buffer A, 3 
column volume (CV) at 2 ml/min, followed by buffer B (50 mM Tris, 0.5 mM 
CaCh, 0.5 mM DTT, pH 7.5), 3 CV at 2 ml/min. The CaM was then eluted with 3 
CV CaM buffer C (50 mM Tris, 1 mM EGTA, 0.5 mM DTT, pH 7.5). Eluted peak 
was concentrated to 5 ml using Amicon® Ultra (Millipore, 3K MWCO).
Secondly a gel filtration step was used to remove any remaining protein 
contaminants using 26/60 Superdex™ 75 (GE Healthcare), pre-equilibrated with 
CaM gel filtration (GE) buffer (50 mM Tris, 200 mM NaCl, 10 mM CaCl2, 0.5 mM 
DTT, pH 7.5). The sample was loaded before isocratic elution with 1 CV GF buffer 
at Imm/min flow rate. The purity of the sample was assessed by SDS-Page gel and 
deemed to be >95% pure. CaM was concentrated using an Amicon® Ultra 
(Millipore, 3K MWCO) and then dispensed into microcentrifuge tubes and 
lyophilised before storage at -20 °C.
To prepare uniformly 15N labelled CaM, media containing 15N ammonium chloride 
in a 2xM9 minimal media (MM) was used (See appendix 1 for details of media). 
The overnight step started with 1 colony grown in 1 ml LB for 4 hours before
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removal of the LB and resuspension in 40 ml MM overnight at 37°C. The cells 
were centrifuged at 5000 g for 10 minutes to remove media before the whole cell 
pellet was added to 1 litre of MM. It was necessary to increase the cell density 
before adding the cell pellet to the MM or no growth would occur; however, this 
had to be balanced against exposure of the cells to LB, the greater the exposure the 
greater the decrease in isotopic labelling of the protein.
3.4.2 Kir2.1 C368 - labelled and unlabelled
The C-terminal cytoplasmic tail of Kir2.1 contains the PDZ binding motif ESEI. 
The C368 construct contains the last 60 residues at the C-terminus in a pGEX-6P-l 
vector that contains a GST affinity tag that can be cleaved by the enzyme Precission 
protease (PP).
C368 was transformed into BL21 (DE3) RP+ cells (Novagen) using the standard 
method above. For expression, cells were grown in LB plus 100 mg/1 Amp to 0.7 - 
0.9 ODeoo before the cells were cold shocked by cooling flasks to approximately 
4°C for 5-10 minutes before cells returned to 37°C to re-equilibrate. Cells were 
induced with 1 mM IPTG for 3 hours at 30°C, harvested by centrifugation for 15 
minutes at 11000 g, and the cell pellets resuspended in PBS and frozen at -20°C 
overnight. The cells were thawed and disrupted by French Press at 1000 PSI, 
DNasel (250 units) added before centrifugation (48000 g at 4°C for 30 minutes). 
The resultant supernatant was collected and filtered through 0.22 pm syringe filter 
ready for chromatography.
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The affinity media used was Glutathione Sepharose™ 4B (GE Healthcare). The 
resin has a binding capacity of approx 10 mg protein per ml resin. Resin is initially 
washed with low salt buffer to remove residual 20% ethanol storage buffer. The 
purification used a batch method. C368 supernatant was added to 2 ml Glutathione 
Sepharose 4B resin and incubated at 4°C for 60 minutes with shaking. The resin 
suspension was then decanted into a column, washed with 10 CV PBS to remove 
any residual unbound proteins and then equilibrated for the enzyme cleavage with 
10 CV Precission Protease (PP) cleavage buffer. The resin was resuspended in 5 
CV PP buffer and 1 mg PP was added and incubated overnight at 4°C. The resin 
was returned to the column and cleaved protein eluted, a further 5 CV PP buffer 
was used to elute any remaining protein. Eluted C368 was concentrated using an 
Amicon® Ultra (Millipore, 3K MWCO) and buffer exchanged using PD 10 
desalting column (GE Healthcare) to remove NaCl.
The sample was then further purified using a 1ml Mono Q 5/5 anion exchange 
column equilibrated with 10 CV anion exchange buffer (20mM Tris, 0.2mM DTT, 
ImM EDTA, ImM benzamidine HC1, pH 7.5) followed by 5 CV elution buffer 
(Anion exchange buffer + 1M KC1) and then a further 10 CV anion exchange 
buffer. C368 sample was loaded, washed and then eluted with a 0 - 500 mM KC1 
gradient over 20 CV at 1 ml/min flow rate. Peak samples were collected.
C368 is unstructured and thus more prone to proteolysis. To protect against 
degradation the purified protein was heat treated at 90°C for 10 minutes.
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To prepare uniformly 15N labelled C368 the same method of expression as with 
CaM above was used. The purification of,15N C368 was performed identically to 
the unlabelled preparations.
3.5 Proteases
All the vectors used to express and purify the different proteins used affinity tags to 
aid with purification (except CaM). Each of these tags required removal. The 
vectors used contained specific restriction sites for highly specific enzymes. Three 
proteases were used, Precission protease for pGEX plasmids, Tev protease for 
pETM-11 and pLEICS plasmids and SUMO protease for pOPIN-S plasmids. The 
proteases also contain the same affinity tag that they will cleave but without the 
cleavage sequence. This helps in purifying the protease and once the protease has 
removed the tag the resultant mixture can be passed back down the affinity resin 
and only the cleaved protein will be eluted.
3.5.1 Precission protease purification
Precission protease was transformed into BL21 (DE3) RP+ cells (Novagen) using 
the standard method above. For expression, cells were grown in LB plus 100 mg/1 
Amp to 0.7 - 0.9 OD^oo before the cells were cold shocked by cooling flasks to 
approximately 4°C for 5-10 minutes before cells returned to 37°C to re-
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equilibrate. Cells were induced with 1 mM IPTG for 3 hours at 37°C. Cells were 
harvested by centrifugation for 15 minutes at 11000 g, the cell pellets resuspended 
in PBS and frozen at -20°C overnight. The cells were thawed and disrupted by 
French Press at 1000 PSI, DNasel (250 units) was added and centrifuged (48000 g 
at 4°C for 30 minutes). The resultant supernatant was collected and filtered through 
0.22 pm syringe filter ready for chromatography.
The PP plasmid contains a GST tag; hence, Glutathione Sepharose™ 4B (GE 
Healthcare) was used. The batch method was used for the purification. PP 
supernatant was added to 5 ml Glutathione Sepharose 4B resin and incubated at 4°C 
for 60 minutes with shaking. The resin suspension was then decanted into a column, 
washed with 10 CV PBS to remove any residual unbound proteins and then 
equilibrated with 10 CV PP cleavage buffer. The PP was eluted with 3 CV PP 
buffer + 30 mM reduced glutathione (Sigma), Eluted PP was concentrated using an 
Amicon® Ultra (Millipore, 10KMWCO).
This was followed by a gel filtration step using a 26/60 Superdex™ 75 (GE 
Healthcare), pre-equilibrated with PP buffer. The sample was loaded before 
isocratic elution with 1 CV GF buffer at 1 mm/min flow rate. The PP was 
concentrated with an Amicon® Ultra (Millipore, 10K MWCO) to 1 mg/ml and 1 ml 
aliquots flash frozen in liquid nitrogen before storage at -80°C
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3.5.2 Tev Protease purification
Tev protease was transformed into BL21 (DE3) cells (Novagen) using the standard 
method above. For expression cells were grown in DYT plus 50 pg/1 Kan to 0.7 - 
0.9 ODgoo- Cells were induced with 1 mM IPTG for 3 hours at 37°C. Cells were 
harvested by centrifugation for 15 minutes at 11000 g. The cell pellets were 
resuspended in His buffer (0.5 M NaCl, 50 mM Tris-HCl, 2 mM DTT} pH 8) and 
frozen at -20 C overnight. The cells were thawed and disrupted by French Press at 
1000 PSI, DNase1 (250 units) was added and centrifuged (48000 g at 4°C for 30 
minutes). The resultant supernatant was collected and filtered through 0.22 pm 
syringe filter ready for chromatography.
Tev piotease contains a hexhistadine tag for purification. The supernatant was 
bound to a 5ml HisTrap™ Fast Flow (GE Healthcare), washed with increasing 
concentrations of imidazole in His buffer (10, 20, 50 mM), at 2 ml/min flow rate, 6 
CV at each increment, then eluted with 250 mM imidazole in His buffer. Eluted 
peak was buffer exchanged using HiPrep™ 26/10 desalting column (GE 
Healthcare) into tev cleavage buffer (150 mM NaCl, 50 mM Tris HC1, 2 mM DTT 
pH 7.5) concentrated with an Amicon® Ultra (Millipore, 10K MWCO) to 1 mg/ml 
and 1 ml aliquots flash frozen in liquid nitrogen before storage at -80°C.
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3.5.3 Sumo Protease Purification
SUMO protease was expressed and purified using the same methods as Tev 
protease, with the only difference being the addition of a second purification step 
after the nickel affinity step (i.e. post HisTrap™).
The SUMO protease was buffer exchange using a HiPrep™ 26/10 (GE Healthcare) 
desalting column to remove the imidazole, before a further purification using a 5 ml 
HiTrap™ Q FF anion exchange column equilibrated with 10 CV anion exchange 
buffer (20 mM Tris, 2 mM DTT, 1 mM EDTA, 1 mM benzamidine HC1, pH 7.5) 
followed by 5 CV elution buffer (Anion exchange buffer + 1 M KC1) and then a 
further 10 CV anion exchange buffer. Sumo Protease sample was loaded, washed 
and then eluted with a 0 - 500 mM KC1 gradient over 20 CV at 2 ml/min flow rate. 
Peak samples were collected concentrated with an Ami con® Ultra (Millipore, 10K 
MWCO) to 1 mg/ml and 1 ml aliquots flash frozen in liquid nitrogen before storage 
at ~80°C.
3.6 Experimental Methods
3.6.1 SDS Page Gel Electrophoresis
A 0.75 mm glass mould was used with a 15 % resolving gel (50% of 30% 
acrylamide, 1.5 M Tris pH 8.8, cftUO, 0.1% SDS, 100 mg/ml ammonium 
persulphate (APS) and 0.1% TEMED) and 4% stacking gel (13% of 30%
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acrylamide, 0.5 M Tris pH 6.6, dH20, 0.1% SDS, 100 mg/ml APS and 0.1% 
TEMED) before a comb was inserted. Five micro litres of sample was then diluted 
with 45 pi dH20 then 50 pi 2x sample buffer was added (0.5 M Tris, 50% glycerol, 
1.6% SDS, 4% [3-mercaptoethanol and 0.1% bromophenol blue, pH 6.8). The 
samples were heated for 5 minutes at 100°C. Ten microlitres of sample was then 
loaded into each lane with 5 pi of low range molecular markers (Sigma) also loaded 
per gel.
Gels were ran using Biorad Protean II kit at 200 V for approximately 45 minutes 
and then stained for 1 hour in Coomassie G250 (0.1% Coomassie blue G250, 45% 
methanol, 45% dH20, 10% acetic acid). The gel was then destained overnight in 
dH20.
3.6.2 Dansylation of Calmodulin
The dansylation of calmodulin followed a previously published method (Vorherr et 
al 1990). Purified CaM was diluted to 50 pM in 20 mM ammonium bicarbonate, 
pH 7.5 and Ca2+ added to a concentration of 1 mM. The CaM was then mixed 1:1 
with 50 pM dansyl chloride in acetone. The mixture was incubated at room 
temperature for 2 hours and vortexed every 20 minutes. After incubation the 
mixture was dialysed (3 KD MWCO) in 4 litres 20 mM ammonium bicarbonate, 
pH 7.5 overnight 4°C. The dansyl CaM (d-CaM) was recovered, centrifuged to 
remove any particulates then buffer exchanged into fluorescence buffer (20 mM 
Tris, 150 mM NaCl, 2 mM CaCl2 pH 7.5) and concentrated to 50 pM d-CaM, using 
Amicon® Ultra (Millipore, 3K MWCO).
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3.6.3 Fluorimetric Experiments
Fluorescence measurements were performed on a Perkin Elmer fluorometer. 
Excitation was at 340 nm and emission measured between 400 - 600 nm, through a 
slit width of 5 nm, curve smoothing was also applied. A 200 pL fluorometer cuvette 
with a path length 1 cm was used for all measurements. SAP97 A70, A461 and 
A546 were buffer exchanged into fluorescence buffer and concentrated to 200 pM. 
The SAP97 constructs were then titrated into 200 pi 5 pM d-CaM in 0.5 pi aliquots 
until saturation occurred. Saturation was observed when three readings in 
succession were taken without increase in measured intensity. Each SAP97 
construct was repeated three times. Buffer blanks were then taken where 
fluorescence buffer was titrated into 5 pM d-CaM, three replicates were taken. 
Analysis measured SAP97 construct concentration minus the buffer blank against 
normalised fluorescence intensity. A plot was derived using Sigma plot 11.0, one 
site saturation curve, which generated a and standard error for each titration.
3.6,4 NMR Experiments.
13C15N Calmodulin (0.2 M) was titrated with unlabelled synthetic AKAP7931^2 
from a ratio 1:0.5 to 1:10 containing 50 mM Tris, 5 mM CaCl2, pH 6.5, 295K. The 
pH was checked for each titrant and experiments ran at 600 MHz using 5 mm O.D 
Wilmard tubes (Sigma). ID and 2D HSQC (Heteronuclear Single Quantum
Coherence) data acquired with instruction from Dr Marie Phelan using the 
programme Topspin (Bruker).
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All other NMR experiments were performed at either 800 or 600 MHz, using 5mm 
O.D. NMR Wilmard or Shigemi tubes (Shigemi Inc) and were acquired by 
Professor Lu-Yun Lian, For AKAP79 M assignment 2D HSQC and 3D
CBCANNH and CBCA(CO)NNH experiments were used and data analysed using 
CCPNMR Analysis, this will be explained in more detail in following chapters.
3.6.5 Size Exlusion Chromatography - Multi-angle Laser Light 
Scattering, SEC-MALLS
All experiments were performed by the Biomolecular Interactions Analysis Facility 
(BMIF) at the University of Manchester using a Dawn DSP (Wyatt Technology). 
The scattering data was then processed using Dynamics™. The samples were 
concentrated to 1 mg/ml and centrifuged to remove particulates before 200 pi of 
sample applied to the machine.
3.6.6 Circular Dichroism, CD
Circular Dichroism, CD is a technique used to determine the secondary structure 
and the folding properties of proteins. The technique utilizes the ability of different 
structures to absorb right and left handed circular polarised light to different extents 
(Greenfield, 2006).
All experiments were performed by the Biomolecular Interactions Analysis Facility 
(BMIF) at the University of Manchester using a Jasco J-810 (JASCO UK) with 150 
W Xenon lamp. The CD data was then processed using Origin™ software. The
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lyophilised samples were resuspended in 50 mM Tris pH 7.0 to 1 mg/ml and 
centrifuged to remove particulates before inserting into a 100 pi CD cuvette. A 
simple titration series with increasing concentrations of tiifluoro ethanol acid (TEE) 
was also earned out. The percentage a-helical formation was calculated from the 
equations
%helix = 100 x (0obs - 0C)/ (0H - 0c)
0c = 640 - 45T
0H = -40000 x (1 - x / N) + 100T
where 0ObS is the observed molar elipticity at 222 mn in deg.cm2/dmol, T = 
temperature in °C, x 15 a constant set at 2.5 and N is the number of amino acids in 
the peptide (Scholtz, Hong et al. 1991)
3.6.7 Isothermal Titration Calorimetry, ITC
Protein - protein interactions can be calculated by Isothermal Titration Calorimetry 
(ITC). Minute changes in enthalpy, either endothermic or exothermic can be 
measured by ITC. The instrument has two cells, one to hold sample, the other a 
reference cell. A syringe containing the binding sample is inserted into the sample 
cell. With each aliquot the temperature difference between the sample cell and the 
reference cell is measured. This is achieved by measuring the amount of heating or 
cooling that is required by the sample cell jacket to match the reference cell. Once 
both cells are back to the same temperature another aliquot is added. The data 
generated is processed using the built in Origin™ software.
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ITC requires only small volumes, approximately 70 pi ligand in the syringe and 300 
pi protein in the sample cell per run. Due to the sensitive nature of the technique 
both protein and ligand were dialysed overnight in the same buffer using Slide-A- 
Lyzer Dialysis Cassettes (Pierce). Both ligand and protein were then concentrated 
by Amicon® Ultra (Millipore). The protein was carefully inserted into the sample 
cell avoiding bubbles and the ligand taken up into the syringe. The syringe was then 
placed into the sample cell and spinning stalled. When the temperatures in the 
sample and reference cells were equal the titration was started. Control titrations of 
buffer into buffer, ligand into buffer and buffer into protein were also tested.
3.6.8 Small Angle X-ray Scattering, SAXS
The SAXS data were collected from the Soleil synchrotron, Gif-sur-Yvette, France 
using the SWING beam line with the help of beam line scientist Dr. Javier Perez. 
The scattering range, S was set to 0.07 - 0.5 A'1, where S = 4jrsin0 / X, 20 is the 
scattering angle and A, = 1.03 A (X-ray length). The beam size was 0.4 x 0.1 mm 
and the flux was about 1012 photons second'1 (David and Perez, 2009). Samples 
were prepared at concentrations between 1—5 mg/ml with at least 150 mM NaCl 
(for HPLC only) and 5 mM DTT (to stop radiation damage), centrifuged to remove 
particulates then approximately 100 pi added to an Agilent HPLC vial with insert. 
The system set up at Soleil, Figure 3.2, utilises two methods. In the standard batch 
method a continuous stream of cffLO at 40 gl/minute was passed through a 
capillary flow cell and through the X-ray beam. A 40 pi sample was then injected 
into the tffiLO stream flanked by two bubbles of air that the syringe inserted to
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prevent the sample diluting and to enable visual recognition of when the sample 
was passing through the beam using the video camera that is always focussed on the 
flow cell. Approximately 250 frames of data were collected for each sample at three 
concentrations and this was repeated with the sample buffer for a control. The data 
was initially processed by Dr. Javier Perez using Primus, the frames were averaged 
for each concentration and the background control subtracted.
In the second method an HPLC system with a 700 kDa size exclusion column 
(Shodex, KW403 -4F, 4.6 mm inner diameter (ID) x 300 mm long) was used. 80 pi 
of each sample was loaded at 150 pl/minute flow rate and passed through an UV 
detector, and then through the X-ray beam. 255 frames over 13 minutes were 
collected with the flat baseline used as the background control. The data were then 
collated by the in house program Foxtrot. The frames responsible for each peak on 
the chromatogram were then collated and averaged and the background subtracted. 
These data were then processed as before by Primus.
The averaged experimental data was then processed by several other computer 
programs with differing algorithms including GNOM, GASBOR, BUNCH and 
EOM (see chapter 2 for more detailed information) to enable computation of Rg 
(radius of gyration), Dmax, molecular envelopes and representative models of the 
proteins.
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Figure 32. Flow diagram of Soleil SWING beam line. Inside the SWING hutch showing the
possible path of both batch and HPLC methods. The sample vials are inserted into the injector port.
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CHAPTER 4
CHARACTERISATION OF A KINASE ANCHORING
PROTEIN, AKAP79
4.0 Introduction
There are three main aspects to each AKAP: a PKA anchoring domain, a means to 
compartmentalise the protein and the ability to bind or interact with other signalling 
molecules (Welling, 2008).
AKAP79 is 427 amino acids long in which several binding domains have been 
identified, Figure 4.0.1. At the N-terminal domain, three binding sites to the plasma 
membrane were identified (Dell'Acqua et ah, 1998) and of these one was identified 
to be a calmodulin and PKC binding site (Faux and Scott, 1997). There is also 
evidence that the central domain contains a possible binding site to MAGUK 
proteins including SAP97 (Colledge et ah, 2000). At the C-terminal there is a 
calcineurin binding domain and a PKA anchoring domain that has been the focus of 
much study (Klauck et ah, 1996).
MAGUK Binding domain CaN / \
..... ................. . ................. . .... j pka\.
145-315 315-360 393-413
CaM / PKC
31-53 76-101 116-145
Figure 4.0.1. Schematic of AKAP79 showing the locations of binding sites. Binding sites A, B 
and C represent the three hydrophilic regions proposed to be membrane binding sites. Site A also 
binds calmodulin (CaM) and PKC. The exact MAGUK binding domain is unknown but has been 
shown to lie within the region shown (Colledge et ah, 2000). The PKA and calcineurin sites are 
towards the N-terminus of the AKAP79 (Dell'Acqua et ah, 1998).
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Most of the work involving AKAP79 was carried out in Hek293 mammalian cell 
lines or using brain extracts. Thus little structural characterisation has been carried 
out.
With this in mind, the aims here are to examine and characterise the structural 
aspects of AKAP79 and individual domains of AKAP79 that were previously 
described (Dell'Acqua et alM 1998), Figure 4.0.2.
The four new AKAP79 constructs to be characterised were cloned into pETM-11, a 
vector created at EMBL derived from pET-24d with the inclusion of a TEV 
protease cleavage site between the hexahistag and the cloning site (Pinotsis et al., 
2006). A summary of the constructs made are given in Table 4.0.
CaM/PKC
MAGUK Binding domain CaN /
/ PKA v
145-315 315-360 393-413
AKAP79 EL (Full Length)
CaM / PKC
315 CaN / 427
/ PKA y,
315-360 393-413
AKAP79 C
Figure 4.02. Schematic of AKAP79 domains. Each of the separate domains were created to 
characterise AKAP79 and its binding domains. Each domain was cloned into pETM-11 vector
A | B ; C i 153
31-53 76-101 116-145
AKAP79 N
153 MAGUK Binding domain 315
AKAP79 M
a) b) c)
31-53 76-101 116 -145
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Table 4.0 Summary of AKAP79 constructs. Including purification tags, specific cleavage site and 
vector to be cloned into.
Protein Construct Vector
AKAP79 Full Length
Mr = 47 kDa
HexaHis-TEV-1 -427 pETM-11
AKAP79 N
Mr = 21.7 kDa
HexaHis-TEV-1 - 153 pETM-11
AKAP79 M
Mr = 21.5 kDa
HexaHis-TEV-153 - 315 pETM-11
AKAP79 C
Mr = 15.9 kDa
HexaHis-TEV-315 - 427 pETM-11
AKAP79 M Sumo
Mr = 30.7 kDa
HexaHis-SUMO cleavage-153 - 315 pOPIN-S
4.1 Results
During the course of the work a new cloning strategy was employed to introduce a 
fusion protein to protect the constructs from degradation and increase recombinant 
protein expression. Ligation independent cloning (LIC) is a high efficiency cloning 
strategy that was developed for high throughput screening of proteins. It forgoes the 
need for restriction enzymes and DNA Ligase, hence streamlining the procedure 
(Berrow et al., 2007). The LIC used was In-Fusion™ developed by Clonetech. 
Primers are designed with a 15 bp extension to both forward and reverse primers, 
complementary to the vector to be used. It uses a custom enzyme with exonuclease 
and proofreading activities that can recognise and fuse the ends of any two 
complementary linear DNA fragments, thus enabling precise insertion into vectors 
(Marsischky and LaBaer, 2004). This creates a three step process; amplification of 
the primers, followed by fusion to the vector and finally transformation (Figure
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4.1). The vectors used were pOPIN vectors designed by the Oxford Protein 
Production Facility (OPPF); these confer blue white screening of clones. The 
specific vector used was pOPIN-S which also contained a cleavable SUMO fusion 
protein containing a hexahistidine tag.
Amplify gene of interest with 
primers designed with a 15 bp 
extension homologous to vector.
izzn~
PCR product
Combine PCR product with cut 
vector containing homologous 
15 bp extensions and add to In- 
Fusion™ enzyme mix
In-FusionTM enzyme creates single stranded 
regions at 15 bp extensions of vector and PCR 
product and then fuses homologous strands
together
In-Fusion™ Enzyme mix
Linearised vector
Transformed plate
Figure 4.1. In-Fusion1 M Cloning. The pictorial scheme outlines the steps used in In-Fusion1 M 
Cloning. The gene is amplified with primers that contain a 15 bp extension by PCR. The product is 
then added with cut vector to the In-Fusion™ Enzyme mix and heated to 42 °C for 30 minutes for the 
fusion to occur before transformation onto an agar plate with IPTG and p-galactosidase for selection 
by Blue White screening. The figure was adapted from the In-Fusion™ Cloning manual produced by 
Clonetech.
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4.1.1 AKAP79 pETM-11 Cloning, Expression and Purification
Primer for AKAP79 full length (FL) and each of the three domains (N, M and C) 
were designed, including restriction sites for Kpnl and Ncol (NEB). The initial PCR 
gave good amplification of each construct (Figure 4.1.1). Insertion into the vector 
and ligation using Quick T4 DNA ligase (NEB) worked efficiently. Four colonies 
of each construct were then selected for screening by PCR using the initial primers 
(Invitrogen). All fours constructs AKAP FL, AKAP N, M and C domains gave 
strong bands inferring successful ligation Figure 4.1.2. The positive colonies were 
then grown up in 10 ml LB overnight and the plasmid extracted by mini-prep 
(Qiagen). Samples of each plasmid were then sent for Sanger sequencing 
(Geneservice) using stock T4 forward and reverse primers. The full sequencing 
confirmed the designed clones (see appendix 3).
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AKAP79 FL AKAP79 N AKAP79 M AKAP79 C
Figure 4.1.1.1% Agarose gel depicting initial PCR of AKAP79 constructs. Each band shows that 
each construct is the correct size, AKAP79 FL is approximately 1300 bp, AKAP79 N and M 500 bp 
and AKAP79 C is 350 bp.
lOOObp
500bp
AKAP79 FL AKAP79 M AKAP79 C
lOOObp 
500bp
AKAP79N
Figure 4.12. 1% Agarose gel depicting PCR screen of AKAP79 constructs post ligation and 
transformation. Transformed colonies were picked from agar plate, diluted in mili Q and used as a 
template for the PCR. The initial PCR primers for each construct were used for each reaction. 
AKAP79 FL, M, N and C gave positive results.
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4.2 AKAP79 Full-length
4.2.1 Expression and Purification
AKAP FL pETM-11 vector was transformed in competent B834 cells containing 
the Takara pG-KJE8 plasmid. The pG-KJE8 plasmid contains the code for five 
bacterial chaperones, dnaK, dnaJ groEL, groES and grpE. The plasmid confers 
chloramphenicol resistance for plasmid selection and has a tetracycline (Tet) and L- 
arabinose promoter for induction of chaperone expression. The chaperones reduce 
inclusion bodies and increase soluble expression (Nishihara et ah, 1998).
Unlabelled AKAP97 FL were expressed in 1 litre LB plus Kan/CM, 10 ng/mL Tet 
and 3 g/L L-arabinose to 0.7 - 0.9 ODeoo at 37°C before the cells were cold shocked 
and induced with 200 pM IPTG overnight at 18°C. Cells were pelleted at 11000 g 
for 15 minutes and resuspended in His buffer (0.5 M NaCl, 50 mM Tris HC1, 2 mM 
(3-mercaptoethanol (J3-ME pH 8) plus one EDTA free protease inhibitor tablet 
(Roche) and 250 ng DNase I. Stored at -20°C overnight.
The cells were thawed and lysed by French press at 1000 PSI, then 10 mM MgCfi 
and 5 mM ATP (bacterial) was added before being incubated at 4°C for 30 min 
with mixing to remove any chaperones still bound to the AKAP79 FL. The lysed 
cells were centrifuged (48000 g at 4°C for 45 minutes). The resultant supernatant 
was collected and filtered through 0.22 pm syringe filter ready for chromatography.
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AKAP79 FL was purified in a two step process. Firstly, it was bound to a 5 ml 
HisTrap™ High Performance (GE Healthcare), washed with increasing 
concentrations of imidazole (10, 20, 50 mM), at 2 ml/min flow rate, 6 CV at each 
increment and then eluted with 250 mM imidazole. Eluted peak was buffer 
exchanged using PD 10 desalting column to remove imidazole and concentrated to 
approximately 5 ml, ready for next purification step.
In the second step, the AKAP79 FL was further purified using a 1 ml Mono Q 5/5 
anion exchange column. The sample was loaded, washed and then eluted with a 0 - 
500 mM KC1 gradient over 20 ml at 1 ml/min flow rate.
4.2.2 Results
4.2.2.1 Expression and Purification
AKAP FL was initially expressed in B834(DE3) cells but showed no expression at 
37°C, 30°C and 18°C overnight induction with either ImM or 0.2mM IPTG 
(Melford). BL21(DE3) RP+ and Rosetta™(DE3) cells were then tested with 
Rosetta™(DE3) only showing very weak expression. It was hypothesised that 
because AKAP79 had very little tertiary structure the bacterial host cells were 
degrading the protein by proteolysis. To solve this, expression using B834(DE3) 
cells containing the Takara plasmids were tried. The best results were obtained 
using cells containing the Takara pG-KJE8 plasmid, which expresses the 
chaperones dnaK, dnaJ groEL, groES and gipE, in LB media. A band of an 
approximate size of 66 kDa was seen by SDS PAGE, Figure 4.2.3.
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AKAP79 FL
B834(DE3) Rosetta(DE3) BL21RP+IDE3) B834(DE3) B834(DE3) B834(DE3) B834(DE3) B834|DE3)
Chaperone A Chaperone 8 Chaperone C Chaperone D Chaperone E
Figure 4.2.3. Expression tests for AKAP79 FL. Each sample was induced with 0.2mM IPTG at 
18°C for approximately 18 hours. The samples were lysed using BugbusterTN1 (Pierce) centrifuged 
at 48000 g and supernatants applied to prewashed Nickel affinity resin (GE). Resin was washed 
with 10 mM imidazole before the resin was loaded onto the SDS PAGE gel. For each different 
strain the first lane is the pre-induced followed by the imidazole elution that shows soluble protein. 
Chaperone A contamed dnaK, dnaJ, grpE, groES and groEL. Chaperone B groES and groEL, 
Chaperone C dnaK, dnaJ and grpE. Chaperone D groES, groEL and tig. Chaperone E tig only.
Cell lysis was performed using a French press (Sim Aminco) and the resultant lysed 
cells centrifuged for 30 minutes at 48000 g to remove cell debris. The resultant fluid 
phase appeared in two layers; the expected clear yellow tinged solution 
(supernatant) and a second more dense brown layer (loose pellet). Increasing the 
centrifugation time to 45 minutes helped to reduced the presence of the loose pellet 
and successfully pelleted the solid phase. Analysis of the loose pellet showed that it 
did contain 5-10% AKAP79 FL together with other E.Coli proteins. To reduce the 
loose pellet further the reducing agent DTT (Melford) was changed to P* 
mercaptoethanol (Sigma), the rationale behind this was that the chaperones dnaK, 
dnaJ contained zinc fingers that precipitated when reduced by DTT
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The cell lysate was purified on a Ni2+ Affinity column, (5 ml HisTrap HP, GE) 
Figure 4.2.4. After elution with 250mM imidazole, the SDS PAGE gel showed the 
presence of AKAP79 together with other contaminating proteins after affinity 
chromatography. To decrease the level of the contaminating proteins, 5 mM Mg2+ 
and 5 mM ATP were added to the cell lysate as together they are known to induce a 
conformation change in DnaK that lowers its substrate binding affinity (Guo et al., 
2007).
1234 5 67 89
Figure 4.2.4. AKAP79 purified on 5ml Histrap HP column (GE). SDS PAGE Gel shows the 
peak fraction after addition of 250 mM imidazole. The prominent band at approximately 66 kDa is 
AKAP79, the other bands are impurities, most likely bacterial proteins or Takara chaperones. 
Lanes 2 through to 9 are pre(2) and post(3) induction, lysate(4), and pellet(5) following French 
press, Nr+ affinity flowthough (6) and buffer wash(7) and 250 mM imidazole elution (8) and 
elution post buffer exchange (9).
The AKAP FL from the Ni2+ affinity column was pooled, buffer exchanged by 
PD 10 (GE) and further purified using a Mono Q ion exchange column (1 ml 
MonoQ 5/50 GL, GE) Figure 4.2.5. The SDS PAGE showed that the main peak
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was found in fractions 5, 6 and 7; fractions were pooled and concentrated to to yield 
approximately 4 mg AKAP79 per litre LB.
AKAP FLMoniiaz^uIttaOOl.lO.UV AMP FL.Mano Q S-WuiOO*!; !0_C-«is
mAU
mma Mki.
1234567 8 9
Figure 4.2.5. AKAP79 purified on 1 ml MonoQ 5/50 GL (GE). Mono Q was run at a flow rate 1 
mL/min with a gradient 0 - 500 mM KC1 over 40 column volumes. Lane 1 shows Low range 
markers. Lane 2 sample post HisTrap, Lane 3 concentrated sample post PD 10 that also increases 
the concentration of the contaminants and Lanes 4-9 Mono Q elution. SDS PAGE Gel insert 
shows pure protein in the main peak that corresponds to AKAP79 at approximately 66 kDa.
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The gel bands of the 66 kDa band were cut out and sent for identification by mass 
spectrometry and confirmed AKAP79 FL.
42.2.2 SEC-MALLS and NMR
A sample of the purified AKAP79 was subjected to size exclusion chromatography 
- multi angle laser light scattering, (SEC-MALLS, Dawn DSP, Wyatt Technology) 
Figure 4.2.6. The scattering data was processed using Dynamics™ and provided a 
molecular mass of 43 kDa and a hydrodynamic radius of 6.6 nm. The molecular 
mass obtained was smaller than the expected 45 kDa but this type of result is 
normal for an unfolded protein. Another observation was the eluate was not initially 
homogenous perhaps due to a certain degree of aggregation so the main peak was 
collected and ran again through the SEC-MALLS. The Hydrodynamic radius was 
also greater than expected for a 45 kDa protein. This was also most likely due 
AKAP79 full length being unfolded.
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0.0 5.0 10.0
volime (niL)
15.0
Molar mass moments (g/mol) Hydrodynamic radius moments (nm)
Mn 4.290e+4 Rh(n) 6.6
Mp 4.304e44 Rh(w) 6.6
Mw 4.297e44 Rh(z) 6.6
Mz 4.304e44 Rh(avg) 2.1
M(avg) 4.287e44
rms radius inoments (nm) Translational diffusion moments (cmVsec)
Rn n/a Dt(n) 9.49e-7
Rw n/a Dt(w) 9.46e-7
Rz n/a Dt(z) 9.43e-7
R(avg) n/a Dt(avg) 3.55e-8
Figure 4.2.6. AKAP79 full length subjected to SEC-MALLS. The data collected gave an 
average molecular weight of 43 kDa and a hydrodynamic radius of 6.6. Green line shows 
absorbance, blue line the refractive index and red line the light scattering.
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ID proton spectrum of full-length AKAP79
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11 10 9876543210-1 ppm
Figure 4.2.7. 600 MHz ID 'H-NMR protein spectrum of unlabelled AKAP79 FL in 50 mM
phosphate, 50 mM NaCl, 0.01 % NaN3 pH 7.5 at 298 K.
The ]H NMR data shows that full length AKAP79 (Figure 4.2.7) is an unfolded 
protein as there is little dispersion of the amino acids resonances. This may explain 
why attempts to crystallise the protein have so far failed to yield successful results. 
The lack of dispersion in the amide region is revealed more clearly in the 15N-'H 
HSQC spectrum shown in Figure 4.2.8.
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Figure 42.8. 600 MHz 2D HSQC spectrum of 15N AKAP79 FL in 50 mM phosphate. 50
mM NaCl, 0.01% NaN3 pH 7.5 at 298 K. Peaks are not dispersed evenly showing that the protein is 
unfolded.
4.3 AKAP79 N and C Domains
Expression of these domains from the pETMl 1 constructs were screened against all 
the same bacterial host strains - BL21 RP+(DE3), Rosetta™(DE3) and B834(DE3) 
including the TAKARA chaperone plasmids- as previously described with 
AKAP79 FL. Unfortunately, no bacterial strain gave any detectable expression. 
This was possibly because of a higher level of proteolysis of the proteins during 
expression due to their shorter lengths. Due to time constraints, no further work 
was undertaken for these domains
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4.4 AKAP79 M
4.4.1 Cloning
Expression constructs were made using two vectors pETM-11 and pOPIN-S 
(Oxford Protein Production Facility), which is based on the pET28a vector 
(Novagen). Expression of AKAP79 M was unsuccessful using the pETM-11 
construct. The pOPIN-S construct has an N-terminal His tag and a Small Ubiquitin 
like Modifier protein (SUMO). Primers were designed that included a specific 15 
bp linker sequence homologous to the vector needed for the ligation independent 
In-Fusion™ cloning (Clonetech). The AKAP79 M was amplified with the primers 
using the AKAP79 FL as the template. The PCR mix was then incubated with Dpn 
I to remove any trace template before cleaning with a mini prep kit (Qiagen). The 
AKAP79 M DNA was then added with the pOPIN-S to the In-Fusion™ mix and 
heated at 42 °C for 30 minutes before the reaction was stopped with cold TE buffer, 
and was transformed into XL-1 blue cells. The infusion cloning followed by blue- 
white screening gave a good mix of white and blue colonies on the agar plate; only 
white colonies were seen on the positive control. Subsequent PCR screening of the 
white colonies with the initial primers confirmed the presence of the construct. The 
colonies were then grown up in 10 ml LB overnight and the plasmid extracted by 
mini-prep (Qiagen). A sample of plasmid (AKAP79 M Sumo) was sent for Sanger 
sequencing (Geneservice) using stock T4 forward and reverse primers. The full 
sequencing confirmed the designed clone (see appendix 3).
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4.4.2 AKAP79 M Expression and Purification
The AKAP79 M Sumo construct was transformed into BL21(DE3) cells and 
expressed at 37°C, before induction at 18°C overnight with 1 mM IPTG. After cell 
lysis and centrifugation at 48000 g, the supernatant was heated at 65°C for 5 
minutes. The sample was centrifuged again at 48000 g for 20 minutes, and 
supernatant was applied to a Ni2+ Affinity column (5 ml HisTrap™ HP, GE), 
washed with 10 column volumes of His buffer (500 mM NaCl, 50 mM Tris, pH 
8.0) and AKAP79M eluted with 250 mM imidazole. After buffer exchange using a 
HiPrep™ 26/10 (GE) desalting column to remove the imidazole, Sumo protease 
(0.2 mg) (prepared in the laboratory- see Chapter 3) was added and cleavage 
allowed to proceed at 30°C for 18 hours. Following cleavage, the protein 
preparation was reapplied to the Ni Affinity column. The flow-through which was 
cleaved AKAP79 M was collected, desalted once more and further purified using an 
anion exchange column (5 ml HiTrap™ Q FF, GE. The final protein was analysed 
by mass spectrometry and confirmed as AKAP79 M.
To prepare uniformly 13C,15N labelled AKAP79 M media containing 13C- labelled 
glucose and 15N ammonium chloride in a 2xM9 minimal media (MM) was used 
(See appendix 1 for details of media). The overnight step started with 1 colony 
grown in 1 ml LB for 4 hours before removal of the LB and resuspension in 40 ml 
MM overnight at 37°C. The cells were centrifuged at 5000 g for 10 minutes to 
remove the media before whole cell pellet was used to seed 1 L MM. It was 
necessary to increase the cell density before seeding the MM or no growth would
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occur but this had to be balanced against exposure of the cells to LB; the greater the 
exposure the greater the decrease in isotopic labelling of the protein.
The expression and purification was performed identically to the unlabelled 
preparations as described above.
The AKAP79 M was concentrated using an Amicon® Ultra (Millipore, 10K 
MWCO) to 1 mM. The protein was inserted into an NMR tube and analysed on a 
Bruker 800 MHz spectrometer at 298 K.
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4.4.3 Results
4.43.1 Expression and purification
Expression of AKAP79 M from the pETM-11 constructs were screened against all 
the same bacterial host strains - BL21 RP+(DE3), Rosetta™(DE3) and B834(DE3) 
including the TAKARA chaperone plasmids- as previously described with 
AKAP79 EL. Unfortunately, no bacterial strain gave any detectable expression due 
possibly to proteolytic cleavage during protein expression. Hence, a new construct 
was made using the pOPINS vector that includes the genes for an N-terminal His 
tag and a Small Ubiquitin like Modifier protein SUMO. The SUMO fusion was 
originally designed to improve the solubility of expressed proteins. However, in 
these studies, the SUMO fusion is used to lengthen the protein construct in order to 
minimise proteolytic cleavage. The fusion protein can be cleaved using a SUMO 
protease, a highly specific protease which cleaves the fusion protein between 
SUMO and the desired protein, hence removing the His tag at the same time. The 
vector is based on the pET28a vector (Novagen).
AKAP79 M Sumo expressed at very high levels. The heat step was introduced to 
denature the endogeneous bacterial proteins, including proteases; this was found to 
be effective in improving the long-term stability of the purified proteins. This was a 
crucial step in the protocol since AKAP79 M, being an unfolded protein, was found 
to be susceptible to proteolytic cleavage even when only traces of protease were 
present. The highly specific Sumo protease was used to cleave off the Sumo fusion 
together with the N-terminus His tag. The optimal working temperature for sumo 
protease had previously been shown to be in the temperature range 22 - 37°C
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although it is has been shown to work at 4°C (Malakhov et al., 2004). In this study, 
several sets of conditions were tested and it was found that cleavage did not proceed 
at 4°C. The cleavage was then repeated at 30°C over the time course 1, 2, 4 and 18 
hours. As shown in Figure 4.4.1, the 45 kDa AKAP M sumo fusion SDS-PAGE 
band decreased in intensity to zero after 18 hours confirming the fusion protein 
cleavage takes a long time. Two gel bands at approximately 30 and 20 kDa 
increased in intensity during the same period. The 20 kDa gel band is the cleaved 
Sumo fusion; although it measures 12.4 kDa it has been shown to migrate to 
approximately 21 kDa (Butt et al., 2005). The 30 kDa band is the cleaved AKAP79 
M (18.4 kDa) that migrates to a greater molecular weight that is attributed to lack of 
tertiary structure.
For preparation of 13C, 15N AKAP79 M, it was necessary to increase the cell density 
before seeding the MM; otherwise no growth would occur. However, it is necessary 
to minimised isotopic dilation by the LB media; only a minimal quantity of the LB 
culture was used for the seeding. The purification of 13C, 15N AKAP79 M was 
performed identically to the unlabelled preparations (section 4.4.1)
The purification of unlabelled AKAP79 M yield approximately 20 - 30 mg/L where 
as the double labelled preparation gave a lower yield of approximately 10-15 
mg/L
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Figure 4.4.1. Effect of time on AKAP M Sumo fusion cleavage analysed by 15 % SDS PAGE.
AKAP79 M was first purified using Nf+ affinity chromatography (5 mL HisTrap HP, GE) and buffer 
exchanged to remove imidazole. To the eluant an aliquot of Sumo protease (0.2 mg) was added to 
give a T=0, Lane 2, then incubated at 30 °C with gentle agitation. Samples were taken at T= 1, 2, 4 
and 18 hours, lanes 3 to 6 respectively. After 18 hours the sample was passed back through a Ni:+ 
affinity column to separate the cleaved AKAP79 M from the sumo fusion containing the N-terminal 
His Tag and the sumo protease. Lane 7. Sumo protease was run in lane 8.
4.4.3.2 NMR Spectroscopy
The AKAP79 M was concentrated using an Amicon® Ultra (Millipore, 10K mwco) 
to 1 mM. The protein was inserted into an NMR tube and analysed on a Bruker 800 
MHz spectrometer at 298 K.
The 15N1H back bone resonance assignments were completed by Dr Marie Phelan, 
using triple resonance CBCANNH and CBCA(CO)NNH spectra. The CBCANNH 
strongly identifies the Ca and C(3 chemical shifts of its own residue correlated to 
the corresponding NH group and weakly identifies the preceding Ca and Cp. 
Whereas CBCA(CO)NNH only correlates the NH group to the preceding Ca and 
CP chemical shifts. Using both spectra together is was possible to walk backwards
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following the chemical shifts of each of the preceding residues in the sequence; 
this is shown graphically in figure 4.4.2 (Protein NMR - A Practical Guide by Dr 
Victoria Higman). Assigned AKAP79 M is shown in figure 4.4.3.
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Figure 4.42. Graphical backbone assignment. Top, showing NH groups linked to the next NH 
group. Middle shows a representation of the assignment as seen from the software. With the 
corresponding NH linking, bottom where Ca dark blue and Cp light blue. Taken from Protein NMR 
- A Practical Guide by Dr Victoria Higman
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Figure 4.4.3. ‘’N-1!! HSQC spectrum of ^C/^N AKAP79 M. The chemical shift dispersion is 
narrow, reminiscent of a predominantly unstructured protein. The 13C15N ‘H backbone and 
C(3 resonances have been completely assigned using triple resonance CBCANNH and 
CBCA(CO)NNH spectra.
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4.5 AKAP79 M NMR Binding Studies
AKAP79 had been reported to bind to PSD95 and SAP97 via a large region 
corresponding to AKAP79 M (aal53-315, 18.4 kDa) (Robertson et al., 2009). 
Previously, AKAP79 was shown to interact with the SH3 and GK domains of 
PSD95 (Colledge et al., 2000). To this end the SAP97 construct A461 (53 kDa) that 
contained a PDZ domain coupled with the SH3 and GK domains was investigated 
for binding to AKAP79 M.
U4 Hook / U5
461 PDZ3
3^ SWA
461-546 571-664
Guanylate 
Kinase ^
721-911
911
153 MAGUK Binding domain 315
Using the NMR method to investigate this interaction, unlabelled SAP97 A461 was 
added and mixed to form a complex. The resultant 15N-1H HSQC spectrum is 
shown in Figure 4.5.1 and a chemical shift histogram in Figure 4.5.2. To express 
changes in the chemical shifts of the individual amide pairs a compound chemical 
shift change (in ppm) was defined as JS = (A1 H)2+0.15 (A1:)N)2, where AH and
AN are the chemical shift differences between the apo and bound in the proton / 
nitrogen dimension respectively. The weight to the amide nitrogen and proton
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chemical shifts measurements was accorded to their relative measurement error.
This differs from one experiment to the next, and should be estimated on a case-by­
case basis, 0.15 was used in this case.
No significant shift changes were observed for the resonance of AKAP79 M, 
suggesting that there was no interaction between the two proteins. The slight 
movements of a few resonances, the greatest being 0.077 ppm, are likely caused by 
small changes in pH between reference AKAP79 M and the complex.
Figure 4.5.1. ^N-'H HSQC spectrum of 13C/15N AKAP79 M in complex with SAP97 A461.
Black = free protein; Red = complexed protein. Negligible shift movement was observed when 
unlabelled SAP97 A461 was added at ratio 1:2.
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Figure 4.5.2. Bar chart of chemical shift from AKAP79 M in complex with SAP97 A461.
Chemical shifts were measured between AXAP79 M and the 1:2 SAP97 A461 2D 15N HSQCs 
respectively. Chemical shift change derived as zf<5 = (A1 H)2+0.15 (A15N)2 AH and AN are
the chemical shift differences between the apo and bound in the proton / nitrogen dimension 
respectively.
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4.6 AKAP79 M Binding to S AP97 by ITC
To further probe the binding of AKAP79 M and SAP97 A461, isothermal 
calorimetry (ITC) was used. This technique measures the tiny changes in enthalpy 
that occur during binding of proteins and ligands. The highly concentrated ligand is 
titrated into the protein and the heat exchanged recorded. This technique is useful 
because it requires no labelling or tagging of proteins and uses very small volumes, 
approximately 70 pi Ligand and 300 pi protein in the cell, although, it often 
requires high concentrations.
Unlabelled 2 mM AKAP79 M was titrated into 0.2 mM SAP97 A461, but showed 
no binding (Figure 4.6.1). Protein and ligand had been dialysed overnight to ensure 
no buffer mismatches and then concentrations measured using nano drop. Several 
concentrations of ligand to protein were tried with no success on different days and 
with two preparations of the proteins in question.
103
Time (min)
o.oo -
-0.10-
-0.20 -
-0.30 -
-0.40 -
-6.00 -
-8.00 -
0.0 0.5 1.0 1.5 2.0 2.5
Molar Ratio
Figure 4.6.1. Isothermal Calorimetry (ITC) of AKAP79 M with SAP97 A461. 2 mM AKAP79 M 
was titrated into 0.2 mM SAP97 A461 at 25°C in 50 mM Tris HC1, 50 mM NaCl pH7.5. The 
thermogram, top and integrated titration, bottom showed no binding.
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4.7 Discussion
AKAP79 is largely unfolded as was shown by the ID NMR. This is most likely the 
reason for the poor expression of the full length and shorter domains since 
unstructured proteins are more susceptible to in-cell proteolysis. The use of 
chaperones and SUMO fusions alleviated the proteolysis problems and enabled 
adequate quantities of E.Coli expressed recombinant AKAP79 and its domains to 
be purified for structural characterisation.
The use of the SUMO tag was shown as essential to express the longer AKAP79 M 
domain. It is possible that other fusion proteins may have also had the same effect 
such as glutathione-S-transferase (GST) or maltose binding protein (MBP) but these 
were discounted as they are often harder to purify and therefore give rise to lower 
yields when compared to His tag purification. Added to this is the cleavage of the 
SUMO tag uses SUMO protease a highly specific enzyme that recognises a specific 
a-Helix rather than just a specific sequence. This enables the cleavage site to be 
flush with the expressed protein and thus leaves no overhanging residues on the 
protein. In further work the other domains, AKAP79 C / N will be subcloned into 
SUMO vectors to enable there expression and purification.
AKAP79 is a known scaffold protein which is able to bind several proteins at the 
same time. These target proteins have been reported to include PKA, PKC, CaM, 
PSD95 and SAP97. The binding sites of these proteins have been mapped out on 
the primary sequence of AKAP79. The region that interacts with PKA. and PKC 
adopt a helical structure when in complex with the two kinases. Likewise for the
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CaM binding region (see Chapter 5). The fact that AKAP79 is unfolded may 
actually be necessary for its function. With no steric hindrances the protein is able 
to bind and possibly coil around its many binding partners or to bind many of the 
binding partners simultaneously when possible.
In the present studies, the binding between AKAP79 was investigated further since 
it had been widely reported in the literature. In a related study in the laboratory 
using NMR, only extremely weak interactions were detected between AKAP79 FL 
and SAP97 A461. AKAP79 M was identified by Colledge et al 2000 as binding site 
for both SAP97 and PSD95. However, no interactions were detected between 
AKAP79 M and SAP97 A461 using either ITC or NMR. There could be several 
reasons for this. It is likely that AKAP79 and SAP97 on their own do not bind to 
each other but require additional components, secondly, that the methods used to 
identify these interactions are cellular based techniques which can sometimes 
provide false positives or lastly, that the methods used were unable to identify the 
binding. Taking each point in turn; firstly AKAP79 does not bind to SAP97 
although the binding was proposed by Colledge et al 2000. Their data was based on 
GST pull downs. Recombinant SAP97 was bound to the resin and AKAP79 from 
brain extract was passed over the beads, washed and eluted with SDS before 
western blotting identified that the AKAP79 had bound. They did note that the 
amount of AKAP79 bound to SAP97 was lower than that of PSD95. That possibly 
suggests a different mechanism of binding or possible non-specific binding of 
AKAP79. Another problem with the pull down was that the AKAP79 was from 
brain extract that may have already been complexed with necessary binding 
partners and was only checked for purity through western blotting. It is also
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conceivable that the AKAP79 was already bound to PSD 9 5 from the brain extract. 
After probing the pull down with anti-AKAP79 antibody the blot was stripped and 
re-probed with anti-GST antibody, many bands were seen in the SAP97 lane as 
seen in Colledge et al 2000. The bands shown may have been degradation products 
of S AP97; if they are they may lead to increased non specific binding. It has been 
observed that AKAP79 will bind strongly to other proteins, in particular heat shock 
proteins that could only be removed through rigorous purification (see AKAP79 FL 
purification above).
The second possible reason for no binding is that the AKAP79 M sequence does not 
contain the binding site to S AP97. It has been suggested that binding of AKAP79 to 
calcineurin inhibits the binding of AKAP79 to PSD95 (Colledge et al., 2000), that is 
calcineurin binds competitively with PSD95. The calcineurin binding site is at 
residues 318 - 357 on AKAP79 (Dell'Acqua et al., 2002) and thus not within the 
AKAP79 M sequence (153 - 315). This would suggest that the SAP97 binding site 
was not located in AKAP79 M. However, Dell’Acqua 2006 believes the contrary; 
that both MAGUKS and CaN can bind to AKAP79 at the same time and that it is 
the binding of PKA that inhibits the CaN interactions. More experiments are needed 
to resolve this controversy.
The third possible reason for the absence of binding between AKAP79 M and 
SAP97 is the binding site on SAP97 is not present or masked. PSD95 was shown to 
bind to AKAP79 within the region of the SH3 - GK domain (Colledge et al., 2000). 
There is one major difference between PDS95 and SAP97 in this region; SAP97 
possesses an extended Hook region that may block the binding site unless another 
binding partner to S AP97 can lead to a displacement of the Hook region. It may be
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that SAP97 full length is required with the intramolecular interactions being 
necessary to afford a conformation that enables AKAP79 to bind.
For future work, the AKAP79 Full length, C and N domains could be cloned into 
the pOPINS vector, expressed and purified before repeating the binding studies. 
Full-length SAP97 full length could also be expressed and purified to test whether 
intramolecular forces are required for the binding to occur.
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CHAPTER 5
AKAP79 INTERACTIONS WITH CALMODULIN
5.0 Introduction
The AKAP79N domain, 1 — 153 residues contains three highly basic binding 
regions, 31 - 52, 76 - 101 and 116 - 145. The first domain, 31-52 contains a 
hydrophilic helix that had been shown to bind to PKC as well as membranes 
(Klauck et al., 1996). Originally it had been purported that the second basic region 
76 - 101 may bind Calmodulin, CaM (Carr et al,, 1992); however, it was 
subsequently shown that the polypeptide region 31-52 interacted with CaM. This 
competition between CaM and PKC for the same region on AKAP79 forms the 
basis for competitive release of PKC by CaM (Faux and Scott, 1997). CaM has also 
been reported to regulate the binding of AKAP79 to membranes both in vitro and in 
vivo, supporting the hypothesis that AKAP79 may have multiple binding sites for 
CaM (DellAcqua et al., 1998).
The CaM binding motifs are defined by the position of the hydrophobic residues. 
The target sequence AKAP79 31 -52 gave a binding motif 1-11, this did not follow 
any of the regular motifs such as 1-10 and 1-14. However, a recent structure of the 
CaM:calcineurin A complex, previously listed in the calmodulin target database to 
bind through a 1-5-8-14 motif was actually shown to have a 1-11 binding mode 
(Majava et al, 2009)
This chapter aims to characterise at the interaction between AKAP79 and CaM. It 
attempts to ascertain the positions on CaM were AKAP79 binds using both a short 
synthetic peptide encompassing residues 31—52 and longer recombinant peptides.
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5.1 NMR Studies Protein - Peptide interaction
To understand the structural basis of the binding of CaM to AKAP79 the 
interactions between a synthetic AKAP7931 -52 peptide and a double labelled CaM 
were studied by NMR.
5.1.1 Calmodulin NMR Spectroscopy
A 13C/15N rat brain calmodulin sample was expressed and purified (see Chapter 3). 
A 0.2 mM sample (10 mM CaC12, 50 mM Tris, pH 6.5) was used for the NMR 
experiments and analysed on a Bruker 600 MHz spectrometer at 298 K. The 
acquired ^N^H HSQC was assigned predominantly by transferring the assignment 
of crane toad CaM (BMRB Database Entry 6541); both CaM shared significant 
sequence homology. Peaks that could not be assigned in this manner (due either to 
different buffer and temperature conditions or differences in the amino acid 
sequence), were assigned from a new set of triple-resonance data collected; Dr. 
Marie Phelan from the laboratory performed these resonance assignments. The 
resonance assignment for rat CaM was complete apart from 5 residues (first three at 
the N-terminus, HI07 and N111) (Figure 5.1).
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Figure 5.1. Assigned 2D 15N HSQC spectra of calmodulin. 0.2 mM CaM in 10 mM CaCli, 50 mM 
Tris, pH 6.5 at 300 K.
5.1.2 CaM - AKAP793i_52Titration
Unlabelled synthetic AKAP7931 _ 52 was purchased lyophilised. Recombinant 
13C/15N labelled CaM was lyophilised from water. Titration of the peptide was 
performed in the following manner. Two samples are first made in identical buffers: 
uncomplexed CaM (sample A) and CaM:peptide complex in a concentration ratio 
of 1:10 (sample B). The protein concentrations are identical in both samples. The 
samples were made up in 10 mM CaCB, 50 mM Tris at pH6.5. The samples of the 
two initial solutions were checked to ensure that the pH’s were identical and 
adjustments were made if necessary. 2D 15N HSQCs and l3C HSQC were acquired 
for each of these starting samples and the spectra represented the start and end-
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points of the titration series. Equal aliquots from samples A and B were and store in 
separate tubes. The withdrawn aliquot (50 pi) from A was added to B and the 
aliquot from B added to A. After thorough mixing, the HSQC and I3C~1H
spectra are acquired for the new samples A and B. After this, another set of equal 
aliquots were again removed, and each added to other tube and the HSQC spectra. 
The idea behind this method of doing a ‘titration’ is to ensure (i) the buffer 
conditions remain identical throughout the titration with no dilution errors; (ii) the 
protein concentration remains the same for all titration points. In all, data for 11 
titration points were acquired. The 2D 15N HSQC data was collated and overlaid 
(Figure 5.2).
With increasing peptide concentration in the sample, the chemical shifts of many of 
the CaM resonances changed gradually. It was also evident that the chemical shifts 
were in different directions suggesting the shifts were caused by binding between 
the peptide and CaM. If shift changes were caused by changes in sample conditions, 
such as salt, then these changes would have been systematic, that is non-specific 
shifts and all in the same direction. In addition, line-broadening was also observed, 
in particular at the higher peptide concentrations.
The shift differences in the 28 most resolved residues were measured at each 
titration point, and were used to calculate the Kd values for the interaction between 
CaM and AKAP7931 - 52 peptide. Table 5.1 shows the 8 residues that gave the 
greatest binding, With Kd between 0.4 and 1 mM. The NMR data suggests very 
weak binding of CaM for AKAP7931 -52 peptide. A selection of the binding curves 
and the corresponding chemical shifts are shown in Figure 5.3. Unfortunately, the 
binding curves do not reach saturation and any further increase in the concentration
113
of the peptide would have been impractical due to insolubility issues with the 
peptide.
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5
Chemical Shift 'H (ppm)
Figure 52. Superimposed 2D 1SN HSQC spectra of calmodulin with additions of AKAPT^j.gj.
Ratios of 1:0.5, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, and 1:10 CaM to peptide were used. The 
colour code for the residues moves from magenta for CaM without peptide through the rainbow to 
violet for 1:10 CaM:peptide. The shifts from a few selected residues were analysed in detail.
Table 5.1. Chemical shift differences and derived binding constant of calmodulin interactions 
with AKAP793i -52 obtained from NMR titration. Only selected residues where the data was clear 
are shown. KD derived using equation [PL]=[LTot]+[PTot]+KD±V([LTot]+(PTot]+KDy-4[LTot][PTot] 
Where PTot is total protein and LTot is total ligand
Assign FI Traj Dist Shift Dist 
(ASppm)
Fit Error NumPeaks MM) Kd error
K115 0.228 0.173 0.101 11 3.93E-04 7.25E-05
T29 0.105 0.091 0.047 11 4.26E-04 8.11E-05
V91 0.181 0.150 0.051 11 6.07E-04 7.59E-05
K148 0.297 0.258 0.151 12 6.67E-04 1.43 E-04
A128 0.219 0.178 0.049 12 6.82E-04 6.68E-05
LI 16 0.073 0.064 0.017 11 7.19E-04 7.57E-05
D64 0.197 0.089 0.106 12 7.97E-04 1.88 E-04
G33 0.163 0.090 0.058 11 9.99E-04 1.81 E-04
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Residue number
51 61 71
105 115
Residue Number
1 ADQLTEEQIAEFKEAFJLFDKDGDGTITTKELGTVMRSLGQNPTEAELODMi:iEVDADGNGT!DFPEFLTMMAR 74
75 KMKDTDSEEEIREAFRv FDKDGNGYISAAELRHV'-'TNLGEKLTDEEVDEMIREADiDGDGQVNYEEFVQMMT 14 8
Figure 5.4. Bar chart of chemical shift as a function of residue number. Chemical shifts were 
measured between the CaM peptide free and the 1:10 CaM:peptide 2D 15N HSQCs respectfully. 
Enclosed circles show unassigned peaks, open circles show merged peaks in which the chemical 
shifts could not be accurately attributed to the residues and stars show residues of peak broadening. 
A8= (A1H)2+0.15 (A15N)2. The pictorial above the bar chart shows the approximate position of
the helix-loop-helix motif of each of the EF-hands. CaM sequence underneath graphs, red shows 
residues that shifted greater than 0.15 ppm and in purple residues that achieved strong binding 
affinities. The blue line above the sequence shows N-Lobe, cyan linker region and green C-terminal 
lobe.
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Table 5.2. Distribution of calmodulin residues affected by chemical shift differences.
N-terminal Lobe (1-69) Linker region (70-85) C-terminal Lobe (86-148)
S17 M72 R86
T29 S81 V91
L32 R106
G33 Ml 09
Q49 K115
N53 LI 16
A57 V121
163 A128
D64 1130
A147
K148
Figure 5.4 is a bar chart showing the magnitude of chemical shift changes. 
Unfortunately, a large proportion of peaks merged with other peaks thereby 
disguising the end points of the chemical shift; these were mainly found in the 
centre of the HSQC, which is the most crowded region. A collection of residues 
also disappeared due to line broadening with increasing peptide concentrations.
The chemical shift change (in ppm) was defined as y= (k'lif+O.lS (AI5N)2, 
where the weight to the amide nitrogen and proton chemical shifts measurements 
was estimated to be 0.15.
Residues with an overall chemical shift of 0.15 ppm were classified as strongly 
affected by the peptide binding, this gave 18 residues. A further four residues were 
also classed as strongly affected due to their stronger binding affinities achieved 
(marked in purple on sequence below histogram). The affected residues were also 
tabulated to show distribution across CaM domains. Table 5.2.
The strongly affected residues based on the interpreted chemical shift changes were 
then mapped onto the open form, human CaM crystal structure (pdb 1CLL)
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(Chattopadhyaya et al, 1992), that is homologous to the rat brain structure, Figure 
5.5. The mapping clearly shows regions on the N-terminal lobe that are affected by 
the presence of AKAP7931 - 52 peptide. More specifically, residues from two of the 
a-helices and a (3-sheet appear to be involved in interactions with the peptide. It is 
interesting to note that these helices and [3-sheet fold to form a channel; it is possible 
that the peptide binds in this channel. There are further areas of interaction along the 
central a-helical span and then onto a further area of interaction at the C-terminal 
lobe. The interactions shown on the 180° image shows fewer possible areas of 
interaction.
In CaM peptide complexes the residues that are most readily perturbed, providing a 
hydrophobic binding surface are the methionine residues (Vogel et al., 2011). Only 
M72 was shown to be perturbed, unfortunately, the peak shifts of the other 
methionine residues were unable to be measured due to the peaks merging and in 
some cases through line broadening that is indicative of fast-intermediate chemical 
exchange between free and bound forms of the peptide. However, with further 
analysis it may be possible to resolve these peaks and peak shifts.
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D64
A57
T29
N-terminal
K115
1 ADQLTEEQIAEFKEAF.’LFDKDGDGTITTKE ' . jTVMRSLGQNPTEAELvDMI EVD \DGNGTIPFPEFLTM AR 74
75 KMKDTDGEEEIREAFR' FDKDGNGYISAAELRHV TNLGEi'LTDEEVDEMIRE .D DGDGQVNYEEFVQMMT 148
Figure 5.5 See next page for legend.
119
Figure S.S.Chemical shift map of interactions between CaM and AKAP793i _ 52 peptide. A
surface representation of CaM with the residues affected by interactions with AKAP7931 _ 52 peptide 
depicted. Residues coloured magenta show interactions from chemical shifts >0.15 ppm .A ribbon 
model is next to each surface representation. B shows CaM rotated through 180°. Blue line above 
shows N-Lobe, cyan linker region and green C-terminal lobe.
From the interaction map the one possible orientation of the peptide would be if it 
spanned both lobes, binding to both lobes and the a-helical linker simultaneously. 
However, the AKAP7931 -52 peptide is only 22 residues long, therefore too short to 
span the gap, Figure 5.6. Since there is substantial line-broadening in the NMR 
spectrum of the CaM- the AKAP7931 _ 52 peptide complex, it was difficult to 
determine the full structure of the complex by NMR. Further work is underway in 
the laboratory using other structural techniques.
Two modes of the known CaM-peptide complexes can also possibly explain the 
current NMR data: (i) the classical compact CaM-peptide structure where the N and 
C- domains sandwich the peptide with the collapse of the helical linker (a 1:1 
stoichiometry), and (ii) the new X-shape dimer of CaM binding to two molecules of 
peptide (a 2:2 complex) These two modes are represented in Figure 5.6 (de Diego et 
al., 2010; Majava and Kursula, 2009). Stoichiometry data would be required to 
verily which mode of binding is most appropriate for the CaM- AKAP7931 - 52 
peptide complex.
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Using the compact model from as a template, pdb 1YR5 (de Diego et aL, 2010) the 
residues affected by the binding of AKAP7931 - 52 peptide were mapped and 
depicted in stick form, Figure 5.7, The model is much improved over the open CaM 
model. The C-terminal lobe residues are mostly positioned close to the peptide 
helix. However, the N-terminal lobe does not fit the model as well, with many of 
the residues far from the peptide surface. This indicates that a further movement in 
the N-terminal lobe will be required to reposition the perturbed residues in close 
proximity to the peptide. Further biophysical analysis is required to prove the 
proposed complex.
122
D64 163
Figure 5.7. Chemical shift map of interactions between CaM and model of AKAP793i _ S2 
peptide based on interactions between CaM and DAPK peptide. A simple AKAP793i -52 peptide 
model showing chemical shifts was created using Pymol assuming that binding structures show 1:1 
stochiometry and using CaM collapsed lobe model 1YR5 (de Diego et aL, 2010). A ribbon model of 
CaM with the residues affected by interactions with AKAP793i -52 peptide, below, depicted in stick 
form. Residues coloured magenta show interactions from chemical shifts >0.15 ppm, the right shows 
CaM rotated through 180°.
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5.2 Recombinant AKAP79 Calmodulin Binding Domain
To investigate the binding of CaM to AKAP79 further it would be necessary to 
repeat the NMR binding experiments with 13C/l5N-labelled in complex with 
unlabelled CaM. The cost of a double labelled synthetic peptide was prohibitive so 
a recombinant peptide was made. The peptide was also made longer for ease in 
cloning and purification plus it was thought the larger peptide might have increased 
the binding affinities.
5.2.1 Recombinant AKAP79 CBD S equence Identification
The highly basic region, 31-52 was predicted to be ct-helical, using the computer 
programme, AGADIR (Munoz and Serrano, 1997), which is a prediction algorithm 
for a-helix and coils based on transition theory. AGADIR identifies each residue 
and calculates percentage helical content for that residue. The 31-52 sequence 
showed a helix would be present but was weak, between 0.1 and 3.8% (Table 5.3). 
To test whether longer peptide sequences still had the propensity to form co-helices 
or whether it was possible to improve the co-helices the short 31-52 peptide 
sequence was elongated towards both the N and C-termini and re-ran through the 
AGADIR program.
When the stalling residue was moved to Ala24 the helix strength increased from 3.8 
to 5.2%. When the residue was moved even further to Alaig the helix strength 
increased further to 7.0%. Increasing the length towards the C-terminus did not 
improve the helical propensity, although a second weak helix was found.
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To understand and characterise the AKAP79 Calmodulin binding domain further 
three elongated constructs were cloned, AKAP79 19.51, 25-61 and 19-61, Figure 5.8.
Residue Sequence Number
Number Amino Acids
31-52 ------------KASMLC FKRRKKAAKALKPKAG--------- 22
25-61 ----- AERQKEKASMLCFKRRKKAAKALKPKAGSEAADVARK 37
19-52 AEGS PGAERQKEKASMLC FKRRKKAAKALKPKAG--------- 34
19-61 AE GS PGAERQKEKASMLCFKRRKKAAKA LKPKAGS EAADVARK 43
**********************
Figure 5.8. Sequence alignment of the AKAP79 Calmodulin binding site. Showing three 
elongated sequences derived to increase the propensity of helix formation of the binding site. The red 
letters indicate the putatative 1-11 CaM binding motif.
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Table 5.3. AKAP79 Calmodulin binding domain a-Hdix prediction. Table shows the percentage 
propensity of each individual residue in a short peptide to form an a-helix as predicted by the 
AGADIR a-helix / coil transition theory algorithm. A value of greater than 2 % is a good indicator of
helix formation (Munoz and Serrano, 1997).
Residue Amino % Helical contentacid 19-61 19-52 25-61 31-52
19 A 0.0 0.0
20 E 0.0
oo
21 G
oo oo
22 S
oo
0.0
23 P 3.2 3.2
24 G 3.4 3.5
25 A 6.4 6.4 0.0
26 E 7.4 7.5 0.2
27 R 8.6 8.6 0.7
28 Q 8.9 8.9 1.3
29 K 8.5 8.5 1.6
30 E 8.1 8.1 1.8
31 K 7.6 7.6 2.1 0.0
32 A 7.3 7.3 2.2 0.1
33 S 6.3 6.4 2.2 0.2
34 M 7.2 7.2 3.9 1.9
35 L 7.2 7.2 4.1 2.2
36 C 7.2 7.2 4.4 2.6
37 F 7.0 7.0 5.2 OJ CD
38 K 6.3 6.2 4.9 3.7
39 R 5.6 5.6 4.6 3.6
40 R 5.2 5.1 4.3 3.5
41 K 4.4 4.3 3.7 3.0
42 K 3.8 3.7 3.2 2.6
43 A 3.6 3.4 3.1 2.5
44 A 3.1 2.9 2.7 2.2
45 K 2.1 1.9 1.9 1.5
46 A 1.8 1.6 1.6 1.3
47 L 1.0 0.9 0.9 0.7
48 K 0.0 0.0 0.0 0.0
49 P 0.0
oo oo oo
50 K 0.1 0.0 0.1
oo
51 A 0.1 0.0 0.1 0.0
52 G 0.1 0.0 0.1 0.0
53 S 0.3 0.3
54 E 1.1 1.1
55 A 1.2 1.2
56 A 1.3 1.3
57 D 1.2 1.3
58 V 1.2 1.2
59 A 1.0 1.1
60 R 0.7 0.7
61 K
oo oo
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5.2.2 AKAP79 CBD Cloning
Following the successful cloning and expression of the unstructured AKAP79 M a 
similar strategy was used for the AKAP79 CBD constructs. The three constructs, 
19-51, 24-61, 19-61 were cloned into the pOPIN-S vector using the same method as 
AKAP79 M, outlined below.
Primers were designed that included a specific 15 bp linker sequence homologous 
to the vector needed for the ligation independent In-Fusion™ cloning (Clonetech). 
The AKAP79 CBD constructs were amplified with the primers using the AKAP79 
FL as the template. The PCR mix was then incubated with Dpn I to remove any 
trace template before cleaning with a mini prep kit (QIAGEN). The AKAP79 CBD 
constructs DNA was then added with the pOPIN-S to the In-Fusion™ mix and 
heated at 42°C for 30 minutes before the reaction was stopped with cold TE buffer, 
and mixture transformed into XL-1 blue cells. The infusion cloning followed by 
blue-white screening gave a good mix of white and blue colonies on the agar plate; 
only white colonies were seen on the positive control. Subsequent PCR screening of 
the white colonies with the initial primers confirmed the presence of the construct. 
The colonies were then grown up in 10 ml LB overnight and the plasmid extracted 
by mini-prep (Qiagen). Samples of each plasmid were sent for Sanger sequencing 
(Geneservice) using stock T7 forward and reverse primers. The full sequencing 
confirmed the designed clones (see appendix 3).
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5.2.3 AKAP79 CBD Expression and Purification
All three AKAP79 CBD were expressed and purified using the same procedures; 
outlined below is the procedure for AKAP79i9-6i.
The AKAP79i9-6i Sumo construct was transformed into BL21(DE3) cells and 
expressed at 37°C, before induction at 18°C overnight with 1 mM IPTG. After cell 
lysis and centrifugation at 48000 g, the supernatant was applied to a Ni2+ Affinity 
column (5 ml HisTrap™ FF, GE), washed with 10 column volumes of His buffer 
(500 mM NaCl, 50 mM Tris, 5 mM DTT pH 8.0) and AKAP79i9^i eluted with 250 
mM imidazole. After buffer exchange using a HiPrep™ 26/10 (GE) desalting 
column to remove the imidazole, Sumo protease (0.2 mg) was added and cleavage 
allowed to proceed at 4°C for 18 hours. Following the cleavage the protein 
preparation was reapplied to the Ni2+ Affinity column. The flow-through which was 
cleaved AKAP79 CBD19.61 was collected, concentrated and desalted using an 
Amicon® Ultra (Millipore, 3K MWCO). The concentrated AKAP79i9-6i was then 
further purified using HPLC on a Cl8 analytical column (4.5mm x 10 cm 5 pm 
resin diameter 100 A pore width, Jones chromatography) with a 5 - 50% 
acetonitrile + 0.01% trifluroacetic acid (TFA) gradient. The final peptide peak was 
gyrovaped to remove acetonitrile before fi-eeze drying to a powder to allow accurate 
mass measurement, which confirmed the peptide to be AKAP79i9-6i.
To prepare uniformly 13C,15N labelled AKAP79i9-6i media containing 13C- labelled 
glucose and 15N ammonium chloride in a 2xM9 minimal media (MM) was used, 
using standard methods for, expression. The purification protocol was as described 
above.
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5.2.4 AKAP79 CBD Results
5.2.4.1 Expression and Purification
The purification steps followed the same rational as with previously purified 
constructs - French press, centrifugation, HisTrapIM affinity column, desalt and 
overnight cleavage with Sumo protease. AKAP7919.51 was cleaved overnight from 
Sumo at 4°C rather than at 30°C as was used for the preparation of AKAP79 M 
(Chapter 4). This gave near 100% cleavage, Figure 5.9. The difference in 
effectiveness at the lower temperature was thought to be caused by the use of a new 
batch of Sumo protease that had greater efficacy. A heat step was also included to 
denature any proteases that may have still been present. This was initially 
introduced after the initial centrifugation following cell lysis. This, however, led to 
a loss of approximately 20% of the yield. The heat step was then moved to after the 
Sumo cleavage with little loss in yield.
kDa
66|»"—
45 
36 “
24
20
14.2
6.5
1 2 3 4 5
AKAP79 CBD19_61 Sumo Fusion
Sumo Protease
Sumo
AKAP79 CBD 19-61
6 7 8 9
Figure 5.9. AKAP79 CBDi^j purification. 18 % SDS PAGE Gel shows: Lanel=markers, 2=post 
induction,3= pellet, 4=HisTrapIM flow through. 5=wash step, 6=the peak fraction after addition of 
250 mM imidazole,7= post Sumo protease incubation at 4°C, 8=post second HisTrap™, post second 
250 mM imidazole elution. The prominent band at approximately 14 kDa is AKAP79 CBD19^i post­
cleavage.
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Another problem faced was the possibility of disulphide bond formation between 
each peptide through a cysteine residue in the centre of the sequence, this led to an 
increase in DTT to 5 mM.
Initially to desalt and concentrate the peptide a combination of dialysis and freeze 
drying was used. Unfortunately, the dialysis membrane used (500 Da cellulose 
ester, Spectra/Por®, Spectrumlabs) did not reliably retain the peptide even though 
the MWCO was six times less than the peptides molecular weight. This was 
possibly due to the membrane which was supplied wet, drying out in places that 
allowed the escape of the peptide. The best technique for freeze-drying the peptide 
was to split the peptide solution into several microcentrifuge tubes before freeze- 
drying the samples. This also allowed for easy storage of the dried peptides. The 
peptides only provide a small change in absorbance at 280 nm and do not react to 
the Bradford assay, most likely due to them containing only one aromatic residue. 
This made it difficult to use a final ion exchange cleaning step because of the lack 
of signal. However, the nature of the unstructured peptide allowed the use of HPLC 
for purification where the absorbance was measured at 214 nm, due to the amide 
bond. A C5 analytical column was used which gave a good peak but on further 
inspection the shoulder was thought to contain other species of very similar 
hydrophobicity. A Cl 8 analytical column was then used with a gradient 5 - 50% 
acetonitrile gradient. This chromatogram showed several separated peaks, Figure 
5.10. The largest peak was identified as the AKAP79i9-62 by mass spectrometry.
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Figure 5.10. AKAP79 CBD^ purified by HPLC. Double labeUed 13C/15N AKAP79 CBD,9. 
62.resuspended in dlbO and 50fil loaded onto Cl8 analytical column with a 5 - 50% acetonitrile + 
0.01% trifluroacetic acid (TFA) gradient. Main peak fraction was gyrovaped to remove acetonitrile 
and freeze dried.
All three AKAP79 CBD constructs expressed and purified well, but due to time 
constraints it was decided that further work would be carried out on AKAP7919.62.
5.2.4.2 Circular Dichroism
CD was used to analyse the secondary structure of the peptide. When the peptide 
was in Tris buffer the (0% TFE) the peptide showed a partial a-helix depicted by 
the single minimal region at 208 nm followed by a rise. As the TFE was introduced
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the sample converted to a predominately a-helical form as depicted by the two 
minimal regions at 208 and 225 nm. This occurred at just 20% TFE with little 
further changes at 40 and 50% TFE, Figure 5.11. The % helix formation for the 
peptide with the addition of TFE increased from -0.37 % (0 TFE) to ~ 2 % helix 
with between 20 and 50 % TFE.
-10-
-15-
Wavelength (nm)
Fig 5.11. CD spectra of AKAP?*)]^. Recombinant peptide, 1 mM in 50 mM Tris buffer, pH 7.0 
was titrated with 10 / 20 / 40 and 50% trifluroethanol, TFE. The Tris buffer was measured and 
subtracted. The % helix of the peptide was initially -0.37 % then increased to 0.49 % at 10% TFE 
before increasing to 2.5, 2.4 and 2.1 % for 20, 40 and 50% TFE respectively.
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52A3 NMR Studies
Lyophilised 13C/15N AKAP79ig„62 was resuspended in 50 mM Tris 5 mM DTT pH 
6.5 buffer and 2D 15N HSQCs were taken. Unfortunately, the spectra were poor 
with variation in peak sizes and degradation seen. The 2D 15N HSQCs were 
repeated using a new preparation of peptide but more poor data was generated with 
fewer peaks also registered. It was thought that there may have been a problem with 
amino acid clipping of the peptide or possible problems with the HPLC 
fractionation. Further analysis showed that the cysteine present (Css) was being 
gradually oxidised over the course of the NMR experiments (as assessed from the 
C chemical shifts of the cysteine Cp) and hence degrading the NMR spectrum. 
This also explained the array of peaks in the HPLC purification of the peptide.
This was later proved correct by re-cloning the peptide with the cysteine mutated 
into a serine (CsgS) (this work carried out by other members of the laboratory while 
this thesis was being written).
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5.3 Discussion
CaM has been shown to be a dynamic protein that can drastically change its 
conformation from a collapsed form to an extended helix with the addition calcium 
(Ishida et al., 2002). Upon binding with peptides large conformational changes in 
CaM have also been seen such as with CaMKII where both lobes collapse around 
the ligand (de Diego et al., 2010; Vetter and Leclerc, 2003). From the CaM 15N 
HSQC spectra presented here the chemical shift changes indicate that the 
conformational change where the lobes collapse around the peptide is most likely. 
From the chemical shift mapping presented, the AKAP79 calmodulin binding 
domain appears to be able to interact with both the N-terminal and C-terminal 
domains of CaM. The model derived from de Deigo, kuper et al. 2010 supports this, 
showing the mapped chemical shift changes in the C-terminal lobe and the linker 
helix that are positioned in proximity to the modelled peptide helix.
The AKAP7931 -52 does not conform to the more common CaM binding motifs but 
to a novel 1-11 binding motif recently found in calcineurin calmodulin binding 
domain, CnA-CBD (Majava and Kursula, 2009). Interestingly the CnA-CBD was 
shown to interact with CaM in a 1:1 and 2:2 ratio. Present experiments cannot rule 
out the formation of a 2:2 ratio for AKAP7931 -52, although a 1:1 ratio is more likely 
further experiments are required.
To map exactly the interaction site of AKAP79 to CaM would require further NMR 
experiments with double labelled AKAP79 peptide. This was not achieved in the 
time available due to unforeseen problems with the cysteine residue of the
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recombinant peptides. The cloning, expression and purification showed that the 
methods worked well and the production of peptides was possible.
One caveat however, is that even with both components - CaM and AKAP79 
peptide - labelled, there will still be problems in using NMR for the high-resolution 
structural work since severe line-broadening in the spectrum of the complex might 
preclude sufficient data from being acquired for the full structural calculations.
The CD of the recombinant AKAP7919-62 peptide was unaffected by the cysteine as 
the experiments were carried out at much lower concentrations than the NMR 
experiments and over a shorter timescale. The CD data showed that the secondary 
structure of the peptides was an a-helix as proposed.
Future work would continue with the NMR study of the CaM and AKAP79 
interaction using recombinant mutant peptides. A crystallisation study might also be 
possible and/or binding interactions analysed via SAXS to show any 
conformational changes.
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CHAPTER 6
BIOPHYSICAL CHARACTERISATION OF
SAP97
6.1 Introduction
SAP97 is a large multi domain protein that acts as a scaffold protein at the cell 
membrane. It contains, from the N-terminus, the L27 domain, three PDZ domains 
and a fused a src homologue 3 (SH3)-gu any late kinase like (GK) domain which is 
separated by a flexible Hook region, Figure 6.1.1. Previous structural 
characterisation of SAP97 included solved structures of the three PDZ domains 
(Cabral et al., 1996; von Ossowski et aL, 2006; Wang et al., 2005; Zhang et al., 
2007) and the L27 domain (Feng et al., 2004). The structure of SH3-GK of SAP97 
has proved elusive, possibly due to difficulties in crystallising the domains caused 
by a longer Hook region than that of the closely related PSD-95 that has two 
solved structures (McGee et al., 2001; Tavares et al., 2001).
Ul/N 1)2 1)3 U4 Hook/1)5
1-70 218-313 314-406 461-546 571-664
Guanylate 
Kinase /
721-911
Figure 6.1.1. Schematic of SAP97 showing the locations of each domain. Individual domains 
are joined together by linker regions termed U regions that are unstructured.
It is unlikely that SAP97 is just a collection of discrete domains. Rather, 
interdomain interactions exist which are important for the function of SAP97. 
Previous work by our group investigated the conformation of the triple PDZ 
region (Goult et al., 2007). A computational model reported by Wu et al 2000, 
which used the high resolution structures of similar domains from other molecules 
predicted fairly extensive conformational changes upon interactions with GKAP
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(Wu et aL, 2000). Low resolution EM images showed SAP97 to exist as a mixture 
of bent or elongated forms (Nakagawa et al., 2004).
The aims here are to characterise SAP97 further, using several constructs which 
express multiple and single domains. Initial characterisation were done using Size- 
Exclusion Chromatography-Multi Angle Light Scattering (SEC-MALS) and 
NMR. Chapter 7 describes in more detail the structural characterisation using 
SAXS. A summary of the multi domain constructs made are in Figure 6.1.2.
SAP97 A70 70
in / n 1)3 U4 Hook / U5
SH3 GuanylateKinaseV 911
218-313 314-406 461-546 571-664 721-911
114 Hook / 1)5
SAP97 \461 461 PDZ3| SH3
461-546 571-664
. Guanylate \ i
/ > I 911Kinase /j
721-911
SAFK)7 A546
U4 Hook/1)5
546 Gsr)i 911
571 - 664 721-911
Figure 6.12. Schematic of SAP97 Constructss. Each construct was created to characterise 
SAP97 overall structure. Each construct was cloned into pLEICS-01 vector.
A full length SAP97 was not created because of concerns about the 
oligomerisation effects the L27 domain might have on the protein. Previously the 
L27 domain of SAP97 was shown to form a heterotetrameric complex with the 
L27 domain of Lin-2 and was still able to interact and bind to further L27 domains
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to form large clusters of complexed proteins (Feng et ah, 2004). Due to the 
potential complications this might create, it was decided to create a SAP97 
construct without the L27 domain.
6.2 SAP97 A70, A461 and A546
6.2.1 Cloning
All the cloning of the SAP97 constructs was carried out by our collaborator Dr 
Mark Leyland, University of Leicester, into the vector pLEIC-01. This ampicillin 
resistant vector contains a hexahistag followed by a TEV protease cleavage site 
which allows removal of the tag after protein purification.
Table 6.1 Summary of all the SAP97 constructs used in this thesis.
Protein Construct Vector
SAP97 A70
Mr = 94kDa HexaHis-TEV-70 - 911 pLEIC-01
SAP97 A461
Mr = 53 kDa HexaHis-TEV -461 - 911 pLEIC-01
SAP97 A546
Mr = 46 kDa HexaHis-TEV-546 - 911 pLEIC-01
SAP97 GK
Mr = 23.5 kDa HexaHis-TEV-721 -900 pLEIC-01
SAP97 N PDZ1
Mr = 29 kDa HexaHis-TEV-70-313 pLEIC-01
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6.2.2 Expression and purification
The three constructs were expressed and purified using the same conditions, 
unless stated.
For unlabelled, rich media preparations the plasmids were transformed into 
BL21(DE3) cells (Novagen) and grown in 1 litre LB containing 0.1 g/L Amp until 
0.7 - 0.9 ODeoo (30°C, 200 ipm). The cells were induced with 1 mM IPTG and 
left to grow overnight at 18°C, 200 rpm. Cells were pelleted at 11000 g for 15 
minutes, resuspended in His buffer (0.5 M NaCl, 50 mM Tris-HCl, 2 mM DTT, 
pH 8) and 1 EDTA free protease inhibitor tablet (Roche) and 250 ng DNase I and 
stored at -20°C overnight.
The cells were thawed, lysed by French press at 1000 PSI and centrifuged at 
48000 g for 30 minutes. The resultant supernatant was collected and filtered 
through 0.22 pm syringe filter ready for chromatography
A three-step purification scheme was used for all three constructs. The clarified 
supernatant was loaded onto a 5ml HisTrap™ High Performance (GE Healthcare). 
The column was washed with increasing concentrations of imidazole (10, 20, 50 
mM), at 2 ml/min flow rate, 6 column volume (CV) at each increment. The 
protein was eluted with 250 mM imidazole and buffer exchanged using HiPrep™ 
26/10 desalting column (GE Healthcare) to remove imidazole ready for the next 
purification step.
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A 5 ml HiTrap™ Q FF anion exchange column (GE Healthcare) was next. The 
sample was loaded, washed and then eluted using a 0 - 500 mM KC1 gradient 
over 100 ml at 2 ml/min flow rate. Following concentration to 5ml using an 
Amicon® Stirred Cell (10k MWCO) to approximately 5 ml the SAP97 samples 
were loaded onto a 26/60 Superdex™ 75 gel filtration column (Superdex™ 200 
used for SAP97 A70) pre-equilibrated with Gel Filtration (GF) buffer (500 mM 
NaCl, 50 mM Tris-HCl, 2 mM DTT, 1 mM EDTApH 7.5). Isocratic elution using 
1 CV GF buffer at Imm/min flow rate yield the desired protein. The peak 
fractions were concentrated with Amicon® filter (10k MWCO). The protein 
samples were deemed to be >95% pure using SDS page gel. Protein samples were 
identified by mass spectrometry.
To prepare uniformly 2H, 15N labelled SAP97, media containing 15N ammonium 
chloride in a 2xM9 minimal media (MM) prepared in D20 rather than H20 was 
used (See appendix 1 for details of media). A single colony was grown in 5 ml LB 
for 4 hours; the sample was spun down, the LB media removed and the cells 
resuspended in 20 ml of unlabelled MM and grown to an OD6oo, of 0.6. The media 
was removed and the cells resuspended in 100 ml 15N MM in D2G. The cell 
culture were allowed to grow for some time, diluted two fold, allowed to grow 
again followed by further additions of D20 until a total of 1 litre of D2G was 
added, the cells were allowed to grow until an OD6oo of 0.5-0.6, 1 mM IPTG 
added and expression allowed to proceed overnight at 18°C. The purification was 
performed identically to the unlabelled preparations as described above. The 
SAP97 protein samples were concentrated using an Amicon® Ultra (Millipore,
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3K MWCO) to 1 mM. All NMR experiments were at acquired 298K on the 
Bruker 800 MHz spectrometer.
6.2.3 Results
The plasmids designed and made by Dr Mark Leyland were transformed in 
BL21(DE3) (Invitrogen) cells and the respective proteins expressed. An 
approximate yield 20 mg/1 of protein was purified from the rich LB media. The 
final purity is as shown in Figure 6.2.1. One problem that arose through 
purification was that the hexahistag could not be removed by Tev protease. 
Several concentrations and temperatures were used but the constructs would 
degrade before complete cleavage. It was decided to use the constructs with the 
hexahistag intact than to risk degradation and decrease the yields to an unusable 
level.
Degradation of the expressed proteins was a problem. Steps such as increasing the 
reducing agent such as DTT or introducing extra purification steps such as ion 
exchange on top of gel filtration did not stop the degradation. This could be seen 
in the samples after the NMR HSQC experiments (800 MHz, 298K,
50mM Tris 500 mM NaCl, pH 7.0), Figure 6.2.2, where extra bands on the gel 
indicated the presence of proteins at lower molecular weights. The degradation 
might be caused by the constructs containing unstructured flexible N-terminal 
domains or the elongated Hook domain found in SAP97. Ultimately, it might be 
necessary to re-engineer the constructs to totally resolve the problem. Fortunately,
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the degradation was not too severe to prevent further analysis of the expressed
proteins.
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Figure 6.2.1. 10% SDS PAGE gel showing purified SAP97 A461. The lanes are Low range 
markers (Sigma), SAP97 A461 pre induction, post induction, lysate, pellet, HisTrap1M flow 
through, wash, 250 mM imidazole elution and elution post gel filtration respectively. White mark 
shown was caused during scanning of the gel after destaining: no bands were masked.
12 3 4
Figure 6.2.2. 10% SDS PAGE gel showing purified SAP97 proteins. The lanes are: (1) High 
range markers (Sigma), (2) SAP97 A70, (3) A 461 and (4) A 546. Each sample was taken after the 
NMR experiments and showed a very small degree of degradation.
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6.2.4. NMR Characterisation
A purified sample of each of the three SAP97 constructs was buffer exchanged 
into 50 mM Tris, 500 noM NaCl, pH 7.0 and concentrated to 0.2 mM before 
insertion into an NMR tube and data collected on the spectrometer. The initial 
spectra of 15N-labelled samples gave very poor signal to noise. This is most likely 
caused by the large size of the proteins. The constructs were then re-expressed in 
deuterated medium. This has the effect of improving the resolution and the 
sensitivity of the spectra. For proteins of this size, the recommend experimental 
technique is based on the TROSY experiment. The experiment overcomes the line 
broadening effects due to rapid transverse relaxation, thereby giving spectra which 
have narrow line widths. Figure 6.2.3 to 6.2.5 show the TROSY spectra of
the 15N/2H labelled samples. Although the growth media was D2O, the amide 
protons are back-exchanged during the purification stages which were all 
performed using H2O buffers.
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To achieve deuteration, the culture media and protein production protocol was 
modified. As described in the methods section, the initial stages took approximately 
15 hours to reach the induction stage but did give a very good level of deuteration 
(approximately 85%) although the yield was lower than when using the protonated 
media, at approximately 10 mg/1 of culture.
The N- H HSQC spectrum of SAP97 A546 showed a large number of peaks 
bunched together hi the centre of the spectra that indicates an unfolded or 
disordered area. This is most likely caused by the U4 linker at the N-terminal end of 
the A546 and the U5 / Hook domain that separates the SH3 and GK domains.
The TROSY spectrum of deuterated 15N-labelled A461 is shown in Figure
6.2.6. The residues from the different domains are easily identified by overlaying 
with the separate spectra of PDZ3 and of A546. The spectrum of PDZ3 was
previously assigned (Goult et al., 2007). Assigning the PDZ3 section within A461 is 
a major undertaking which is beyond the scope of this thesis. In this work, the 
PDZ3 resonances from A461 were assigned using the ‘nearest neighbour’ approach, 
that is, the peak from the spectrum of A461 which is closest to the peak from the 
isolated PDZ3 was tentatively assigned to a PDZ3 residue within A461. This 
method is an accepted method when comparing spectra in the absence of complete 
sequential resonance assignment The current comparison suggests that PDZ3 is 
mobile and has limited contacts with the SH3-GK domain of SAP97. This approach
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of comparing resonance from different domains and ascribing which residues arise 
from which domain will be used throughout this thesis.
The 15N-2H TROSY spectrum of A70 shows only approximately half of the 
expected 805 peaks (847 total residues - 43 prolines residues which have no amide 
protons). The good chemical shift dispersion of many of the resonances indicate the 
presence of folded domains (Figure 6.2.5) When the spectra was overlaid with both 
the PDZ1 N domain and SAP97 PDZ123 (Goult et al., 2007) approximately 95 % 
of the peaks matched (Figure 6.2.7 left). This interestingly suggests that the residues 
missing from the A70 spectra belong to the SH3-GK domain. In addition, the good 
match of the resonances from the PDZ123 domain in the spectra of PDZ123 and 
A70 suggests that the SH3-GK domains do not interact with the PDZ123 domains 
to cause changes in conformation.
When A70 was overlaid with the individual PDZ domains (spectra previously 
acquired by other members of the group) the spectra did not align completely. 
Correcting for differences in pH, this results suggests that within the PDZ region, 
intramolecular interactions exist.
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Figure 6.2.8. ,SN-2H TROSY spectrum of SAP97 A70 in at 298K 50mM Tris 500 mM NaCl, pH 
6.5. A70 (black) overlaid with A461 (red) and A546 (cyan). Little movement between A70 and A461 
with most prominent peaks, 546 overlaps well with 461. and unstructured area in centre is possibly 
Hook region.
When SAP97 A70 was overlaid with A461 and A546 (Figure 6.2.8) the prominent 
peaks from A546 matched up well to the A461 peaks which in turn matched up well 
to the A70 peaks. Taken together with the above comparison with the PDZ123 
spectrum, the data suggests that the PDZ domains have little, and probably transient 
interactions, with the SH3 - GK domain.
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6.2.5 SAP97 SEC-MALLS Characterisation
Each of the purified SAP97 constructs was subjected to size exclusion 
chromatography - multi angle laser light scattering, (SEC-MALLS, Dawn DSP, 
Wyatt Technology). The scattering data was processed using Dynamics™ and this 
gave the full molecular weight of each construct as 93.7 kDa, 53.3 kDa and 46.7 
kDa and a hydrodynamic radius of 4.3, 2.1 and 2.0 nm for A70, A461 and A546 
respectively. This suggests that A70 is twice as long as the other constructs and that 
A461 and A546 are very similar in size. The SEC-MALLS also demonstrated that 
constructs are predominantly monomeric, Figure 6.2.8.
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A___J
A70 A461 A546
Molar mass moments (g/mol)
Mn 9.412e-f4 5.392644 4.683e44
Mp 9.504e+4 5.542644 4.741e44
Mw 9.425e44 5.409644 4.690e44
Mz 9.438e44 5.426644 4.696e44
M(avg) 9.372e44 5.323644 4.667e44
rms radius moments (nm)
Rn n/a n/a n/a
Rw n/a n/a n/a
Rz n/a n/a n/a
R(avg) n/a n/a n/a
Hydrodynamic radius moments (nm)
Rh(n) 4.3 6.5 8.2
Rh(vv) 4.3 6.6 8.0
Rh(z) 4.3 6.8 7.8
Rh(avg) 4.3 2.1 2.0
Translational diffiision moments (cn^/sec)
Dt(n) 5.69e-7 1.07e-6 1.10e-6
Dt(w) 5.69e-7 1.07e-6 1.10e-6
Dt(z) 5.68e-7 1.07e-6 l.lle-6
Dt(avg) 5.61e-7 1.59e-8 2.68e-8
Figure 6J.8. Top SEC-MALLS elution profile for SAP97 A461. Table of SEC-MALLS data for 
SAP97 A70, A461, A546.
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6.2.6 SAP97 A70, A 461 and A 546 - Interactions with 
Calmodulin
Calmodulin, CaM, is a Ca2+ binding protein that acts a secondary messenger within 
the cytoplasm that has previously been shown to bind to SAP97 by surface plasmon 
resonance, SPR (Paarmann et ah, 2008). To characterise our constructs further the 
interactions between each construct and CaM were investigated by fluorescence 
spectrophotometry. Both CaM and the SAP97 have no intrinsic fluorescence 
(Vorherr et aL, 1990). To impart excitation fluorescence, CaM was bound to dansyl 
chloride which fluoresces at 340 nm. The presence to dansyl chloride does not 
affect the binding properties of native CaM (Malencik et aL, 1982).
The fluorescence intensities of dansylated CaM often varies from preparation to 
preparation. This was due to the presence of free dansyl chloride. To resolve this, 
extensive dialysis was used with an initial two hour, room temperature dialysis 
followed by a second overnight dialysis at 4°C, both in 20 mM ammonium 
bicarbonate, pH 7.5. ) Emission Spectra for A70 show an increase in absorbance 
with increased A70 and a small shift to lower wavelengths (blue shift). The blue 
shift is most likely caused by intrinsic tryptophan emission from A70, Figure 6.2.9.
The fluorescence data yielded three binding curves (Figure 6.2.10) and from these 
the K& value for each binding reaction was determined (Table 6.2. The binding data 
for A546 gave a very large standard error. This was due to increasing dansyl CaM 
fluorescence with each repeat assay. A possible reason for this was free dansyl still 
present in the sample. From the binding curve for A461 it is noticeable that a greater
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concentration of A461 was required to reach saturation. In each case complete 
saturation was not achieved, this could lead to discrepancies with the Bmax and the 
Kd values.
1.2 pM
1.6 pM
2.4 pM
2.8 pM
Wavelength (nm)
Figure 6.2.9. Emission Spectrum of dansyl calmodulin after complex formation with SAP97
A70. Excitation was performed at 340 through a slit width of 5 nm with a path length 1 cm. Titration 
of increasing concentration SAP97 A70 (pM) into 5 pM D-CaM. Complex formed in the presence of 
Ca2+.
Table 6.2. The kinetic characteristics of the interaction with dansyl CaM with SAP97, Average 
of three repeats using a one-site saturation curve, V = (Bmax x X) / (Kd + X). The equilibrium 
dissociation constant Kd is given.
SAP97 Construct Kd (pM) n=2
A546 3.21 ±0.8
A461 27.2 + 1.5
A70 1.01 +0.2
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The equilibrium dissociation constant from the SPR was 122 ±46 nM for a 
SAP97 A575 construct (Paarmann et ah, 2008) compared to the 3.21 ± 0.8 pM for 
A546. It is not clear why there is such a large difference between the two studies; it 
is possible that the tethering of the SAP97 A575 construct in the SPR altered the 
conformation of the construct opening the binding site to allow the CaM to bind 
more freely. Or the dansylation of the CaM in the fluorescence experiments 
inhibited the binding to SAP97; saturation in the titrations was also not achieved 
that could also lead to an inaccurate calculation of K&\ more investigations are 
required to resolve these differences. The addition of a PDZ3 domain in A461 
showed a further decrease in binding affinity 27.2 ±1.5 while A70 showed the 
greatest binding affinity 1.01 ± 0.2 pM. Using dansylated CaM for these 
experiments have proved not to be too reliable; further studies of the interactions 
between CaM and SAP97 proteins were abandoned at this stage until a more 
reliable method could be found.
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SAP97 546 (mM)
• Data 2
SAP97 461 (pM)
SAP97 A70 (pM)
Figure 6.2.10. Fluorescence measurements of SAP97 and Calmodulin interaction. Top graph 
shows the normalised peak intensity of dansyl calmodulin binding to a varying SAP97 A546 
concentration, error bars show standard error. Middle graph shows the normalised peak intensity of 
d-CaM binding to a vaiying SAP97 A461 concentration, error bars show standard error. Bottom 
graph shows the normalised peak intensity of d-CaM binding to a vary ing S AP97 A70 concentration, 
error bars show standard error.
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6.3 SAP97 GK Domain
A new construct of SAP97 GK domain was produced by Dr. Mark Leyland from 
the University of Leicester. The expectation is that the GK domain would give 
improved NMR data which would be suitable for further structural studies.
6.3.1 S AP97 GK Expression and Purification
The expression and purification of SAP97 GK domain was similar' to the other 
SAP97 constructs.
For unlabelled, rich media preparations the plasmid was transformed into 
BL21(DE3) cells (Novagen) and expressed in 1 L LB plus 0.1 g/1 Amp until 0.7 - 
0.9 ODeoo (30°C, 200 rpm). The cells were induced with 1 mM IPTG overnight at 
18°C, 200 rpm. Cells were pelleted at 11000 g for 15 minutes and resuspended in 
His buffer (0.5 M NaCl, 50 mM Tris-HCl, 2 mM DTT, pH 8) and 1 EDTA free 
protease inhibitor tablet (Roche) and 250 ng DNase I and stored overnight at -20°C.
The cells were thawed and lysed by French press at 1000 PSI and centrifuged at 
48000 g for 30 minutes. The resultant supernatant was collected and filtered 
through 0.22 pm syringe filter ready for chromatography
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A two-step protocol was used for the purification of SAP97 GK. The supernatant 
was loaded onto a 5ml HisTrap™ Fast Flow (GE Healthcare) and washed with 
increasing concentrations of imidazole (10, 20, 30 mM), at 2 ml/min flow rate, 6 
CV at each increment. Proteins were eluted with 250 mM imidazole and the 
recovered sample from the elution buffer exchanged using HiPrep™ 26/10 
desalting column (GE Healthcare) to remove imidazole. SAP97 GK was further 
purified using a 5 ml HiTrap™ Q FF anion exchange column (GE Healthcare). The 
sample was loaded, washed and then eluted with a 0 - 500 mM KC1 gradient over 
100 ml at 2 ml/min flow rate. The protein was then concentrated using Amicon® 
Ultra (Millipore, 10k MWCO).
To prepare uniformly 13C,15N labelled SAP97 GK, media containing 13C- labelled 
glucose and 15N ammonium chloride in a 2xM9 minimal media (MM) was used 
(See appendix 1 for details of media). The overnight step started with 1 colony 
grown in 1 ml LB for 4 hours before removal of the LB and resuspension in 40 ml 
MM overnight at 37 °C. The cells were centrifuged at 5000 g for 10 minutes to 
remove the media before whole cell pellet used to seed 1 L MM. It was necessary to 
increase the cell density before seeding the MM or no growth would occur but this 
had to be balanced against exposure of the cells to LB; the greater the exposure the 
greater the decrease in isotopic labelling of the protein.
The expression and purification was performed identically to the unlabelled 
preparations in accordance to the methods above.
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6.3.2 SAP97GK Results
SAP97 GK was expressed satisfactorily and purified to five >95% pure protein 
(Figure 6.3.1). A 13C15N labelled protein was expressed and purified. However, 
problems were encountered during the buffer exchange stage. At pH below 7.0 the 
protein has a tendency to crash out of solution, forming white precipitates. At pH 
above 7.0, the protein does not appear to be fully folded. The expressed GK domain 
also had a solubility issue in that although soluble at low concentrations, it had a 
tendency to precipitate at concentrations above 1 mM. As the pi of the GK domain 
is 6.05 the poor solubility at pH greater that 7 is a surprise. The most likely 
explanation for this is that the absence of the SH3 domain destabilises the GK 
domain on its own. At the C-terminal of the GK domain there is a p-sheet that 
forms part of the SH3 fold. It is possible that this split domain also confers stability 
to the GK domain. Furthermore, the crystal structure of the SH3-GK domain from 
PSD95 (McGee et al., 2001) showed that there are important hydrophobic 
interactions between the SH3 and the GK domain. Absence of the SH3 domain 
removes these stabilising hydrophobic interactions as well as exposes a 
hydrophobic surface on the GK domain. Both these factors can explain the 
observation made here of poor protein solubility at high concentrations.
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Figure 6.3.1. 15% SDS PAGE gel showing purified SAP97 GK. Tlie lanes are (1) Low range 
markers (Sigma), (2)SAP97 GK pre induction, (3) post induction. (4) pellet, (5) lysate, (6) HisTrap™ 
flow through, (7) 10 mM imidazole, (8) 250 mM imidazole elution, (9) elution post ion exchange 
HiTrap1M Q FF and (10) Low range markers respectively. Lanes 9 and 10 were from a second SDS 
PAGE gel.
Although the protein was fragile a 13C15N sample was made. The lH HSQC 
spectrum was acquired at 600 MHz (Figure 6.3.2). This spectrum showed a good 
distribution of peaks which reflects that the protein was folded. What was also clear 
was that the protein was degrading over time in the spectrometer as seen by the 
resonances around 8ppm/128ppm (Figure 6.3.2). This degradation occurred even 
when the temperature of the NMR experiment was lowered to 295K. The 
degradation was such that 3D NMR experiments were not feasible and thus no 
structure determination was possible.
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Figure 632. HSQC spectrum SAP97 GK domain. 600 MHz 50 mM NaCl 50 mM Tris
HC1 pH 7.5, 295 K. Red circle indicates resonances from degraded protein fragments.
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6.3.3 SAP97 GK : GMP Binding
The GK domain in yeast has catalytic activity, catalyzing the reversible phosphoryl 
transfer from ATP to GMP.
The GK domain had been shown to undergo conformational change when in 
complex with GMP (Blaszczyk et al., 2001). Although it is recognised that the GK 
domain in MAGUK’s is non-catalytic, it was wondered whether GMP could still 
bind to the GK domain from SAP97. A titration of GMP (Sigma) into the GK 
domain was conducted in the 800 MHz spectrometer (Figure 6.3.3) and specific 
chemical shifts were observed, demonstrating that the GK domain was able to 
interact with the GMP.
• * » 0 8.3 8 0 7.3 7.0 F2 (ppm)
Figure 63.3. ,SN-Tl HSQC spectrum SAP97 GK : GMP complex. 800 MHz 50 mM NaCl 50 
mM Tris HC1 pH 7.5, 295 K. SAP97 GK in red and SAP97 GK : GMP complex (0.8 mM GMP) in 
black. The broad line al ~8.0 ppm is the resonance from the GMP.
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6.3.4 Comparison of SAP97 GK domain with SAP97 A546 and 
A461
The GK domain is not a stable protein, due possibly to the absence of the split 
domain that it shares with the SH3 domain. To see if this had any large effect on the 
structure of the GK domain the lH HSQC of the 13C/15N labelled GK domain was 
overlaid over both the SAP97 A546 and A461 domains which both contain the SH3 
and GK domains (Figure 6.3.4). Only about a handful of the resonances overlaid 
well in the spectra of the GK, A546 and A461. For the remaining resonances, there 
were considerable differences in shifts. What is clear from the overlaid spectra is 
that the GK domain does not contribute to the unstructured areas seen in A546 and 
A461. The significant differences in shift between the isolated GK domain and the 
GK domain in A564 and A461 suggests that the presence of the SH3 domain affects 
the magnetic environment around the GK domain. Removal of the SH3 is also 
likely to cause some conformational changes of the GK domain. The NMR results 
are not surprising since the SH3 domain is intimately linked to the GK domain, with 
considerable degree of interdomain interactions. It must be added here that 
resonances from the SH3-GK domain in A461 are weak in comparison with the 
resonances from the PDZ domain and Hook domains due to a higher degree of 
mobility in the PDZ and Hook domain. The intensities of the resonances from these 
two mobile domains are such that they visually mask the signals from the SH3-GK 
region.
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6.4 SAP97 N-PDZ1 Domain
To investigate the interactions between the N domain (U1 linker region) and PDZ1 
a new construct was created my Dr Mark Leyland from 70-318 that contains both 
PDZ1 and the N Domain.
ui / N
70
218-313
6.4.1 SAP97 N-PDZ1 Expression and Purification
The expression and purification of SAP97 N-PDZ1 domain was identical to the 
SAP97 GK domain (see section 6.3.1.).
6.4.2 Results
The expression and purification were unproblematic and yielded approximately 15 
mg/ml. A 15N labelled purification was produced, Tev protease cleaved and buffer 
exchanged into 50 mM naCl, 50 mM Tris HC1, pH 6.5 and analysed by 15N-!H 
HSQC spectrum on the 600 MHz spectrometer.
The ^N^H HSQC spectrum is shown in Figure 6.4.1. The plots are of the same 
spectrum plotted at different contour levels. The right hand figure clearly shows a
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mixture of narrow and broader line widths with chemical shift characteristics to
suggest that SAP97 N-PDZ1 has two domains - a folded and an unfolded domain. 
The unfolded region is identified by the bunching up of the resonance around 8- 
8.5ppm. The spectra of the PDZ1 domain overlay well with the dispersed 
resonances found in the spectrum of SAP97 N-PDZ1.
The data suggests that 150 or so amino acid downstream of the PDZ1 domain do 
not adopt a folded conformation; rather this region of SAP97 is unstructured. When 
the single SAP97 PDZ1 domain was overlaid with SAP97 NPDZ1 almost all of the 
peaks lined up suggesting that the N domain is not interacting with the PDZ 
domain.
sap97to>ozl_a_301109_8 2 1 /mrjrdata yuo
7.0 F2 [ppm]
Figure 6.4.2. 15N-‘H HSQC spectrum SAP97 NPDZ1 domain overlaid with PDZ1. The SAP97 
NPDZ1 (black) is overlaid with PDZ1 (red).
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Figure 6.4.1. HSQC spectrum SAP97 NPDZ1 domain. The two plots are at different
contour levels to emphasise the presence of two domains. The top plot, plotted at higher threshold 
levels has poor proton chemical shift dispersion and these signals must be from the unfolded domain 
upstream of the folded PDZ1 domains. The spectmm was acquired at 600 MHz, 50 mM Tris,50 mM 
NaCl pH 6.5.
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6.5 SAP97 PDZ 2 Domain Interactions with Kir2.1 C-
Terminus Domain.
Class I PDZ domains recognize the carboxyl terminal motif S/T- X - O, where X is 
any amino acid and <D is a hydrophobic amino acid. In work carried out in our lab 
the three PDZ domains of SAP97 were each able to bind independently to the 10
а. a, C-terminal peptide, from Kir2.1 418EPRPLRRESEI428 . Both NMR and 
fluorescence spectrophotometry showed that PDZ2 binds with higher affinity than 
the other two PDZ domains (Goult et aL, 2007). The peptide sequence contained the 
classical PDZ binding motif; the aim in this study is to investigate precisely how 
many amino acids in the C-terminus are in fact involved with PDZ interactions, and 
what additional residues might play a role in determining ligand specificity. To test 
this, a DNA construct expressing the last sixty amino acids of Kir2.1 was created by 
our collaborator, Dr. Mark Leyland, University of Leicester.
15N labelled C368 (Mr 7127 Da) was successfully expressed and purified to 99% 
purity (Figure 6.5.1). As expected, its NMR spectrum showed that C368 is 
predominantly unstructured. The spectrum was assigned through collaboration with 
Dr Ben Goult at the University of Liverpool. Aliquots of unlabelled SAP97 PDZ2 
were then titrated into 15N labelled C368. The chemical shift changes observed are 
shown in the overlay of titrated C368 in complex with PDZ2 with free C368, Figure
б. 5.2. This data showed a disappearance of three of the C368 peaks indicating that 
they were involved in binding PDZ2. Thus, from this data we are able to
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definitively define that residues E425, E427 and 1428 of Kir2.1 form the binding 
site to SAP97 PDZ2. Based on chemical shift changes, it would appear that these 
three residues form the primary PDZ-binding site for Kir2.1.
KD
20
14.2
1 2
Figure 6.5.1. SDS PAGE gd showing concentrated C368 after Nickel affinity and anion exchange 
chromatography. Lane 1 = molecular weight markers Lane 2= C368.
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ppm
Figure 6.5.2. C368 : PDZ2 NMR spectrum. 15N-1H HSQC spectrum of C368 in complex with 
SAP97 PDZ2 domain at 298K. Black =free protein; Red =complexed protein 40 mM phosphate pH 
6.8. The S426 peak at 8.07970, 115.14680 ppm in uncomplexed C368 is present but at very low 
intensity in the spectrum of the conplex. Assigned residues are visible in free form but masked in 
complex.
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6.6 Discussion
The SAP97 multi domain constructs each presented unexpected results during their 
characterisation. A546 consists of the U4-SH3-GK domains. The NMR spectrum of 
A546 consists of resonances from folded and unfolded protein domains, as 
concluded from the line widths and chemical shift characteristics of the resonances. 
For this protein the resonances from the folded region are very weak compared with 
the peaks from the unfolded region. This significant difference in line widths 
virtually led to most of the signals from the folded regions being masked by the 
intense resonances of the unfolded Hook region and prevented complete analysis of 
the data from this protein. It also made comparisons with the spectrum from the 
single GK domain very difficult.
A461 is an N-terminal extension of A546 with an additional PDZ3 domain. The 
NMR spectra showed more well-dispersed peaks when compared to A546. Overlay 
of A461 with the single PDZ3 spectrum shows that the extra peaks belong to the 
PDZ3 domain. The line width difference between the resonances are not as 
pronounced for A461 as for A546, suggesting that the flexible regions such as the 
U4 and/or Hook regions in A461 may be more constrained than in A546. The NMR 
spectra also showed that the presence of the PDZ3 domain does not significantly 
affect the chemical shifts of the SH3-GK resonances. This suggests that PDZ3 does 
not interact tightly with SH3-GK domains. In addition, the line widths of the SH3 
domain are much narrower that those from the A546 domain. It can be concluded 
that the PDZ3 domain within A461 is rather more mobile and tumbles at a different 
rate than the SH3-GK. The SEC-MALLS for both A546 and A461 showed similar
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Rg values, 2.0 verses 2.1. This suggests that both constructs are similar in size. This 
is somewhat counter-intuitive when considering the NMR data and the postulated 
mobility of the PDZ3 domain. It must be remembered that the MALLS method is 
more suited for proteins >100kD and therefore will not be able to distinguish small 
differences in size (the Mr difference between A461 and A546 is about lOkD).
The A70 NMR spectra showed many well dispersed peaks that through overlays 
were shown to belong to the PDZ domains and the U1 / N domain. Very few of the 
peaks were shown to belong to the SH3-GK domain. This suggests that the PDZ 
domains are much more mobile than the SH3-GK domain. Interdoraain mobilities 
has previously been shown to exist in SAP97 and hence the NMR results are not 
unexpected (Goult et ah, 2007). What is new here is the presence of the SH3-GK 
domain in the construct that appears not to have significantly constrained the 
movement of the PDZ domains. The SEC-MALLS data supports this view with an 
Rg twice that of A546 and A461; had A70 been more compact the Rg would be 
similar to A546 and A461.
CaM was shown to bind to SAP97 through fluorescence measurements. Previously 
through SPR CaM was shown to bind to the Hook region on SAP97 (Paarmann et 
ah, 2002). It was also shown that the SH3 domain was not required for binding but 
without, it the binding was decreased 3 fold. Another finding was that binding only 
occurred in a calcium dependant manner (Paarmann et ah, 2008). Interestingly, 
when Tavares et al (2001) attempted binding experiments between CaM and PSD95 
SH3-GK domains they were unsuccessful. They believed that the Hook region was 
not large enough to interact with the CaM protein without being sterically hindered
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by the GK domain and for binding to occur the intramolecular interactions through 
the SH3 split domain would have to be disrupted. This is thought not to occur in 
CaM binding to SAP97 because the Hook region of S AP97 contains a further 35aa.
In these new fluorescence experiments, SAP97 A461 showed the lowest binding 
affinity of 27.2 ±1.5 pM; this could possibly have been due to the mobile PDZ3 
domain moving or rotating away to a position that unblocked or unhindered the 
Hook domain binding site. In A70 the binding affinity is greater at 1.01 ± 0.2 pM. 
This difference in affinity from A461 could be explained by a conformation change 
induced by the presence the additional PDZ1 and 2 domains affecting the location 
of the PDZ3 domain. It is conceivable that the PDZ3 domain is ‘displaced’ from 
obscuring the CaM-binding region of the Hook domain. A similar difference in 
affinity of CaM for A461 and A546 was also observed in a parallel study in the 
laboratory when using ITC (unpublished data). Thus the more native folding of the 
A70 may promote the accessibility of the Hook domain leading to the greater K& 
than for A461.
The fluorescence experiments gave a weak binding affinity for CaM to SAP97, at 
an affinity of 1 pM it could be argued that it is not physiological relevant because 
the CaM has many other binding partners which it will bind more strongly and thus 
will out compete the SAP97. This may suggest that the SAP97:CaM complex 
requires another protein present to increase the binding affinity to SAP97 or that the 
fluorescence data grossly underestimates the binding affinity of CaM to SAP97.
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SAP97 GK domain was unfortunately not stable and could not be concentrated 
above 1 mM. This precluded extensive characterisation of the domain. The most 
logical reason for the instability is that the GK domain requires the SH3 domain for 
its stability. The SH3-GK pairing contains a split domain with the final SH3 (3-sheet 
being formed by a polypeptide sequence downstream of the GK polypeptide 
sequence (McGee et al., 2001; Tavares et al., 2001), This [3-sheet may also stabilise 
the GK domain.
A construct of the SH3 domain was attempted by our collaborators and myself but 
the addition of the spilt J3-sheet proved unattainable and with pressing time 
constraints, focus was placed elsewhere.
The SAP97 NPDZ1 domain showed that the U1 / N region was unstructured and 
flexible. This flexibility was also observed through overlay of the A70 spectra. The 
NMR studies here contradict a previously reported intramolecular interaction 
between the N domain and the SH3-Hook domain (Wu et al., 2000). However, the 
Wu et al study (2000) used full length SAP97 and determined that residues 1-104 
were required for intramolecular interactions with the SH3 Hook domains. 
Although no specific binding studies between SAP97 NPDZ1 and A546 were 
attempted due to time constraints there were no observations from the A70 NMR 
spectra to support an intramolecular interaction involving the N domain. A70 
contains the N domain; if it was interacting with the SH3 and/or the Hook domain 
this would be expected to be visible in the NMR spectra, because the bound N 
domain would be stabilised and would therefore not appear as mobile and flexible. 
Nevertheless, more careful studies need to be undertaken to be absolutely certain.
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In previous work from this lab it was shown, by NMR, that the 10 a.a. peptide, 
Kir2.1 C418 - 428 interacted with each of the PDZ123 domains of SAP97.PDZ2 
was also shown to have the greatest affinity compared with PDZ1 and PDZ3 (Goult 
et ah, 2007). The binding data using PDZ2 showed that R424, E425, and I428 from 
Kir2.1 C368 form the major sites of interactions with PDZ2. There is indication that 
both E427 and S426 are also involved in the interaction; this makes sense since the 
serine residue is a consensus residue with a PDZ-binding motif. Further work to 
probe the interactions between PDZ2 and Kir2.1 would involve determining the 
high resolution structure of the complex either by NMR or X-ray crystallography.
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CHAPTER 7
Small Angle X-ray Studies of SAP97
7.1 Introduction
Small angle X-ray scattering (SAXS) is a tool to study the shape and conformation 
of a molecule. Unlike the high resolution NMR and X-ray crystallographic 
techniques SAXS does not define the three dimensional structure at atomic 
resolution. However, in combination with the high resolution techniques, SAXS has 
the ability to study the organisation of domains of molecules and provide 
information about conformation and shape. This is particularly useful in the 
situation when the proteins are either too large or too flexible for studies using 
NMR or X-ray crystallography. SAXS also has the advantage of being a solution- 
based technique.
As already stated earlier, no high resolution structures of any full length MAGUKs 
have been resolved. However, low resolution negative staining electron microscopy 
was used on full length SAP97 and showed that it existed in two major forms as 
extended rods (65 %) and as c-shaped or ring like structures (35 % ) (Nakagawa et 
al, 2004).
SAXS was previously also used to determine the conformation of PDZ12 and 
PDZ123 domains (Goult et al., 2007); these data showed that the U4 linker and 
PDZ3 domain were mobile although the dynamics were restricted, with PDZ3 
located within 40 A from PDZ12.
This work focuses on SAXS analysis of the three SAP97 constructs A546, A461 and 
A70 (see Chapter 6 for details of protein preparation and other characterisation) and
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will attempt to elucidate their shape and the orientation of the individual SAP97 
domains. The methods used involve many computational steps that are outlined in 
the flow diagram below, Figure 7.1.1. The individual programs used are discussed 
in chapter 2.
Sample prep
GASBOR DAMAVER
If DAMAVE3 model •$ poor individual 
GASOOR models might give a better fitScattering Data
GNOM
BUNCH CRYSOL
FOXTROT / Primus
CRYSOL
It model is poor repeat 
using different conditions
Best model Chosen 
and fitted into 
DAMAVER model
At the Synchrotron
MODELLER
Known PDB 
Structure
Create
Structure
l-TASSER
Figure 7.1.1. Flow diagram of SAXS interpretation. Initial data collection and data processing is 
carried out at the synchrotron or X-ray source. Tie remaining interpretation requires freeware 
programs and can be processed on any modem computer.
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7.2 SAP97 A546 Results
7.2.1 SAP97 A546 Scattering Results
The SAXS data for three different concentrations, 1, 2, and 3 mg/ml was collected 
in batch mode on the SWING beamline at the SOLEIL Synchrotron, Paris. The data 
was initially analysed by the synchrotron principal beamline scientist, Dr Javier 
Perez using the in-house software “Foxtrot” and freeware program PRIMUS which 
averaged data for the three concentrations and then subtracted the background 
scattering. The SAP97 A546 scattering data was then further processed using the 
program GNOM and obtained a Dmax of 115 A and an Rg 29.2 A, distribution of 
scattering mass and radius of gyration respectively,(Figure 7.2.1) where the Dmax is 
the maximum dimension of the proteins and the Rg is a measure of the size of the 
protein derived from the root mean square distance of the central particle to the 
scattering length density distribution.
The P(r) value (regularization parameter) was also calculated directly from 
scattering curve using GNOM (Figure 7.2.1) which depicts the distribution of 
intramolecular atomic distances within the molecule (Svergun, 1992). The broad 
peak indicates a spherical shape and the tail possibly indicates a smaller longer area 
present.
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Scattering. S - 4^ sinij) / y (A)
Figure 12.\. Small angle X-ray scattering of SAP97 A546. The averaged scattering data from 1, 2 
and 3 mg/ml concentrations of SAP97 A546. The lower plot shows the P(r) value (regularization 
parameter) calculated by GNOM and gives the Rg 29.2 A and the Dmax 115 A.
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7.2.2 SAP97 A546 GASBOR and DAMAVER
Although the P(r) enables the molecular shape to be deduced, there are now 
algorithms that allow the production of 3D models from the ID scattering data 
(Svergun and Koch, 2002). GASBOR is an ab initio modelling program that uses 
dummy residues (small spheres) to build a compatible model inside the Dmax of the 
molecule that allows the fitting of the ID scattering curve up to 0.5 nm resolution 
(Svergun et al., 2001). Models of A546, were created using GASBOR and were 
then averaged using the program DAMAVER (Volkov and Svergun, 2003).
The A546 models or envelopes generated by GASBOR (n = 10 no rejections) each 
showed a large compact area with lumps and protrusions that in some cases showed 
a hollow centre with a second smaller elongated area protruding at one end (Figure 
7.2.2). It is most likely that the protrusion is the N-terminal U4 linker and 
hexahistag tail of A546 (see Appendix for the complete polypeptide sequence of 
A546). When averaged by DAMAVER (Figure 7.2.3) the envelope created showed 
a smooth large spherical area that has a depression on one side followed by a 
second smaller sphere protruding at one end.
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Figure 7.2.3. Averaged model envelope for SAP97 A546. Three orientations of the 3D envelope 
generated from ID scattering data using program GAS BOR and averaged using program 
DAM AVER (n=10).
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7.2.3 SAP97 A546 Rigid-Body Modelling
Multidomain proteins can be fitted to the scattering data using rigid body modelling 
programs such as BUNCH or EOM. This requires high resolution structures for the 
individual domains form either NMR or X-ray crystallography. This provided 
problems for SAP97 that has no high resolution structures available for the SH3 and 
GK domains, although X-ray and/or NMR structures for the individual PDZ 
domains do exist. Fortunately there are structures available for PSD95 whose SH3- 
GK domain shares 70 % homology with SAP97, and where the main difference 
between PSD95 and SAP97 is in the Hook region. In SAP97 this region, also 
known as the U5 linker, is elongated (80 amino acids in SAP97 rather than 35 in 
PSD95). This allows PSD95 to be used as a template to create models of SAP97 
SH3 and GK domains using ab initio or comparative modelling using, respectively, 
I-TASSER and MODELLER programmes.
7.2.3./ I-TASSER Modelling
A model of SAP97 SH3-GK domain was generated using the ab initio modelling 
program I-TASSER (discussed in chapter 2). The SAP97 A546 sequence was input 
into the web server and 5 models generated using the PSD95 (1KJW) and other 
SH3 and GK domains from the CaV P-subunit-2a (1T3L) and a PDZ domain 
(2FY5) as templates. To test how reliable the models were the program CRYSOL 
(Svergun et ah, 1995) was used that fit the model to the scattering data (Figure 
7.2.4). The best fit was given by model 5 so this model was used for the further 
experiments. Only the individual domains were required for the rigid body
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modelling because the programs would add any unstructured areas or linker 
regions. The coordinates of only the SH3 (SH3mod5), GK (GKmod5) domains and 
two separate helices that formed the U4 linker were selected from the PDB files of 
the models to create the templates for the rigid body modelling (Figure 7.2.5).
-2.0'
-3.0"
0.30 0.400.20
q = 4jt sinG / X (A)
0.00 0.10
Figure 7.2.4. CRYSOL curve for I-TASSER model of SAP97 A546. The curve fit in blue 
represents how close the I-TASSER model generated is to the experimental scattering data (in red).
The SH3mod5 and GKmod5 domains were overlaid with the PSD95 SH3 and GK 
domains and showed good chain alignment; however, not all of the (3-sheets of the 
PSD95 model were replicated in both SH3mod5 and GKmod5 (Figure 7.2.6). To 
improve the models individual SAP97 SH3 and GK domains were then generated 
with I-TASSER using specific domain sequences without the linker regions. I- 
TASSER only predicted one result for both domains, SH3Tassl and GKTassl. 
These new models when overlaid with PSD95 showed a greater similarity and 
showed a far better alignment of the p-sheets (Figure 7.2.7).
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Figure 72.5. I-TASSER model of SAP97 A546. The amino acid sequence of SAP97 A546 was 
inserted into I-TASSER on line program and 5 models were generated. (Top) The model that gave 
the closest match to the scattering data as judged by CRYSOL. The individual domains have been 
coloured, SH3 Magenta, GK Forrest green. Hook domain blue and the U4 linker a-Helices in green 
and cyan. (bottom)The SH3 (SH3mod5) and GK (GKmod5) domains ‘excised' from the above 
model, leaving out the flexible linker regions.
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Figure 72.6. PSD95 SH3, GK domains overlaid with SAP97 SH3mod5 and GKmodS models 
generated using I-TASSER. SH3 Magenta, GK Forrest green. The PSD95 (grey) was taken from 
the crystal structure 1KJW (McGee et al., 2001). PyMOL was used for the overlay.
Figure 72.7. PSD95 SH3, GK domains overlaid with SAP97 SH3Tassl and GKTassl 
generated models. Models generated using I-TASSER on individual domains of SAP97, SH3 
Magenta, GK Forrest green. The PSD95 (grey) was taken from the crystal structure 1KJW (McGee 
et al., 2001). PyMOL was used for the overlay.
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72.3.2 MODELLER Modelling
In comparative modelling, the SAP97 SH3 and GK domains models were also 
generated using MODELLER with a PSD95 template. There are two crystal 
structures for PSD95 in the PDB database (1KJW and 1JXO, respectively, from 
McGee et al. (2001) and Tavares et al. (2001).). The SH3 domains of both are 
different with the a-Helix longer in 1JXO than 1KJW. The 1KJW pdb file shows all 
the a-helices, p-sheets and residues in between intact whereas 1JXO pdb file has 
one of the loops of residues undefined. The GK domains do not differ noticeably. 
The template 1KJW was used because of the intact loop of residues that may have 
proven more difficult for MODELLER to predict correctly.
The 5 models predicted for both SAP97 SH3 and GK domains were analysed by 
DOPE, an analysis program used with MODELLER to show goodness of models 
pictorially. For SAP97 SH3 the plotted DOPE results (Figure 7.2.8) showed a good 
comparison between each of the MODELLER predicted models with the exception 
of the second model, SAP97SH32 that varied in the last 10 residues. The overlay of 
all the MODELLER predictions shows that there is much variation at the C- 
terminus of the SH3 domain as this is the least constrained region. Also included in 
the DOPE analysis was the SH3mod5 model from I-TASSER (named model5C and 
model5N in Figure 7.28); this too matched up well except for the lastlO residues. 
This is because it was modelled using both PSD95 templates (1JXO and 1KJW ) 
and this facilitates a greater change in the a-Helix motif.
The SAP97 GK predicted domains all showed similar DOPE profiles with the 
1KJW template except for the first 10 residues and the last 5 residues. When
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looking at the overlaid models both the C- and N-terminus of the domains are 
unstructured, which may account for the variation observed in the DOPE analysis.
"sh31kjw.profile’ using 1:42--------
"SAP97SH31.PROFILE" using 1:42
'•SAP97SH32.PROFILE" using 1:42 --------
'•SAP97SH33.PROFILE" using 1:42 --------
x”SAP97SH34.PROFILF using 1:42 
1'$AP97SH35.PROFILE" using 1:42 
\ \ "modelSN,profile" using 1:42--------
"gklkjw.proflle'' using 1:42--------
"SAP97GK1.PROFILE" using 1:42 -------
"SAP97GK2PROFILE" using 1:42--------
"SAP97GK3.PROFILE” using 1:42--------
"SAP97GK4.PROFILE" using 1:42 
"SAP97GKSPROFILE" using 1:42
"modelSCprofile" using 1:42--------
Figure 7.2.8. DOPE analysis for SAP97 8113 and GK domains. MODELLER generated DOPE 
curves showing the energy differences between the PSD95 (1KJW) template and 5 generated 
profiles, top SH3, bottom GK domain.
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Figure 7.2.9. SAP97 SH3 GK domains generated by MODELLER overlaid with PSD95. The 5
models generated show good comparison with PSD-95. Same colour scheme used as Figure 7.2.8 
DOPE analysis. The PSD95 (grey) was taken from the crystal structure 1KJW (McGee et al., 2001). 
PyMOL was used for the overlay.
7.2.3.3 I-TASSER - MODELLER Comparison
Models of the SAP97 SH3 and GK domains generated with I-TASSER and 
MODELLER were evaluated using the RMSD when overlaid against the PSD95 
template, 1KJW in PyMOL (Table 7.2). CRYSOL could not be used to test 
reliability. CRYSOL measures the model against the reference scattering data and 
because each of these models was of individual domains only, they would not fit the 
scattering data. The RMSD results show that MODELLER generated structures for 
both SAP97 SH3 and GK domains gave lower RSMD scores and these are 
interpreted as better models. There are two possible reasons for this:
(a) the MODELLER program concentrates not only on main chain orientation but 
also on the side chains of the model when compared with I-TASSER. This can 
clearly be seen when SAP97SH32 (Modeller) and SH3Mod5 (I-TASSER) are 
overlaid with 1KJW (Figure 7.2.10). Whether or not the side chains predicted
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positions from MODELLER are actually correct for SAP97 cannot be determined 
until higher resolution models of SAP97 are solved.
(b) The I-TASSER models use a combination of both of the PSD-95 crystal 
structures, 1KJW and 1JXO so when compared to just the 1KJW structure they 
show a greater RSMD.
Table 7.2.SAP97 SH3 and GK RMSD comparisons of I-TASSER and MODELLER models
using PSD95 1KJW as a template.
SH3 Model RMSD (A)
SH3Mod5 (I- TASSER) 1.03
SH3Tassl (I-TASSER) 0.807
SAP97SH32 (Modeller) 0.422
GK Model RMSD (A)
GKModS (I- TASSER) 0.952
GKTassl (I-TASSER) 0.696
SAP97GK1 (Modeller) 0.322
Figure 7.2.10. SAP97 SH3 domain side chain overlays. The MODELLER generated SAP97SH32 
(left) and I-TASSER generated SH3Tassl (right) models showing only backbone and side chains 
overlay with PSD95 SH3. The PSD95 side chains (red) was taken from the crystal structure 1KJW 
(McGee et al. 2001). PyMOL was used for the overlay.
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The choice of which SAP97 SH3 and GK models to use for the rigid body 
modelling really comes down to personal preference as all models are acceptable. 
Since the SAXS scattering can only interpret globular proteins, the finer twists and 
turns of a-helices and p-sheets or position of side chains will not influence the 
modelling. For this reason both models generated from I-TASSER and 
MODELLER will be used.
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7.2.3.4 SAP97 A546 Bunch Rigid body modelling
The SH3Mod5 and GKMod5 SAP97 models and the two a-Helices that constituted 
the U4 linker were fitted to the scattering data using the program BUNCH (See 
chapter 2 for explanation). The SH3Mod5 and GKMod5 were fixed to show the ab 
initio modelling and the possible positions of the U4 linker and the Hook region 
(Figure 7.2.11). When six BUNCH runs were overlaid the U4 linker region, that 
contained the two short helices, was seen to be very flexible and able to exist in 
many positions that surround the core SH3-GK domain and are often elongated. 
The Hook was modelled and shown to lie between the SH3 and GK domains.
Figure 7.2.11. SAP97 A546 Rigid Body modelling. An overlay of 6 BUNCH analyses with GK 
(forest green) and SH3 (magenta) fixed and two a-Helices that form part of the U4 linker (cyan, 
green) flexible. The individual dots each represent the linker region or Hook region
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To test which of the BUNCH models best fit to the scattering data the .pdb files of 
each model was passed through CRYSOL. 546r2, the second BUNCH run, gave x = 
11.2 which is well within tolerances for multi domain proteins (Petoukhov and 
Svergun, 2005). The BUNCH model also showed an intact modelled Hook region 
and a more compact U4 linker region (Figure 7.2.12).
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Figure 7.2.12. Analysis of SAP97 A546 by BUNCH and CRYSOL. Shown in the inset is the A546 
conformer analysed for goodness of fit by CRYSOL
The BUNCH model was then superimposed over the averaged GASBOR image 
(Figure 7.2.13) and visually showed a poor fit. There are large areas of free space 
around both the GK and SH3 domains and the base of the SH3 domain does not fit 
very well within the envelope. The Hook region could possibly flex to fill some of 
the spaces but not all. The U4 linker region also does not fit the envelope but this is 
of less concern as the flexibility in the unstructured region could move within the 
envelope.
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7.2.3.5 SAP97 A546 EOMRigid Body Modelling
To attempt to improve the superimposed fit the SAP97 SH3-GK domains were 
analysed using Ensemble Optimisation Method, EOM, another rigid body modeller 
that was developed for proteins which are more unstructured or flexible in nature 
(Bemado et al., 2007). The expectation was that EOM might help to determine the 
position of the Hook region. Initially SH3Mod5 and GKMod5 models were used 
for consistency (section 7.2.3.4) however, this resulted in the two domains being 
separated which is physiologically impossible because of the split domain that the 
GK and SH3 domains share. To remedy this, the BUNCH 546r2 model was used 
but the flexible U4 region was removed and replaced with an U4 alpha helix from 
the PDZ3 domain (1PDR). EOM created 10000 theoretical curves and then selected 
the ensemble of curves that best fitted the experimental data. Of these, the 
conformers that showed the greatest frequency or abundance were selected and 
models generated.
The SAP97 A546 EOM frequency distribution (Figure 7.2.14) shows the pool of 
10000 structures spread from 24 to 34 A while the A546 conformers best fitting the 
data is spread from 24 to 29 A with an average Rg ~25 A. This concurs well with an 
Rg -29.2 A that was calculated by GNOM (see section 7.2.1) This shows that A546 
exists in a predominantly compact form with 60 % of conformers between 24 to 29 
A. The more elongated conformers are most likely caused by elongation of the U4 
linker.
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Rg(A)
Figure 7.2.14. Analysis of SAP97 A546 by EOM. A frequency distribution of the SAP97 A546 
conformers as a function of Rg. Black dashed line is the distribution of the initial 10000 pool 
conformers and the black line is the distribution of the analysed A546 ensemble. Two representative 
structures for the conformers within the EOM ensemble were judged to realistically fit the A546 
model
In total, the ensemble generated 17 conformers where the U4 linkers were either 
close to the SH3 domain or completely extended giving a very elongated model. 
When the intensities plotted as a function of momentum of transfer, a measure of fit 
equivalent to CRYSOL (Figure 7.2.15) it was shown to give a good fit, yj A19 that 
was lower than the fit given by BUNCH.
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Figure 7.2.15. Analysis of SAP97 A546 by EOM fitting. SAXS intensities plotted as a function of 
momentum of transfer. Dots represent experimental data; solid line is fit obtained from the ensemble 
of 14 conformers
The 17 EOM models were superimposed over the SH3-GK domain and overlaid on 
one GASBOR model to show the conformational variety for U4 region which 
contains the a helix (Figure 7.2.16). The U4 linker can be seen to vary in position 
that suggests that it is highly mobile.
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7.23,6 SAP97A546 Bunch and EOM-GASBOR Overlay
When the SAP97 A546 BUNCH model was overlaid with the averaged GASBOR 
model it was not a good fit, with areas of the envelope volumes unoccupied. The 
SAP97 A546 EOM models were also overlaid but these too did not create a good 
fit. When analysing the individual GASBOR envelopes (Figure 7.2.2) it was 
noticed that some envelopes provided a smaller volume that might fit the rigid body 
models more tightly. The BUNCH and EOM models were then superimposed over 
the individual envelopes. SAP97 A546 BUNCH model 546r2 fit well into the 
envelope J; for comparison PSD95 crystal structure was also successfully fitted into 
the same envelope. The EOM models also superimposed well into the individual 
envelopes with SAP97 A546 EOM 3588 fitting into the GASBOR G individual 
model respectively (Figure 7.2.17 a-c). The linker regions in each overlay did not 
always match up with the envelope that is most likely caused by the flexible nature 
of the linker region.
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7.2.4 SAP97 A546 SAXS Analysis Discussion
The modelling of SAP97 A546 worked well using both I-TASSER and 
MODELLER. For the low resolution approach the overall shape of the model was 
all that was required for the rigid body modelling and superimposition of the 
GASBOR envelopes. The LTASSER model using two PSD95 structures as 
templates gave the overall best model.
BUNCH is the first starting point for rigid body modelling as it attempts to find the 
best solution to the scattering data. This method works well for multi domain 
proteins that are stable in conformation and have few flexible regions. For A546 
BUNCH struggled with the positioning of both the Hook and the U4 linker region 
and the ab initio modelling of the regions, often wrapping the domains around other 
domains. One good model was produced that overlaid well with the PSD95 crystal 
structure.
BOM was developed to analyse flexible proteins or proteins with flexible linker 
regions. The models generated using EOM were mostly compact (60 %) in 
structure as expected from the PSD95 model but the U4 linker also showed 
movement and elongation.
When the different EOM models along with the BUNCH model were superimposed 
into the individual GASBOR envelopes different models fitted different envelopes. 
This suggests on this data alone that the movement and flexibility U4 linker domain 
is real and not an artefact of the EOM, highlighting that A546 is a dynamic system. 
This movement would also account for why there are so many differences in the 
GASBOR envelopes and why BUNCH was not very successful at modelling A546.
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7.3 SAP97 A 461 Results
7.3.1 SAP97 A461 Scattering Results
As with A546 above the SAXS data was collected by batch method for 1, 2, and 3 
mg/ml concentrations, and then initially analysed by the synchrotron principal 
beamline scientist, Dr Javier Perez the data was averaged and the background 
subtracted. The scattering data was then further processed using the program 
GNOM, and Dmax 150 A and Rg 31.9 A were derived for SAP97 A461 (Figure 
7.3.1).
The P(r) distribution shows a broad peak that indicates a spherical shape followed 
by a hump from ~60 - 120 A. This suggests that there is another area that is quite 
elongated possibly with a smaller domain present. The Dniax is quite large for just 
the addition of a PDZ domain. With the P(r) almost at zero at 120 A it is most likely 
that this is the actual Dmax5 the further elongation to 150 A is just an effect of the 
GNOM processing.
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Figure 7-3.1. Small angle X-ray scattering of SAP97 A461. The averaged scattering data from 1, 2 
and 3 mg/ml concentrations of SAP97 A461. The inset shows the P(r) value (regularization 
parameter) calculated by GNOM and gives the Rg 31.9 A and the Dmax 150 A.
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7.3.2 SAP97 A461 GASBOR and DAMAVER
Models of A461 were created using GASBOR (Figure 7.3.2). The variation 
between the individual envelopes was less than with the A546 envelopes. They each 
showed a large mass followed by a smaller mass and then a thin ribbon and a small 
nodule. Some of the envelopes were also noticed to be thinner than A 546 appearing 
to be all in one plane. This suggests that the PDZ3 domain would be positioned 
alongside the SH3-GK domain. The envelopes were then averaged (Figure 7.3.3) 
using the program DAMAVER (Volkov and Svergun, 2003). The averaged 
envelopes (n = 10 no rejections) smoothed out any differences between the first and 
second large masses and widened the ribbon area and increased the volume of the 
nodule. It is possible that the nodule volume is caused by the hexahistag tail and the 
other domains are within the main body of the envelope.
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Figure 73.3. Averaged model envelope for SAP97 A461. Three orientations of the 3D envelope 
generated from ID scattering data using program GAS BOR and averaged using program 
DAM AVER (n=10).
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7.3.3 SAP97 A461 EOM Rigid Body Modelling
The rigid body modeller, BUNCH was first tested with A461 however, the resultant 
models were not physiologically possible; the PDZ3 domain would often overlap 
with the SH3 domain possibly due to the flexibility in the U4 linker region seen in 
A546. Therefore, EOM modelling was used to create high resolution template 
structures. Initially the EOM used separate GK and SH3 domains but this did not 
work as EOM created many conformers in which both domains were strung apart 
by the Hook linker region. This led to the use of the previously defined SAP97 
546r2 BUNCH model. This structure provided a good model that matched up well 
with the PDS95 crystal structure. Small adjustments to the model were required, the 
hexahistag was removed to match with the A461 sequence and the two helixes that 
contributed to the U4 linker were also removed to allow EOM to appropriately 
model the flexible regions. In addition, the high resolution SAP97 PDZ3 ciystal 
structure that had previously been determined by Cabral et al 1996 was also used 
(1PDR).
The SAP97 A461 EOM frequency distribution (Figure 7.3.4) shows the pool of 
10000 structures spread from 25 to 48 A. Most strikingly however is that two 
distributions of A461 are present, a compact structure spread from 24 to 30 A with 
an average Rg ~28 A that contains 59.6 % of all conformers and a second 
distribution peak 39 to 48 A with an average Rg ~45 A that contains 38.1 % of all 
conformers. This shows that A461 exists in two forms spending over half its time in 
a compact form and the rest elongated. The compact form has an Rg similar to 
A546 that suggests that the PDZ3 domain is very close to the GK-SH3 domains.
212
0.10
0.08-
0.06-
2 0.04 -
0.02-
Figure 73.4. Analysis of SAP97 A461 by EOM. A frequency distribution of the SAP97 A461 
conformers as a function of Rg. The black dashed line shows the distribution of the initial 10000 pool 
conformers and the black line the distribution of the analysed A461 ensemble.
In total, the ensemble generated 13 conformers, of these 8 were compact (Figure 
7.3.5a) and 5 were elongated (Figure 7.3.5b). The compact forms showed PDZ3 
restricted about the SH3 domain with the U4 linker tightly wrapped beside the 
PDZ3 domain. The elongated forms showed the U4 linker region fully extended 
with the PDZ3 domain at the end of the linker.
When the intensities plotted as a function of momentum of transfer (Figure 7.3.6) 
the best fit gave a good fit for the lowest angle but overall showed a poor fit, x~ 
14.3, this was because at the increased scattering levels, between 0.3 and 0.4 A. 
This indicates possible inaccuracies with background subtraction during the initial
213
processing of the scattering. Unfortunately, this can only be remedied at the 
synchrotron using the “Foxtrot” program.
1 E-6
Figure 73.6. Analysis of SAP97 A461 EOM fitting. SAXS intensities plotted as a function of 
momentum of transfer. Dots represent experimental data; solid line is fit obtained from the ensemble 
of 13 conformers
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7.3.5 SAP97 A461 EOM GASBOR Overlay
The SAP97 A461 EOM models using the BUNCH template were superimposed 
over the individual GASBOR envelopes (Figure 7.3.7) as with A546 earlier, the 
averaged GASBOR envelopes were too large for the models. Only the compact 
forms were overlaid as these fit the GASBOR envelopes better.
The compact EOM models found a good fit into an envelope leaving little free 
volume. The small nodule at the ends of the envelopes was not filled. All the 
overlays show that the PDZ3 needs to be tight to the SH3 domain but can move 
about the SH3 domain.
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7.3.6 SAP97 A461 SAXS Analysis Discussion
The structure of the three domains, PDZ3-SH3-GK together has never been solved 
at high or low resolution. The BUNCH modelling failed, indicating a flexible 
model. Using EOM together with the high resolution SAP97 PDZ3 domain and the 
modelled SAP97 SH3-GK domain showed that the SAP97 A461 can exist in two 
conformations a compact form and an elongated form.
The P(r) for A461 showed an elongated tail that gave a much larger Dmax than 
expected this could be due to the elongation of the PDZ3 and U4 linker region.
The EOM also showed that the PDZ3 domain was not fixed in one position when in 
the compact form. It was able to move about the SH3 domain though always in one 
plane as shown when the models were superimposed over the flat GASBOR 
envelopes.
Although the EOM fitting gave a high x2 indicating a poor fit, possibly due to mitial 
background subtraction, this small error in pre processing would not invalidate the 
two conformations that were seen.
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7,4 SAP97 D70 Results
7.4.1 SAP97 A70 Scattering Results
Unlike A546 and A461 the data for SAP97 A70 was not collected through the batch 
method. The protein was passed through a HPLC system and eluant was 
continuously passed through the X-ray beam enabling the scattering data to be 
collected over the whole length of the column run. This allowed the scattering data 
of separate peaks to be collected which is useful when studying complexes or if 
slight degradation had occurred, which was true in this case. Thus the HPLC 
cleaned the sample of any slight impurities. The data from the appropriate peak was 
selected, averaged and the background signal subtracted as before in “Foxtrot” and 
using program PRIMUS. The data was then treated the same as with A546 and 
A461. The scattering data was then further processed using the program GNOM, 
and Draax 150 A and Rg 42.9 A were derived for SAP97 A70 (Figure 7.4.1).
The P(r) distribution shows a very broad peak with peak at about 40 A that indicates 
an oval shape, followed by humps at 80 A and 110 A. This suggests that there is an 
elongated section with two areas of possible spherical volume, possibly 
representing the PDZ1 and 2 domains. The Dniax is quite large, which is expected 
for a protein of this size.
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Figure 7.4.1. Small angle X-ray scattering of SAP97 A70. The averaged scattering data from 5 
mg/ml concentration of SAP97 A70 passed through a HPLC. The lower plot shows the P(r) value 
(regularization parameter) calculated by GNOM and gives the Rg 42.9 A and the Dmax 150 A.
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7.4.2 SAP97 A70 GASBOR and DAMAYER
Models of A70 were created using GASBOR (Figure 7.4.2). They each showed a 
large mass followed by a longer drawn out area that is either straight on or at 90° to 
the larger mass. In many cases lumps protruded from the main body of the 
envelope. The envelopes were then averaged (Figure 7.4.3) using the program 
DAMAYER (Volkov and Svergun, 2003). The averaged envelopes (n = 10 no 
rejections) showed the large mass, smoothed with a long arm like protrusion 90° to 
the larger oval. It is possible that the largest volume holds the SH3-GK domains and 
possibly the PDZ3 domain, the longer arm like envelope possibly holds the 
remaining two PDZ domains and the linker regions.
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Figure 7.4.3. Averaged model envelope for SAP97 A70. Three orientations of the 3D envelope 
generated from ID scattering data using program GAS BOR and averaged using program 
DAM AVER (n=10).
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7.4.3 SAP97 A70 EOM Rigid Body Modelling
As before, the EOM modelling required high resolution template structures. For 
consistency the previously defined SAP97 546r2 BUNCH model that was used to 
model A546 and A461 was used again with the SAP97 PDZ3, (1PDR, Cabral et al 
1996) Ei addition, the recently solved high resolution crystal structure of PDZ1 and 
PDZ2 together (3GSL, Sainlos, Tigaret et al 2011)
The SAP97 A70 EOM frequency distribution (Figure 7.4.4) shows the pool of 
10000 structures spread from 30 to 87 A. Most strikingly, however, is that two 
distributions of A70 are present, a compact structure spread from 30 to 51 A with an 
average Rg ~38 A that contains 58.6 % of all conformers, a second distribution peak 
60 to 87 A with an average Rg ~73 A that contains 35.2 % of all conformers. This 
shows that A70 exists in more than one, a compact form and a fully elongated form. 
There were also intermediate forms in between the compact and elongated form.
To test that this result was real, not just an artefact of the EOM program it was 
repeated four more times (Figure 7.4.5) and an average frequency distribution 
generated. The same distribution was seen for the compact form between -30 and 
51 A.
This shows that A70 is in at least two states with the elongated conformation more 
fluid and dynamic that is probably caused by the flexibility of the linker regions 
which leads to more than one conformation being seen.
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Figure 7.4.4. Analysis of SAP97 A70 by EOM. A frequency distribution of the SAP97 A70 
conformers as a function of Rg. The black dashed line represents the distribution of the initial 10000 
pool conformers and the solid line the distribution of the analysed A70 ensemble.
Figure 7.4.5. Analysis of SAP97 A70 by EOM. Frequency distributions for five SAP97 A70 
confonners as a function of Rg. Black dash line, the distribution of the initial 10000 pool conformers 
and coloured lines shows the individual results for each of the five ensemble distributions.
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In total, the ensemble generated 15 conformers, of these 9 were compact (Figure 
7.4.6a) 5 were elongated that corresponded to the 60 to 87 A distribution peak 
(Figure 7.4.6b). The compact forms showed PDZ3 domain always in close 
proximity to the end of the SH3 domain with the PDZ1 and 2 domains always close 
to each other, due to the short linker between them, but able to move about GK- 
SH3-PDZ3 domains. In the intermediate elongated forms the U4 linker is extended 
moving the PD3 domain away similar to A461 with the PDZ1 and 2 domains in 
close proximity to the PDZ3. The further extended forms show the PDZ1 and 2 
domains not in proximity with the PDZ3 domain.
When the intensities plotted as a function of momentum of transfer (Figure 7.4.7) 
the best fitting conformer gave a good fit, 6. 9.
Figure 7.4.7. Analysis of SAP97 A70 EOM fitting. SAXS intensities plotted as a function of 
momentum of transfer. Dots represent experimental data; solid line is fit obtained from the ensemble 
of 14 conformers.
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7.4.4 SAP97 A70 EOM GASBOR Overlay
When the EOM conformers were superimposed over the GASBOR envelopes no 
conformer gave a good fit with any envelope. It did appear that the larger oval 
sphere would hold the GK- SH3 -PDZ3 domains and then the other PDZ domains 
may fill the arm area of the envelope but the flexibility of the linker regions caused 
this not to happen in this distribution.
7.4.5 SAP97 A70 SAXS Analysis Discussion
The addition of two extra PDZ domains and long unstructured linker regions 
showed an imderstandingly greater change to the shape of the SAP97 A70 than the 
addition of just one PDZ domain. The EOM frequency distributions showed that 
like with the A461 more than one form is possible for the protein.
A70 was compact with the PDZ3 domain close to the SH3 as seen in A461 with the 
PDZ1/2 domains close by or A70 exists in more than one conformation, most likely 
dynamically moving between each conformation. One of these conformations has 
the same compact GK-SH3-PDZ3 core but the PDZ 1/2 move away extending the 
U3 linker between the PDZ2 and PDZ3. This linker region had been previously 
shown to be flexible and dynamic from previous SAXS experiments on the 
PDZ 1/2/3 domains (Goult et al., 2007) A third possible structure sees the PDZ3 
domain move away from the SH3 domain as with A461 but with the PDZ 1/2 in 
close proximity as seen previously (Goult et al., 2007). A final conformation sees 
both the U4 and U3 linker extending to maximum creating a long drawn out
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protein. I describe these different conformations as compact, semi-elongated and 
fully elongated (Figure 7.4.7) and examples of each were seen in the EOM 
frequency distributions (Figure 7.4.5b)
Compact
Semi-elongated
Semi-elongated
Fully-elongated
Figure 7.4.7: Schematic representation of possible SAP97 A70 conformations.
GASBOR was not able to produce envelopes to fit any of the EOM conformers for 
A70 that suggests the program is not suited to building envelopes for large multi 
domain highly flexible proteins. It might be necessary to either find another 
program that can handle the larger flexible proteins or new algorithms may need to 
be written.
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7.5 SAP97 SAXS Conclusion
A range of SAXS experiments have been used to probe the conformation of the 
three SAP97 constructs A546, A461 and A70 each with varying success.
The GASBOR envelope produces a range of configurations or areas not one unique 
solution from the scattering data with the averaged envelope giving the most 
probable structure (Svergun, Petoukhov et al 2001). Here the averaged envelopes 
did not fit any model but fortunately the individual envelopes were able to have 
individual ensemble conformers and BUNCH models superimposed upon them for 
A546 and A461. This was probably due to the individual GASBOR envelopes 
varying so much that the averaged model, created by DAMAVER was not a true 
representative model.
It is also probable that both GASBOR and DAMAVER are just not able to produce 
and average envelopes for large, highly flexible proteins.
The rigid body modelling using BUNCH gave good results for the positioning of 
the GK and SH3 domains for A546 but struggled to predict the more flexible 
regions often pooling many of the amino acids together. The best BUNCH model 
(546r2) did have the flexible regions modelled and did match well with the 
previously solved PSD95 crystal structure of the GK - SH3 domains.
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When the rigid body modeller, EOM, a program that was designed for use with 
more flexible or unstructured proteins (Bernado et ah, 2007) was used on A546 the 
results generated agreed in part with the BUNCH showing that the construct was 
compact in nature but the U4 linker was able to elongate.
With the introduction of the PDZ3 domain in A461 the frequency distributions 
created using template 546r2 GK - SH3 from BUNCH fitted the GASBOR 
envelopes.
The most interesting result from the EOM of A461 was that it existed in more than 
one conformation with a compact form where PDZ3 is present close to the SH3 
domain and an elongated form with the PDZ3 tethered at the end of the U4 linker. 
This was replicated with the EOM of A70 where the PDZ3 domain was seen to be 
either next to the SH3 domain or tethered at the limit of the U4 linker. Interestingly, 
the U3 linker between the PDZ2 and PDZ3 domains also showed this tendency to 
be coiled up or strung out. This suggests that the conformations are dynamic and 
moving between each conformer.
This new evidence of dynamic protein domains is not unheard of. It was recently 
suggested that the long taught mechanism of binding by “Induced fit” may not work 
in every case. Instead “Conformational Selection” might be more relevant. In this 
hypothesis before binding the protein exists in an “ensemble of different 
conformations in dynamic equilibrium” in which the specific binding partner would 
interact with one of the conformations leading to a shift in the equilibrium of the 
whole protein to that conformation (Boehr and Wright, 2008). This new 
Conformational Selection model would fit with the modelling data generated by 
EOM for A461 and A70.
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Another similar binding mechanism that would benefit from a protein with flexible 
linkers is the “Fly-casting mechanism” here the unstructured or unfolded protein 
has a greater capture radius or a greater reach for its binding partners than a 
constrained protein with restricted movement, and this allows the unstructured 
protein to interact weakly at first with its binding partner at long distance and then 
fold back bringing the binding partner closer and binding stronger (Shoemaker et 
ah, 2000). Although this mechanism would utilize some of the dynamics of the 
system in SAP97 each of the PDZ domains has distinct binding partners that bind 
tightly in the first instance. However, if the fly-casting mechanism was adapted 
slightly so that each domain could be “cast-out” to enable them to locate binding 
partners, once bound then the protein could “reel-in” or fold back to a compact 
structure that would enable interactions between binding partners or help to create 
the scaffold. So the mechanism would be more akin to “net-fishing” or “barbed 
fishing” or if the three PDZ domains are taken into account then “multiple line­
fishing” might be more relevant to carry on the mechanistic metaphor.
To prove if either of these mechanisms would be applicable to SAP97 specific 
binding experiments and further measurements would have to be earned.
In 2000, Wu et al proposed a model of SAP97 using computational molecular 
modelling with the available crystal structures at that time. Their data suggested that 
SAP97 was found in a compact structure that allowed intramolecular interactions 
between the N-terminal domain and the GK domain. They suggested that this 
compactness and / or the intramolecular interactions would interfere or block 
certain domain binding sites and that protein interactions might be required to
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change the shape and allow further protein-protein interactions. They went on to 
describe a situation where it would be necessary that some of the domains would 
have to disassociate from the compact structure to interact with other proteins thus 
leading to the formation of many possible conformational states which may help 
SAP97 to act as a scaffold at the synaptic junctions.
The results generated here do back up some of this earlier modelling work. SAP97 
A70 was shown to form both compact conformation and elongated conformations. 
However, no evidence of intramolecular interactions between the N-terminus and 
the GK or SH3 domain were observed. This may be caused by the clipping of the 
SAP97 molecule at A70 where Wu et al 2000 had no deletions or that different 
buffer conditions or binding partners are required.
The SAXS collection processing through a combination of GNOM, GASBOR, 
BUNCH and EOM has given much new experimentally derived information in 
relation to how SAP97 behaves in solution, showing that it is dynamic and can form 
multiple different conformations that may allow SAP97 to regulate the assembly of 
MAGUK complexes at the cell membrane.
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CHAPTER 8
CONCLUSIONS
The work carried out in this thesis has increased the understanding of the individual 
proteins AKAP79 and SAP97 their relationship with each other and their 
interactions with other proteins such as calmodulin and Kir 2.1. The work has also 
thrown up more questions and some interesting results.
AKAP79 has been shown to be a difficult protein to work with. The main 
explanation for this is that AKAP79 is largely unstructured as shown through NMR 
and SECMALLS experiments. The expressed protein was hence susceptible to in­
cell proteolysis. The fact that AKAP79 is unfolded may actually be necessary for its 
function. With no steric hindrances the protein is able to bind and possibly coil 
around its many binding partners or to bind many of the binding partners 
simultaneously.
The use of SUMO as a cleavable fusion protein enabled the purification of the 
AKAP79 M domain. The AKAP79 M domain had previously been shown to bind 
to SAP97 (Colledge et al., 2000). However, no interactions were detected through 
NMR and ITC. This does not dismiss the previous findings, but does indicate that 
the system is far more complicated than first thought and that further work is 
required to solve it. It is possible that intramolecular interactions within SAP97 as 
supported by Wu et al (2000) are required before binding or that another binding 
partner for either SAP97 or AKAP79 is crucial to form a tripartite complex.
AKAP79 was shown to interact with calmodulin, confirming previous studies (Faux 
and Scott, 1997). However, in this work, it was not possible to completely
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determine the high-resolution structure of complex due to complications with its 
NMR spectra. It appears from the NMR data collected that one of two modes of 
binding are most likely; either the lobes of CaM enclose around the peptide or an X- 
shape dimer of CaM binding to two molecules of peptide (a 2:2 complex) occurs. 
SAXS experiments on CaM-peptide complexes would resolve this problem.
If the proposed CaM dimer binding is correct then it suggests that there would be 
two AKAP79 proteins bound in close proximity to act as scaffolds and to localise 
kinases and phosphatases.
Multi-domain SAP97 constructs were created to characterise and investigate any 
interdomain interactions. What was found was rather unexpected. The NMR spectra 
showed that there were little or no interactions between the PDZ3 domain and the 
SH3-GK domains and that there was movement in the PDZ123 domains from A70 
as previously seen (Goult et ah, 2007). The corresponding SAXS data then showed 
that the U3 and U4 linker regions were actually highly mobile that led to the 
formation of several different confonners of A461 and A70. This shows the power 
of the SAXS technique and how it can be used as a good complementary technique 
to NMR. Given the mobility detected by both NMR and SAXS, it is possible to 
predict that it would be difficult for intact SAP97 to be crystallised. The SAXS data 
also enabled differentiation between the different mobile confonners of the SAP97. 
However, one problem with SAXS was encountered; the analysis programs, notably 
GASBOR and DAM AVER were unable to manage the large flexible proteins 
which limited their usefulness for such studies, they also were unable to constrain
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separate domains. This may lead to further research requiring new algorithms to be 
written to handle the data.
The further work earned out investigating CaM and Kir2.1 interactions with SAP97 
confirmed the interactions demonstrated in previous studies by Paarmann et al. 
(2002) and Goult et al. (2007). Here the work went further with the CaM binding 
showing that the extra flexibility in the SH3-GK domains of A546 and A461 
actually hindered the interactions compared to the more stable A70. However, the 
use of fluorescence with dansyl-CaM as the flurophore may not have been the best 
approach as this method gave binding affinities far smaller than previously reported 
that were not physiologically relevant due to the competition for CaM in the cell. A 
recent parallel study in the laboratory using ITC (unpublished data) gave a greater 
binding affinity more comparable to Paarmann et al. (2002) but it also observed a 
similar difference in affinity of CaM for A461 and A546 showing that fluorescence 
observations were real and in this case ITC is a more reliable method to measure the 
interactions.
Low resolution EM on SAP97 showed that two conformations were also present, an 
extended rod (65 %) and ring shaped (35 %) (Nakagawa, Futai et al, 2004). In 
SAP97 A70 the proportion in the extended form is 52 % showing that the removal 
of the N“terminal L27 domain influences the preference in conformation.
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What functional significance the changing conformations of SAP97 from compact 
to elongated will have within the cells is unknown. However, Nakagawa, et al, 
(2004) postulated from that the two isoforms influenced the dynamics and 
recruitment and trafficking of proteins to the AMPER receptors. It is possible that 
A70 in the elongated form is more readily able to bind to target molecules and 
traffic them to the required sites of action such as Kir2.1 to the membrane, while the 
compact form would require further cofactors for binding. Possible extra cofactors 
could be AKAP79 or CaM or a combination of the two.
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CHAPTER 9
FURTHER WORK
Characterising and investigating the interactions between several different proteins 
will always create many more questions that will require more study.
AKAP79 interactions were not ftilly investigated and will require further study; the 
investigation into the binding of AKAP79 M to CaM will require further NMR to 
probe the interaction using the recombinant peptides. However, if there are 
problems with line broadening then it may be necessary to form the complex using 
X-ray crystallography. This method has been shown to work previously with CaM 
binding interactions (Majava and Kursula 2009; de Diego, Kuper et al., 2010). The 
use of SAXS with the bound complex should be able to differentiate betwen a 2:2 
ratio and a 1:1 interactions but mutations to the CaM binding sites may be necessary 
to help identify the exact binding mechanism. It would be interesting once the 
mechanism for CaM binding has been solved to investigate how PKC, that has been 
shown to bind to the same sequence (Klauck et al., 1996) interacts with the peptide. 
Following the successful expression using the pOPIN-S, SUMO fusion vector, 
AKAP79 constructs of the C and N domains could be recloned. The AKAP79 N 
domain contains the three basic regions that interact with the plasma membrane 
(Dell'Acqua et al., 1998) and has been postulated to contain a second site of CaM 
interaction (Carr et al., 1992). These questions could be resolved using the same 
methodology as AKAP79 peptide:CaM binding interactions.
The successful expression of AKAP79 C after recloning into pOPIN-S would allow 
investigations into CaN binding interactions.
AKAP79 FL could be recloned into pOPIN-S and expressed to enable further 
binding studies with CaN and PtdIns(4,5)P2 and PKC could investigated together.
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In their current vectors little more work can be investigated with the large SAP97 
constructs, except for probing binding interactions using SAXS. This would be 
useful to try and show whether the flexibility in the linkers and the different 
conformations formed, help in binding interactions. If, for instance when the PDZs 
are bound to their ligands only the compact, constrained model is formed then this 
would support my “multiple line fishing” analogy of the binding mechanism. 
However, it may be necessary to first redone the SAP97 constructs. Throughout 
this work cleavage of the hexahistag has proved problematic from constructs cloned 
into the pLEICS vector, possibly caused by the flexibility in the constructs 
hindering the Tev protease.
A SAP97 full length construct needs to be constructed to finally answer the 
question of intermolecular interactions between the N-terminus (L27 domain) and 
the SH3-GK domain (Wu et al., 2000). This may pose problems though with the 
L27 domain known to cause dimer formation (Nakagawa et al., 2004).
Further work to investigate the relationship between SAP97 conformation and 
preferential binding will also need to be undertaken.
Much of the work here focused on the biophysical characterisation of the proteins. 
Eventually it would be necessary to take the findings investigate the system in a 
physiological environment. This could then help to evaluate the initial proposed 
model of SAP97-AKAP79-Kir2.1, This would require further binding interactions 
and in cell measurements to investigate the effects on channel activation using 
patch-clamping.
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Appendix 1
Buffer A
Minimal Media, 2M9. pH 7.2 in 990 ml cffl^O then autoclaved.
Reagent Mass (in g)
Na2HP04 12.5
KH2PO4 7.5
Buffer B
Made in 10 ml dH20 and sterile filtered through 0.2 pm syringe filter. 
For labelled media substitute in 13C Glucose of 15N NH4CI
Reagent Mass (in g)
glucose 4
NH4CI 1
MgS04.7H20 0.24
CaCl2.2H20 0.02
Thiamin HC1 0.01
Buffer A and Buffer B are mixed and the correct antibiotic added for the 
expression. Buffer B can be stored at -20°C and Buffer A at room temp once 
autoclaved
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Commonly Used Buffers
His Buffer_________ _______ pH 8
Reagent
Mol
Wt
mass for
1 L
1 M NaCI 58.44 58.44
0.05 M Iris HCI 157.6 7.88
0.00 154.2
2 M DTT 2 0.31
10 % glycerol - 100 ml
His Elution Buffer pH 8
Mol mass for
Reagent Wt 1 L
1 M NaCI 58.44 58.44
0.05 M Tris HCI 157.6 7.88
Imidazol
1 M e 68.08 68.080
0.00 154.2
2 M DTT 2 0.31
10 % glycerol - 100 ml
PBS* 10 pH 7.3
Mol mass for
Reagent Wt 1 L
1.4 M NaCI 58.44 81.82
0.02
7 M KCI 74.57 2.01
Na2HPO 141.9
0.1 M 4 6 14.20
0.01 136.0
8 M kh2po4 9 2.45
Anion Exchange buffer A pH 8
Mol mass for
Reagent Wt 1 L
0.02 M KCI 74.57 1.49
0.02 M Tris HCI 157.6 3.15
0.00 372.2
1 M EDTA 4 0.372
0.00
1 M B me 78.13 0.078
Anion Exchange buffer B pH 8
Mol mass for
Reagent Wt 1 L
1 M KCI 74.57 74.57
0.02 M Tris HCI 157.6 3.15
0.00 372.2
1 M EDTA 4 0.372
0.00
1 M B me 78.13 0.078
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Appendix 2 AKAP79 construct sequencing
AKAP FL sequencing 1-427
MKHHHHHHPMSDYDIPTTENLYFQGAMETTI 
SEIHVENKDEKRSAEGSPGAERQKEKASMLCF 
KRRKKAAKALKPKAGSEAADV ARKCPQEAG 
ASDQPEPTRGAWASLKRLVTRRKRSESSKQQ 
KPLEGEMQPAINAEDADLSKKKAKSRLKIPCI 
KFPRGPKRSNHSKIIEDSDCSIKVQXEAEILDI 
QTQTPLNDQATKAKSTQDLSEGISQKDGDEV 
CESNVSNSITSGEKVISVELGLDNGHSAIQTGT 
LILEEIETIKEKQDVQPQQASPLETSETDHQQP 
VLSDYPPLPAIPDQQIVEEASNSTLESAPNGKD 
YESTEIVAEETKPKDTELSQESDFKENGITEEK 
SKSEESKRMEPIAIIITDTEISEFDVTKSKNVPK 
QFLISAENEQVGVFANDNGFEDRTSEQYETLL 
IETASSLVKNAIQLSIEQLYNEMASDDNKINN 
LLQ
Sequence histag and Tev cleavage site shown in Red
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CLUSTAL 2.0.12 multiple sequence alignment
100.0% identity in 274 residues overlap; Score: 1385.0; Gap frequency: 0.0%
GenBank: M90359.1
AKAP79 FL, 1 METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVAR
AKAP1FWD, 1 METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVAR
********** **^*^^rV^^^*^rfc***Ve-A-**9f*'*-**St'A‘,A;***,*,*'*-*-Ar**-*‘3|ir-*-**T>rT<r-fr-fr***
AKAP79 FL, 1 KCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
AKAP1FWD, 61 KCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
-k'k'k'k'k'k'k'k'k'k'k'k'k'k-k'k'k'k'k'k'itie'k'k'kie'k'iric'k-kie-kir-kic-k-kir-k-k-k-kicic-k'k-k'k-kir-k-k-k-k-k'ktk'k'fe
AKAP79 FL, 121 AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQTPLNDQATKAKSTQ
AKAP1FWD, 121 AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQTPLNDQATKAKSTQ
************ •k'k'kik'kit'k'kl'iK'kie'k’biT'kiflii'ir'k'kitiiiic-k-klrlc-k-k-k-k-k-klck-k-k-k-k-k-kic-k-k-k'k
AKAP79 FL, 181 DLSEGISQKDGDEVCESNVSNSITSGEKVISVELGLDNGHSAIQTGTLILEEIETIKEKQ
AKAP1FWD, 181 DLSEGISQKDGDEVCESEVSNSITSGEKVISVELGLDNGHSAIQTGTLILEEIETIKEKQ
************************* * * *-Ar**'^**'Ar*'Ar'5lf********-*‘-*19r**'A:-Ar*9r**Tt-Ar-**
AICAP7 9 FL, 241 DVQPQQASPLETSETDHQQPVLS DVPPLPA1PDQ
AKAP1FWD, 241 DVQPQQAS PLETSETDHQQPVLS DVPPLPAIPDQ
********■****■*:****■*****************
99.7% identity in 288 residues overlap; Score: 1423.0; Gap frequency: 0.0%
AKAP79 FL, 140 NHSKIIEDSDCSIKVQEEAEILDIQTQTPLNDQATKAKSTQDLSEGISQKDGDEVCESNV
AKAPlrev, 1 NHSKIIEDSDCSIKVQXEAEILDIQTQTPLNDQATKAKSTQDLSEGISQKDGDEVCESNV
**************** *******************************************
AKAP79 FL, 200 SNSITSGEKVISVELGLDNGHSAIQTGTLILEEIETIKEKQDVQPQQASPLETSETDHQQ
AKAPlrev, 61 SNSITSGEKVISVELGLDNGHSAIQTGTLILEEIETIKEKQDVQPQQASPLETSETDHQQ
************************************************************
AKAP79 FL, 260 PVLSDVPPLPAIPDQQIVEEASNSTLESAPNGKDYESTEIVAEETKPKDTELSQESDFKE
AKAPlrev, 121 PVLSDVPPLPAIPDQQIVEEASNSTLESAPNGKDYESTEIVAEETKPKDTELSQESDFKE
************************************************************
AKAP79 FL, 320 NGITEEKSKSEESKRMEPIAIIITDTEISEFDVTKSKNVPKQFLISAENEQVGVFANDNG
AKAPlrev, 181 NGITEEKSKSEESKRMEPIAI11TDTEIS EFDVTKSKHVPKQFLISAENEQVGVFANDNG
************************************************************
AKAP79 FL, 380 FEDRTSEQYETLLIETASSLVKNAIQLSIEQLVNEMASDDNKINNLLQ
AKAPlrev, 241 FEDRTSEQYETLLIETASSLVKNAIQLSIEQLVNEMASDDNKINNLLQ
************************************************
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AKAP M SUMO (152-321)
MGSSHHHHHH GSDSEVNQEA KPEVKPEVKP ETH1NLKVSD GSSEIFFKIK 
KTTPLRRLME AFAKRQGKEM DSLRFLYDGI RIQADQTPED LDMEDNDIIE 
AHREQIGG IKVQEEAEILD IQTQTPLNDQ ATKAKSTQDL SEGISQKDGD 
EVCESNVSNS ITSGEKVISV ELGLDNGHSA IQTGTLILEE IETIKEKQDV 
QPQQASPLET SETDHQQPVL SDVPPLPAIP DQQIVEEASN STLESAPNGK 
DYESTEIVAE ETKPKDTELS QESDFKENG
Sequence hi stag, SUMO fusion and SUMO protease cleavage site shown in green 
Theoretical pI/Mw: 4.52 / 30784.70
Cleaved
IKVQEEAEILD IQTQTPLNDQ ATKAKSTQDL SEGISQKDGD 
EVCESNVSNS ITSGEKVISV ELGLDNGHSA IQTGTLILEE IETIKEKQDV 
QPQQASPLET SETDHQQPVL SDVPPLPAIP DQQIVEEASN STLESAPNGK 
DYESTEIVAE ETKPKDTELS QESDFKENG
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CLUSTAL 2.0.12 multiple sequence alignment
AKAP79M Template MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60 
AKAP79M Sequence MGSSHXHHHHGSDSEWQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
it "k "k "k 'k ‘k'k'k’k'kk'k’k'kk^k'k'kkk'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k
Template AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGIKVQEEAEILDI 120
Sequence AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGIKVQEEAEILDI 120
'k'k'k'k'k'k'k'k-k'k-kk'kifkick'kk'k'k'k'kit-k'kkK'k'kifk^k'k-kkrk'k'k-k'k'kk'kk'k-k'k-k'kk-k'k-kk'kk-k-k
Template QTQTPLNDQATKAKSTQDLSEGISQKDGDEVCE SNVSNSITS GEKVISVELGLDNGHSAI 180
Sequence QTQTPLNDQATKAKSTQDLSEGISQKDGDEVCESNVSNSITSGEKVISVELGLDNGHSAI 180
********************************* ******************************
Template QTGTLILEEIETIKEKQDVQPQQASPLETSETDHQQPVLSDVPPLPAIPDQQIVEEASNS 240
Sequence QTGTLILEEIETIKEKQDVQPQQASPLETSETDHQQPVLSDVPPLPAIPDQQIVEEASNS 240
************************************************************
Template TLESAPNGKDYESTEIVAEETKPKDTELSQESDFKENG 278
Sequence TLESAPNGKDYESTEIVAEETKPKDTELSQESDFKENG 278
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AKAP N pETM-11 (1-167)
MKHHHHHHPMSDYDIPTTENLYFQGAMETTISEIHVE
NKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKAL
KPKAGSEAADVARKCPQEAGASDQPEPTRGAWASLK
RLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAE
ILDIQTQT
Sequence histag and Tev cleavage site shown in Red
CLUSTAL 2.0.12 multiple sequence alignment
100.0% identity in 167 residues overlap; Score: 846.0; Gap frequency: 0.0%
AKAP2, 1 METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVAR
AKAP2fwd, 1 METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVAR
************************************************************
AKAP2, 61 KCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
AKAP2fwd, 61 KCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
•k'k'k'k'k'k'k'k'k’kir'kick’k'kir’k'k’k'k it ■k’kmkmkmkmk’k'kmk'k‘kmk,k,kmkicmkmk1cick'kmkmkmkmk’kmkit’kiric'kmkmk'klT’k
AKAP2, 121 AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQT
AKAP2fwd, 121 AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQT
mki(mk'kmk‘k'kii;mk'k‘k‘k,k‘k'k'k'k‘k'k'k'k'k'k'k'k,kit'k'k'k‘k'k'k'k'k'k’k'k'k'k‘k'k‘k'kickmk
100.0% identity in 167 residues overlap; Score: 846.0; Gap frequency: 0.0%
AKAP2, 1 METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVAR
AKAP2rev, 1 METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVAR
************************************************************
AKAP2, 61 KCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
AKAP2rev, 61 KCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKK
'kii'kii'kit'k'kifkitit'k'kit'ft-kit'X'k'kit'k'k-kit'kifX'kic'kie'k'k'k'k'k'k'k'k'kit'k'&'kItitifk'kit'k'k'k’k-kit**
AKAP2, 121 AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQT
AKAP2rev, 121 AKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQT
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AKAP79 18-52
MGSSHHHHHH GSDSEVNQEA KPEVKPEVKP ETHINLKVSD 
GSSEIFFKIK KTTPLRRLME AF A KRQGKEM DSLRFLYDGI 
RIQADQTPED LDMEDNDIIE AHREQIGG AEGSPGAERQK 
EKASMLCFKRRKKAAKALKPKAG
Sequence histag, SUMO fusion and SUMO protease cleavage site shown in green
Sample 18-52 Fwd (1)
Template MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
Sequence MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
************************************************************
Template AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAEGSPGAERQKE 120
Sequence AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAEGSPGAERQKE 120
************************************************************
Template KASMLCFKRRKKAAKALKPKAG 142
Sequence KASMLCFKRRKKAAKALKPKAG 142
**********************
Sample 18-52 Rev (1)
Template MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
Sequence MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
************************************************************
Template AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAEGSPGAERQKE 120
Sequence AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAEGSPGAERQKE 120
•k'k'k'k'k'k'k •k'k'k'k'k'k'k'k'kit'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'Jt'k'k'k'k  it'k'k'k'k'k’kic'k'k'k'k'k'k'k'&'to'k'k
Template KASMLCFKRRKKAAKALKPKAG 142
Sequence KASMLCFKRRKKAAKALKPKAG 142
•k'km$c$r’kmic’km}cjc‘k-,kmic'kmk'k‘k,krk'km'ir'k
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AKAP79 i§-6i
MGSSHHHHHH GSDSEVNQEA KPEVKPEVKP ETHINLKVSD 
GSSE1FFKIK KTTPLRRLME AFAKRQGKEM DSLRFLYDGI 
RIQADQTPED LDMEDNDIIE AHREQIGG AEGSPGAERQK 
EKASMLCFKRRKKAAKALKPKAGSEAADVAR 
K
Sequence histag, SUMO fusion and SUMO protease cleavage site shown in green
Template MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
Sequence MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
’k'k'k'k'k-k’k'k'k'k'k-k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k it'k'k'k
Template AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAEGSPGAERQKE 120
Sequence AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAEGSPGAERQKE 120
■k-k'k-kic-k'k-k-kic'k-kic-kii-k-kieit-k-kic'k'k'k'k'k'kic'kitii-k'kit-k'k'k'kit-k'kicir'kir-k'k-k'icirit-k-kii'fr'kie-k-k
Template KASMLCFKRRKKAAKALKPKAGSEAADVARK 151
Sequence KASMLCFKRRKKAAKALKPKAGSEAADVARK 151
•kiek'k'kirit'k'k'k'k'kii'k'kiricif'kit'k'k'k'kic'k'k-k'kitii;
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AKAP79 24-61
MGSSHHHHHH GSDSEVNQEA KPEVKPEVKP ETHINLKVSD 
GSSEIFFKIK KTTPLRRLME AFAKRQGKEM DSLRFLYDGI 
RIQADQTPED LDMEDNDIIE AHREQ1GG AERQKEKASM 
LCFKRRKKAAKALKPKAGSEAADVARK
Template MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
Sequence MGSSHHHHHHGSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLME 60
Template AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAERQKEKASMLC 120
Sequence AFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGGAERQKEKASMLC 120
★ ★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★It***
Template FKRRKKAAKALKPKAGSEAADVARK 145
Sequence FKRRKKAAKALKPKAGSEAADVARK 145
★ ★★★★★★★★★★★★★★★★★★★★★★★•A:
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Appendix 3 SAP97 sequences
SAP97 A70
MHHHHHHSSGVDLGTENLYFOS MSKQ CEPVQPGNPW ESGSLSSAAV 
TSESLPGGLS PPVEKYRYQD EEVLPSERIS PQVPNEVLGP ELVHVSEKSL 
SEIENVHGFV SHSHISPIKA NPPPVLVNTD SLETPTYVNG TDADYEYEEI 
TLERGNSGLG FSIAGGTDNP HIGDDSSIFI TKIITGGAAA QDGRLRVNDC 
ILRVNEADVR DVTHSKAVEA LKEAGSIVRL YYKRRKPASE KIMEIKLIKG 
PKGLGFSIAG GVGNQHBPGD NSIYVTKHE GGAAHKDGKL QIGDKLLAVN 
SVCLEEVTHE EAVTALKNTS DFVYLKVAKP TSMYINDGYA PPDITNSSSQ 
SVDNHVSPSS YLGQTPASPA RYSPISKAVL GDDEITREPR KWLHRGSTG 
LGFNIVGGED GEGIFISFIL AGGPADLSGE LRKGDRIISV NSVDLRAASH 
EQAAAALKNA GQAVTIVAQY RPEEYSRFEA KIHDLREQMM NSSVSSGSGS 
LRTSQKRSLY VRALFDYDKT KDSGLPSQGL NFKFGDILHV ENASDDEWWQ 
ARQVTPDGES DEVGVIPSKR RVEKKERARL KTVKFNSKTR GDKGSFNDKR 
KKNLFSRKFP FYKNKDQSEQ ETSDADQHVT SNASDSESSY RGQEEYYLSY 
EPVNQQEVNY TRPVIILGPM KDRVNDDLIS EFPDKFGSCV PHTTRPKRDY 
EVDGRDYHFV TSREQMEKDI QEHKFIEAGQ YNNHLYGTSV QSVRAVAEKG 
KHCILDVSGN AIKRLQIAQL YPISIFIKPK SMEN1MEMNK RLTDEQARKT 
FERAVRLEQE FTEHFTAIVQ GDTLEDIYNQ VKQHEEQSG PYIWVPAKEK L 
Number of amino acids: 847
Molecular weight: 93874.9 
Theoretical pi: 5,84
261
SAP97 A461
MHHHHHHSSGVDLGTENLYFOSMS TREP RKVVLHRGST GLGFNIVGGE 
DGEGIFISFI LAGGPADLSG ELRKGDRIIS VNSVDLRAAS HEQAAAALKN 
AGQAVTIVAQ YRPEEYSRFE AKIHDLREQM MNSSVSSGSG SLRTSQKRSL 
YVRALFDYDK TKDSGLPSQG LNFKFGDILH VINASDDEWW QARQVTPDGE 
SDEVGVIPSK RRVEKKERAR LKTVKFNSKT RGDKGSFNDK RKKNLFSRKF 
PFYKNKDQSE QETSDADQHV TSNASDSESS YRGQEEYVLS YEPVNQQEVN 
YTRPVIILGP MKDRVNDDLI SEFPDKFGSC VPHTTRPKRD YEVDGRDYHF 
VTSREQMEKD IQEHKFIEAG QYNNHLYGTS VQSVRAVAEK GKHCILDVSG 
NAIKRLQIAQ LYPISIFIKP KSMENMEMN KRLTDEQARK TFERAVRLEQ 
EFTEHFTAIV QGDTLEDIYN QVKQIIEEQS GPYIWVPAKE KL 
Number of amino acids: 490
Molecular weight: 55760.3 
Theoretical pi: 6.65
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SAP97 A546
MHHHHHHSSGVDLGTENLYFQSMS RPEE YSRFEAKIHD LREQMMNSSV 
SSGSGSLRTS QKRSLYVRAL FDYDKTKDSG LPSQGLNFKF GDILHVINAS
DDEWWQARQV TPDGESDEVG VIPSKRRVEK KERARLKTVK FNSKTRGDKG 
SFNDKRKKNL FSRKFPFYKN KDQSEQETSD ADQHVTSNAS DSESSYRGQE 
EYVLSYEPVN QQEVNYTRPV IILGPMKDRV NDDLISEFPD KFGSCVPHTT
RPKRDYEVDG RDYHFVTSRE QMEKDIQEHK FffiAGQYNNH LYGTSVQSVR
AVAEKGKHCI LDVSGNAIKR LQIAQLYPIS IFIKPKSMEN LMEMNKRLTD
EQARKTFERA VRLEQEFTEH FTAIVQGDTL EDFYNQVKQI EBEQSGPYIW
VPAKEKL
Number of amino acids: 405 
Molecular weight: 46962.3 
Theoretical pi: 6.59
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Appendix 4 NMR Chemical Shift differences
Chemical Shift Differences for CaM interaction with AKAP79 peptide
Residue
Chemical
Shift Residue
Chemical
Shift Residue
Chemical
Shift Residue
Chemical
Shift
1 0 38Ser 0 75Lys 0.03829 112Leu 0
2 0 39Leu 0.01616 76Met 0 113Gly 0
3 0 40G!y 0 77Lys 0 114Glu 0
4Leu 0.02345 41Gln 0.07516 78Asp 0.06807 115Lys 0.17265
5Thr 0.07206 42Asn 0.08228 79Thr 0.08438 116Leu 0.06364
6Glu 0.02007 43 0 80Asp 0.09806 117Thr 0.04962
7Glu 0.04273 44Thr 0.06165 81Ser 0.18404 118 Asp 0
SGIn 0 45Glu 0.02116 82Glu 0.01644 119Glu 0.07164
9lle 0 46Ala 0.00867 83Glu 0.04902 120Glu 0
lOAIa 0.03363 47Glu 0 84Glu 0 121Val 0.16507
HGIu 0 48Leu 0.07928 85ile 0.06956 122Asp 0.0881
12Phe 0.05893 49Gln 0.16661 86Arg 0.16984 123Glu 0
IBLys 0.06396 50Asp 0.06248 87Glu 0 124Met 0
14Glu 0 51Met 0.05099 88Ala 0.06963 125lle 0
15Ala 0.06358 52lle 0.06396 89Phe 0 126Arg 0
16Phe 0.08739 53Asn 0.18431 90Arg 0.11336 127Glu 0.12096
17Ser 0.15299 54Glu 0 91Val 0.15003 128Ala 0.17821
ISLeu 0.13384 55Val 0.02525 92Phe 0.04875 129Asp 0
19PheH 0 56Asp 0 93Asp 0.1339 130lle 0.17263
20Asp 0 57Ala 0.34856 94Lys 0.14169 131Asp 0.04179
21Lys 0.00211 58Asp 0.10384 95Asp 0.06493 132Gly 0
22Asp 0 59Gly 0 96Gly 0.0209 133Asp 0.0358
23Gly 0.02302 60Asn 0 97Asn 0 134Gly 0.10089
24Asp 0.09671 61Giy 0.00361 98GlyH 0.05207 135Gln 0.0339
25Gly 0.07223 62Thr 0.09069 99Tyr 0.11586 136Val 0.01807
26Thr 0.12226 63Ile 0.16784 lOOIIe 0.00526 137Asn 0.11227
27lle 0.11134 64Asp 0.08877 lOlSer 0.00328 138Tyr 0
28Thr 0.05349 65Phe 0.08931 102 Ala 0.0588 139Glu 0
29Thr 0.09053 66 0 103Ala 0 140Glu 0.06724
30Lys 0.05843 67Glu 0 104Glu 0 141Phe 0
31Glu 0.11066 68Phe 0 105Leu 0.1467 142 Val 0.13213
3 2 Leu 0.18341 69Leu 0 106Arg 0.17096 143Gln 0
33Gly 0.0899 70Thr 0 107 0 144 Met 0
34Thr 0 71Met 0 108 Val 0 145 Met 0.12216
35Val 0 72Met 0.20738 109 Met 0.21421 146 0
36Met 0 73Ala 0 llOThr 0.05617 147 Ala 0.34112
37Arg 0 74Arg 0 111 0 148 Lys 0.25846
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Chemical Shift Differences for AKAP79 M and SAP97 A461 interaction
Residue ShiftDifference Residue
Shift
Difference Residue
Shift
Difference
3V 0.01425 60S 0.00429 1251 0.00883
4Q 0.01562 62E 0.00541 126V 0.01081
5E 0.00875 64G 0.00411 128E 0.01028
7A 0.01117 65L 0.00748 129A 0.00967
8E 0.00689 67N 0.00890 130S 0.00618
91 0.00949 68G 0.01111 132S 0.00505
10L 0.00190 70S 0.00142 1331 0.00000
121 0.00000 73Q 0.00146 134L 0.00696
13Q 0.00593 75G 0.00497 136S 0.01043
14T 0.00524 76T 0.00753 137A 0.00577
15Q 0.07360 111 0.01081 139N 0.00801
16T 0.00147 781 0.00000 140G 0.00618
18L 0.00918 79L 0.00898 141K 0.00000
20D 0.00000 84T 0.01039 142D 0.00000
21Q 0.00000 851 0.00819 143Y 0.00855
22A 0.00275 91V 0.00788 144E 0.00000
231 0.00632 940. 0.00270 145S 0.00000
24K 0.00318 96A 0.00918 1461 0.00000
25A 0.00268 97S 0.00054 147E 0.00331
26K 0.01914 99L 0.00774 150 A 0.00753
27S 0.05382 100 E 0.00000 151E 0.07664
281 0.00515 101T 0.00758 152E 0.01040
31L 0.00684 102S 0.00309 154K 0.01025
34G 0.00000 104T 0.00000 1581 0.00479
351 0.00151 106H 0.04710 159E 0.05966
36S 0.00250 107Q 0.00000 160L 0.03091
38K 0.00618 1080 0.02313 160L 0.00000
40G 0.01486 110 V 0.02509 161S 0.06151
41D 0.00000 1111 0.00830 163E 0.00808
521 0.00132 112S 0.00754 166F 0.01005
53T 0.00238 114 V 0.01100 167K 0.01138
54S 0.00337 117L 0.00920 169N 0.00751
55G 0.00443 119 A 0.00460 170G 0.00275
56E 0.01407 122D 0.00275
591 0.01050 123Q 0.00000
265
Appendix 5 Mass spectrometry
SAP97 GK
GK29-Sep-200913:13:59
20090928 MT GK Lock 155 (5.427) Cn (Cen,5, 80.00, Ht); Sm (SG, 3x3.00); Ml (Ev-458389,lt9] (Gs,0.750,400:3000,1.00,L33.R33); Sm (SG, 3x3.
23512.260 3.18e3
3182 1100
23543.605
23575.90823484.656
22672.094 24418.908
160 25255.90821769.545
86
26868.56420154.145
71
23640.494 28215.55922731.252
22575.037 25861.959
o WB 
20000 21000 22000 23000 24000 25000 26000 27000 28000
AKAP79 M
M 29-Sep-200913.33:16
20090928 MT M Lock 156 (5.462) Cn (Cen,5. 80.00, Ht); Sm (SG, 3x3.00); M1 [Ev-291405,lt7] (Gs.0.750,629:2056,1.00,L33,R33); Sm (SG, 3x3.0' 
inn 30654.445 1.51e3
IW1 1513 “I
30689.129
30724.740
255
30040.87325419.939 30834.799 32565.688
163 92 35035.91824522.922 36786.250 38126.656 39405.35527500.668 29640.586 
83 130
24000 26000 28000 30000 32000 34000 36000
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SAP97 NPDZ1
N129-Sep-200915:46:24
20090928 MT N1 Lock 165 (5.777) Cn (Cen,5. 80.00, H(): Sm (SG, 3x3.00); Ml [Ev-112002.1129] (Gs,0.750,697:1794,1.00,L33.R33); Sm (SG, 3x3
1nn 12602.079 1.44e4
14398 H
11380.055
15173.586
16318.196
10592.06311053.448
15615.346:194514934.130
10500 11000 11500 12000 12500 13000 13500 14000 14500 15000 15500 16000 16500
SAP97 PDZ 2
PDZ229-Sep-200916:08:07
20090928 MT PDZ2 Lock 143 (5.007) Sm (SG. 3x3.00): Ml [Ev0.lt35] (Gs,0.750.400:3000.1.00,L33.R33): Sm (SG. 3x3.00); Sb (19.1.00 ); Cm (14 
100 10175.000 1.83e5
183186
■ 3s?
10207.000
56109
0-’—~—- 
7000 8000 9000
10220.000
21357
10158.0001 10358,001:11422 
6916 k
10000 11000 12000 13000
-u—‘  ------------- - ■ ■—y mass
14000 15000 16000
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AKAP79 18-61
985 5
Mil 10DT (18.825) TOrr/SCS-*-
100 ^597.1 3.06c4
4563.5
4682 1
4179.3 
4-70 6
4-77.9
4174.:
4455 1
444' 0
4>‘4:-! K
4242 3
4297.1
4313.' 4439.4
I
4313 8
4200 4300
Crs&S 4
4456 4
44G3.6
44:)3 3 
45793..
46ti9.3
•'538.7
4465.3
4636.2
4508 3
48l'».8
4K1tt.r>
(4G'8.9
4746.3
4746.9
(4721.4
1
4*552 1 49345.
4 S44.54360.1
4863.1
4460 4bJJ
HUir
4600 4700
47G1.3
4&no
49302
4500
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AKAP19-61 cleaved
liquid sample digest
UTliisarrple 94 (2S95) Sb {2.10,00}; Srr. (SS. 2x3 00). Err (SS 2x3 03); Sit {SG, 2x303); Cm (1:106) TOP LDr
103 2584 2 56
%
57 Tt
low 1200 1400 1000 1800 2000
2672 82823 5 35498
2457.9
2319 4
2200 2400 2000
mt
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